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The C-terminal tail (CTT) of HIV gp41 has been traditionally viewed as a cytoplasmic 
domain. Genetic studies demonstrating functional interactions between the CTT and 
various intracellular partners have implicitly reinforced this view. However, antibody 
neutralization data and biochemical studies have suggested that the CTT is, or can be, 
externally localized under certain condition. Additionally, other studies have 
demonstrated that the CTT is dispensable for in vitro virus replication. After nearly three 
decades of HIV research, the function and structure of the CTT remain elusive. 
Our goals, then, were twofold: (i) to determine the overall conservation of the 
CTT in an attempt to provide an understanding of the functional and structural relevance 
of the CTT; and, (ii) to provide an experimental topological map of the CTT in an 
attempt to understand and align observed CTT topology(ies) with the functional 
necessity of a cytoplasmic CTT. We believe that we made significant contributions to 
the understanding of CTT topology and its relationship to current published functional 
studies. 
The initial studies demonstrated that the CTT sequence is conserved at a level 
that is intermediate between the highly variable gp120 region and the relatively 
conserved gp41 ectodomain. Additionally, physicochemical and structural properties of 
CTT sequences were found to be conserved in spite of the relatively high sequence 
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variability. These studies demonstrated for the first time that the CTT sequence, while 
highly variable, contains highly conserved structural and chemical properties that 
suggest a functional requirement for the CTT. 
Topology studies of the CTT indicated that the topology of the CTT can be 
distinct between the surface of Env-expressing cells and viral particles. Additionally, 
dynamic rearrangement of the CTT was observed as a function of antibody 
neutralization. These findings prompted a theoretical study of gp41 CTT predicted 
topology and the proposal of a topological model that we believe is consistent with all 
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1.0  INTRODUCTION TO THE HUMAN IMMUNODEFICIENCY VIRUS AND 
PRINCIPLES REGARDING THE GENERATION OF MEMBRANE PROTEIN 
TOPOLOGY 
1.1 HUMAN IMMUNODEFICIENCY VIRUS 
The human immunodeficiency virus (HIV) is the causative agent of AIDS. HIV infection 
of the human population has led to a world-wide AIDS epidemic that has recently 
passed 30 years since its recognition as a distinct disease, and 27 years since the 
identification of the responsible virus (Barré-Sinoussi et al., 1983; Gallo et al., 1984). In 
the three decades of the epidemic, more than 25 million people have died as a result of 
HIV infection, and an estimated 40 million people are currently infected (UNAIDS Global 
Report 2010). In 2009, the last year for which data has been reported, 2.6 million (2.3 - 
2.8 million) new infections were reported, with 1.8 million (1.6 - 2.1 million) deaths.  
These numbers represent 8% and 21% decreases, respectively, from the incidence and 
mortality data reported in 2004. While the epidemic is truly global in nature, its weight is 
borne predominantly by the developing world, in particular sub-Saharan Africa, with 
69% of new infections and 72% of deaths attributable to AIDS or AIDS related diseases 
(UNAIDS Global Report 2010). A comparison of land area maps adjusted for population 
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Figure 1. World-wide HIV prevalence and AIDS deaths 
World maps with land area adjusted for total population (top), HIV 
prevalence (middle), and AIDS deaths (bottom). Maps used by 
permission of WorldMapper.org under a Creative Commons 
License. 
 3 
and HIV prevalence and deaths demonstrate this point more clearly than any words 
(Figure 1). Of concern epidemiologically is that the potential impact of the epidemic has 
only recently been considered in China, where poor reporting and governmental 
obfuscation likely have led to underestimation of the number and extent of infections 
(Beck, 2004). However, notwithstanding the geographical and cultural borders 
separating the most-affected from the least-affected countries, HIV infection and AIDS 
must be considered among the most important, and devastating, infectious epidemics 
humanity has encountered. 
1.1.1 Viral genome 
HIV is a member of the Retroviridae family, and belongs to the Lentiviridae genus (lenti-
: derived from Latin, meaning slow). As a retrovirus, RNA is the genetic material for HIV, 
and each virion contains two positive strand copies of the viral genome containing a 5' 
cap and a 3' poly-A tail (Luciw et al., 2002). As such, the viral genome is not infectious. 
The genome organization of HIV is shown in Figure 2. As with all retroviruses, the HIV 
genome contains the three primary structural and enzyme-coding genes, gag 
(structure), pol (enzyme), and env (structure), but also encodes for six accessory genes 
(vif, vpr, vpu, tat, rev, and nef) that determine the replicative and pathogenic potential, 
which tend to vary by the genetic subtypes (described below) (Levy, 2009). gag 
encodes the major structural proteins matrix/p17, capsid/p24, nucleocapsid/p7, and p6, 
in addition to minor proteins p1 and p2. The pol gene encodes the viral enzymes 
protease (PR), reverse transcriptase (RT), and integrase (IN). env predominantly codes 
 4 
 
Figure 2. HIV genome organization 
HIV genes and gene products are organized relative to their genomic nucleotide position. 
 5 
for the viral envelope (Env) glycoprotein, but also contains coding sequences for the 
accessory proteins Vpu, Tat, and Rev. The coding sequence for Vif overlaps with the 3' 
end of pol. Of the accessory proteins, only Vpr and Nef utilize coding regions solely 
outside the major gag, pol, and env genes. 
 HIV is divided into phylogenetically distinct groups based on sequence 
differences in the env gene (Korber et al., 2001). The three main groups are M (for 
“main”), N (for “non-M and non-O”), and O (for “other”). Most circulating viruses and the 
vast majority of clinical isolates derive from group M. Group M is further divided into 
additional phylogenetically distinct groups, called clades (designated A, B, C, D, F, G, 
H, J, and K), that display distinct geographical distributions. Viruses with recombinant 
Env, likely resulting from superinfection, are also among the circulating strains and 
further increase the genetic diversity of Env. 
1.1.2 Virion morphology and viral protein functions 
Morphologically, HIV is an irregular, roughly spherical virus with a characteristic 
electron-dense conical core surrounded by a lipid envelope that is derived from the host 
cell during the budding process (Luciw et al., 2002). The virion lipid content is distinct 
from the overall lipid content of the parental cell, however, and is suggestive of budding 
from cholesterol- and sphingomyelin-enriched membrane microdomains (Brügger et al., 
2006). A schematic of the virion detailing the location and identity of viral proteins in the 
mature virion is shown in Figure 3. 
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Figure 3. HIV virion structure 
1.1.3 Gag proteins 
gag is translated as the Gag polyprotein, Pr55Gag, that is subsequently cleaved to yield 
the individual Gag domains (Luciw et al., 2002). Pr55Gag is trafficked to the cellular 
plasma membrane by interactions of the matrix (MA) domain with the lipid bilayer. MA 
contains an N-terminal myristic acid as well as a basic patch near the membrane-
proximal side of the folded domain that keeps the protein localized to the membrane 
(Hill et al., 1996; Massiah et al., 1994; Parent et al., 1994). MA also functions to direct 
the incorporation of Env into the budding virion, which will be considered in more detail 
below. The capsid domain (CA) participates in Gag-Gag interactions during virion 
Schematic representation of a mature HIV virion detailing the localization of viral proteins and the 
approximate virion structure. The representation is not to scale. Virion schematic courtesy of Jodi 
Craigo, Ph.D. 
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assembly (Byeon et al., 2009; Pornillos et al., 2009) and is the structural component of 
the conical viral capsid in the mature virion (Luciw et al., 2002). Nucleocapsid (NC) 
facilitates the binding, and thus incorporation, of the viral genomic RNA into the budding 
virion, and also contributes to Gag-Gag interactions (Bieniasz, 2006; Demirov and 
Freed, 2004; Hurley et al., 2010; Morita and Sundquist, 2004). Finally, p6, through its 
late domain, recruits (i.e. "hijacks") the cellular ESCRT assembly machinery normally 
utilized by the cell for membrane budding and scission events, to effect virion budding, 
predominantly from the plasma membrane (Balasubramaniam and Freed, 2011; Finzi et 
al., 2007; Jouvenet et al., 2008; Welsch et al., 2007). Following budding, Pr55Gag is 
cleaved by the viral protease, after which CA undergoes condensation from the viral 
membrane to form the characteristic conical core structure that encapsulates the NC-
associated viral genome (Ganser-Pornillos et al., 2008). 
1.1.4 Pol proteins 
The Pol proteins are translated and incorporated into the virion as the gag-pol 
polyprotein Pr160gag-pol (Luciw et al., 2002). Viral protease cleaves Pr160gag-pol after viral 
budding from the cell as part of the process of virion maturation (Luciw et al., 2002). 
These virally-encoded enzymes carry out functions specific to the virus, and for which 
no cellular functionality is known (Luciw et al., 2002). Following infection of a target cell, 
reverse transcriptase (RT) converts the genomic viral single-stranded RNA into double 
stranded DNA through coordinated action of its RNAse H and DNA polymerase 
functionalities (Luciw et al., 2002). Importantly, RT lacks a genomic proofreading 
capability, making it the major contributing factor in the observed genetic diversity 
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among HIV strains (Korber et al., 2001). Finally, integrase contains both DNA cleavage 
and strand-transfer (joining) functions to incorporate the newly reverse-transcribed viral 
DNA into the host cell genome, resulting in a cell capable of producing progeny virions 
(Luciw et al., 2002). 
1.1.5 Env proteins 
Env is the only viral protein exposed on the virion surface, and it is the main target of 
the host humoral immune system (McElrath and Haynes, 2010). The targeting of Env, 
through direction of the immune response by vaccination, or by traditional small-
molecule pharmaceuticals provides the best hope for controlling the epidemic (McElrath 
and Haynes, 2010). As such, the study of Env structure and function has yielded 
important insights into the properties and features of these viral proteins. Functional 
virion-associated Env is a trimer of heterodimers derived from extensive processing of 
the env gene product, presented schematically in Figure 4. Env is translated and 
cotranslationally N-glycosylated as a 160 kDa polyprotein (gp160) in the endoplasmic 
reticulum. Env gp160 is thought to multimerize in the ER into predominantly trimers, 
before trafficking to the Golgi (Earl et al., 1990; Earl et al., 1991; Pinter et al., 1989). In 
the Golgi, Env gp160 is cleaved by a cellular furin-like protease at a conserved 
K/R(X)K/RR motif into gp120 (or surface unit (SU)) and gp41 (or transmembrane (TM)) 
(Freed et al., 1989; McCune et al., 1988). The cleaved gp120 and gp41 products non-
covalently associate to form the active trimeric Env unit. 
 9 
1.1.5.1 gp120 structure and function 
gp120 is a structurally complex molecule. Sequence analyses of gp120 from diverse 
HIV-1 isolates identified a high degree of sequence variation, determining the presence 
of five variable regions (V1 - V5) sequentially interspersed in the primary sequence with 
five relatively conserved regions (C1 - C5) (Starcich et al., 1986; Willey et al., 1986). 
Sequence analyses also identified 18 highly conserved cysteine residues that form nine 
disulfide bonds that play an important role in the formation of gp120 tertiary structure 
(Leonard et al., 1990). The variable regions determined by sequence analysis coincide 
with loop structures predicted to be formed by the disulfide bonds (Leonard et al., 1990). 
These loop regions vary considerably in size, with the V1/V2 loop ranging from 50 - 90 
amino acids in length, while V4 ranges from 19 - 44 amino acids, and V5 from 14 - 36 
amino acids (Chohan et al., 2005; Kitrinos et al., 2003; Masciotra et al., 2002; Palmer et 
al., 1996; Sagar et al., 2006; Shioda et al., 1997). V3, on the other hand, does not vary 
appreciably in size. The presence of these loops has been confirmed by x-ray crystal 
structures of gp120 proteins (Huang et al., 2005; Kwong et al., 1998). In addition, gp120 
contains 20-30 canonical N-linked glycosylation sites and is thus extensively 
glycosylated with oligosaccharides accounting for approximately half of its molecular 
Schematic representation of the primary structural layout of HIV-1 Env. The variable loops of gp120 
are labeled as V1, V2, V3, V4, and V5. The three primary domains of gp41 are indicated. 
Figure 4. Env protein primary structure 
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mass. The location and number of glycosylation sites also varies by strain and change 
over time during the course of infection (Allan et al., 1985; Montefiori et al., 1988). 
 HIV-1 gp120 has been studied extensively, and a number of atomic resolution 
structures have been elucidated, all in conjunction with one or more binding partners, 
including CD4 and coreceptor binding site MAbs 17B (Kwong et al., 1998) and X5 
(Huang et al., 2005), or CD4 binding site MAbs b12 (Zhou et al., 2007) and VRC01 and 
VRC03 (Wu et al., 2010). Due to what is likely extensive flexibility, the V1/V2 loops were 
deleted from gp120 proteins used for structure determination (Kwong et al., 1998). The 
relative location of the V1/V2 loops on the virion-associated Env trimer has been 
recently determined, however, by fitting (V1/V2 deleted) gp120-CD4 crystal structures 
into cryo-electron microscopy (cryo-EM) density maps of CD4-bound Env (Liu et al., 
2008). The inclusion of CD4 in the cryo-EM Env structure determination allowed for 
unambiguous orientation and fitting of preexisting structures that led to the identification 
of V1/V2 density in the cryo-EM Env structure (Liu et al., 2008; White et al., 2010). 
 The primary function of gp120 is to initiate and modulate virus-cell interactions 
through binding to the primary receptor, CD4, and the coreceptor, predominantly CCR5 
or CXCR4. gp120 initiates virus-cell contact by binding to CD4 and subsequently 
undergoes structural rearrangements that result in the formation of the coreceptor 
binding site. These conformational changes allow for high affinity binding of gp120 to 
coreceptor, that in turn leads to conformational changes in gp41 to begin the process of 
virus-cell membrane fusion (Myszka et al., 2000). Because of its receptor binding 
functionality and the identification of antibodies that exhibit cross-clade neutralizing 
activity (broadly neutralizing antibodies), gp120 is a major focus for experimental 
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vaccines (McElrath and Haynes, 2010). In addition, one commercially-licensed small 
molecule therapeutic, maraviroc, targets the gp120-coreceptor binding interaction 
(Dragic et al., 2000). However, maraviroc acts by binding CCR5, and does not 
specifically interact with gp120 and is inactive against viruses that utilize CXCR4 as 
coreceptor (Dragic et al., 2000). 
1.1.5.2 gp41 structure and function 
gp41 can be structurally subdivided into three major domains (see Figure 4): the 
extracellular domain (or ectodomain); the membrane-spanning domain (MSD); and the 
C-terminal tail (CTT), also referred to classically as the intracytoplasmic tail. Of these, 
experimental protein structures for only the gp41 ectodomain have been determined at 
atomic detail, and then only for the six-helix bundle of what is generally considered the 
fusion-competent state (Caffrey et al., 1998; Chan et al., 1997; Shi et al., 2010). Little to 
no information exists on the native structure of gp41. Even recent cryo-EM structures of 
Env on the virion surface provide little insight into the structure of gp41 beyond that it 
appears to present as a thin stalk upon which gp120 rests (Liu et al., 2008; White et al., 
2010). 
gp41 ectodomain The location and function of the gp41 ectodomain is well studied and 
generally unquestioned. gp41 is also N-glycosylated, although to a much lesser extent 
than gp120, at three to five potential sites (Montefiori et al., 1988). The ectodomain 
contains the major determinants of membrane fusion (Figure 5): a hydrophobic N-
terminal domain termed the fusion peptide (FP) (Bosch et al., 1989; Freed et al., 1992; 
Freed et al., 1990); two heptad repeat regions, termed HR1 and HR2 (also referred to  
 12 
 
Figure 5. Schematic of gp41 ectodomain 
Schematic representation of the gp41 ectodomain, with the N-terminus located to the left and the C-
terminus located to the right of the MPER. FP = fusion peptide; HR = heptad repeat; MPER = 
membrane proximal external region 
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as the N- and C-helix, respectively) that form alpha-helical coiled-coil structures and are 
linked by a disulfide-bridged loop (Caffrey et al., 1998; Chan et al., 1997; Dubay et al., 
1992; Lu et al., 1995; Weissenhorn et al., 1997); and a tryptophan-rich region referred 
to as the membrane-proximal external region (MPER) (Muñoz-Barroso et al., 1999; 
Salzwedel et al., 1999). The MPER is an important target for broadly neutralizing MAbs. 
 The primary function of the gp41 ectodomain is to drive virus-cell membrane 
fusion. The gp41 fusion peptide (FP) is normally buried in the gp120/gp41 complex, but 
following conformational rearrangements induced by receptor and coreceptor binding, 
FP is exposed and inserts into the target cell membrane. The three HR1 domains then 
fold into a stable six-helix bundle in an anti-parallel fashion with the three HR2 domains 
(Figure 6) to bring the virus and cell into close proximity to allow fusion to occur (Chan 
et al., 1997; Weissenhorn et al., 1997). The mechanism by which the actual fusion step 
occurs is not well elucidated. However, peptide analogs of both the fusion peptide and 
the MPER have been demonstrated to both disorder and reduce the bending modulus 
for lipid bilayers, and thus may lower the free energy barrier to membrane fusion, a 
decidedly non-spontaneous process (Greenwood et al., 2008; Tristram-Nagle et al., 
2010; Tristram-Nagle and Nagle, 2007). 
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Figure 6. gp41 ectodomain six helix bundle in fusion-competent state 
The gp41 six helix bundle of gp41 is shown in a bottom-up view (from the cell membrane perspective; 
left) and a side perspective (right), where the N-terminus of HR1 is at the top, and the N-terminus of 
HR2 is toward the bottom. HR1 and HR2 are colored as in Figure 5. Figure made in Chimera using 
PDB coordinates 1AIK. 
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gp41 Membrane-Spanning Domain (MSD) In contrast to the gp41 ectodomain, the 
gp41 MSD remains, despite much study, structurally enigmatic. Early studies identified 
a hydrophobic 25 amino acid sequence that acted as a ribosomal stop-transfer signal, 
leading to the classical identification of the gp41 ectodomain, MSD, and 
intracytoplasmic tail (Haffar et al., 1988). The MSD amino acid sequence is highly 
conserved among HIV isolates, and contains a conserved GXXXG helix-helix interaction 
motif and an absolutely conserved midspan arginine residue. The classical structural 
view of the MSD is that of a single membrane spanning alpha helix. The presence of the 
midspan arginine, as well as results from both previous and more recent studies, 
however, lead to conflicting views of the sequence and structural characteristics of the 
MSD in contrast to the classical definition. These studies are briefly discussed below. 
 Prior studies attempting to generate antibodies (in rabbits) to peptides spanning 
the full Env protein (gp120 and gp41) identified a strongly reactive peptide derived from 
positions 728 to 745 that is referred to as the Kennedy epitope (Chanh et al., 1986; 
Kennedy et al., 1986). This sequence is located in what is now known as the CTT, but is 
classically thought of as the intracytoplasmic tail. Intriguingly, the sera directed at the 
Kennedy epitope strongly neutralized virus (Chanh et al., 1986), suggesting an external 
localization of the epitope on the virion, as antibody cannot cross intact lipid 
membranes. These results were largely dismissed in light of the identification of the 
stop-transfer signal and the division of gp41 into the classical external, membrane-
spanning, and intracytoplasmic domains (Haffar et al., 1988). More recently, however, 
accumulating evidence also points to possibly different MSD sequence and/or structure. 
Studies examining the exposure of the Kennedy epitope on the surface of Env-
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expressing cells suggest that under some circumstances the Kennedy epitope is 
extracellularly exposed, indicating a need for either additional MSD sequences, or an 
alternative structure for the MSD other than the traditionally-held alpha-helix (Cheung et 
al., 2005; Cleveland et al., 2003; Heap et al., 2005; Reading et al., 2003). The two 
proposed MSD models are shown in Figure 7. 
 One of the most successful techniques for examining the structure of the MSD has 
been the use of molecular dynamics (MD) simulations. Two recent studies use MD 
simulations to examine the stability of monomeric and trimeric forms of the MSD in lipid 
membranes (Kim et al., 2009) and conformational variation in the MSD (Gangupomu 
and Abrams, 2010). A general caveat of these techniques, however, is that the starting 
assumptions have a major impact on the outcome. As such, both studies begin with the 
assumption that the MSD sequence adopts a helical conformation in the membrane. In 
general, this is a reasonable assumption given that the most energetically-favorable 
conformation of a peptide in a membrane is an alpha helix due to the internal 
stabilization of all potential hydrogen-bonding partners (White and Wimley, 1999). It 
does not, however, account for the experimental data that suggests alternative gp41 
topologies, and thus alternative sequences or structures for the MSD. With that 
understanding, both studies provide interesting insights into the potential structure of the 
MSD. Engelman and colleagues demonstrated a remarkable stability of the HIV MSD 
sequence (using FIMIVGGLVGLRIVFAVLSI) as a monomeric helix in the lipid 
membrane, but rapid unfolding of the helix in water (Kim et al., 2009). They also 
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Figure 7. Proposed models for the membrane-spanning sequences of HIV gp41 
The two models for the HIV gp41 MSD are shown schematically using the sequence from HIV-1 89.6. 
(Left) The traditional model, with the MSD as a single alpha helix. (Right) The alternative model 
proposed by Hollier and Dimmock (Hollier and Dimmock, 2005) with three membrane-spanning beta 
sheets. Residues are numbered according to the standard HXB2 sequence, and residues 706 - 746 
are left out for simplicity. 
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demonstrated conformational stability of a right-handed helical bundle that increased 
further when the central arginine residues were deprotonated (Kim et al., 2009). These 
results suggest that a right-handed helical bundle with deprotonated arginine residues is 
the most stable trimeric conformation for the gp41 MSD sequence. In contrast, 
Gangupomu and Abrams examined the conformational flexibility of a monomeric MSD 
sequence (using KLFIMIVGGLVGLRIVFAVLSIVNRVR). Their findings indicate that the 
MSD monomer forms a stable tilted helix in the membrane, but that metastable states 
are formed when the midspan arginine “snorkels” to either side of the membrane 
(Gangupomu and Abrams, 2010). When the arginine snorkels towards the outer leaflet, 
the N-terminal end of the MSD is unfolded. However, when the midspan arginine 
snorkels towards the inner leaflet the MSD kinks at phenylalanine 697, and the 
remaining 10 amino acids form a helix along the inner leaflet at the water-membrane 
interface (Gangupomu and Abrams, 2010).  Collectively, and importantly, these MD 
simulation results suggest multiple (meta)stable conformations of the MSD, even in an 
alpha-helical state. 
 Functionally, the primary role of the MSD has been thought to be to anchor the 
Env protein to the cellular and viral membrane. Additional studies have identified a role 
for the MSD in overall Env function. In particular, mutations in the MSD have been 
shown to have an effect on Env-mediate fusion such that mutations of conserved 
residues in the MSD led to decreased cell-cell fusion and decreased viral infection 
(Kondo et al., 2010; Shang and Hunter, 2010; Shang et al., 2008; Yue et al., 2009). The 
mechanism(s) by which these mutations act to decrease fusion are not well understood. 
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gp41 C-terminal tail 
Structure Of the three gp41 domains, the structure of the gp41 CTT is the least 
understood. Results from early topogenesis studies led to the view of gp41 (and thus 
Env as a whole) as a type I membrane protein, with an extracellular N-terminus, a single 
MSD, and an approximately 150 amino acid long cytoplasmic CTT (Haffar et al., 1988). 
Comparisons of this model to other retroviral Env proteins supported this view, with a 
major difference in the length of the proposed cytoplasmic CTT. For most retroviral Env 
proteins, the cytoplasmic CTT sequences are generally between 20 - 40 amino acids 
long (Checkley et al., 2011). The presence of a very long CTT is not unique to HIV, as 
other lentiviruses such as the simian immunodeficiency virus (SIV) and the equine 
infectious anemia virus (EIAV) have similarly long CTTs, at 150 and 200 amino acids, 
respectively (Rushlow et al., 1986). The presence of a long CTT in most lentiviruses 
suggests an important functional role, as viruses do not generally replicate non-
functional sequences. This functional importance is supported by the finding that 
truncation of the CTT leads to in vivo suppression of viral replication in animal models 
(Shacklett et al., 2000). A decade earlier, however, studies demonstrated that the CTT 
was dispensable for in vitro viral replication (Chakrabarti et al., 1989; Hirsch et al., 1989; 
Kodama et al., 1989), leading to a long-held view that the CTT was not functionally 
important. This view was subsequently popularized by the finding that truncation of the 
CTT led to increased Env incorporation into the virion, which was an important 
consideration at the time as a means by which to boost the anti-Env immune response 
in vaccine studies. It is now generally accepted that the CTT plays multiple important 
functional roles in the virus life cycle. Structurally, very little is still known, and no full-
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length atomic level structures exist for any CTT sequences. 
 Some CTT sequences have been studied structurally. The most well-studied 
domains, the lentivirus lytic peptides (LLPs), are sequences that were initially identified 
by sequence scanning as having extraordinarily high hydrophobic moments (Eisenberg 
and Wesson, 1990). Subsequent studies on peptide analogs of these domains 
demonstrated high levels of structural similarity with naturally occurring cytolytic 
peptides (Miller et al., 1991) as well as the ability of the peptides to alter cell membrane 
permeability (Miller et al., 1993). Peptide analogs of these domains have been 
demonstrated to be generally unstructured in aqueous buffer, but to rapidly adopt 
amphipathic alpha-helical structure in membrane or membrane-mimetic environments 
as determined by circular dichroism spectroscopy (Chernomordik et al., 1994; Kliger 
and Shai, 1997; Srinivas et al., 1992). There are no atomic level structures of the 
peptides interacting with membranes or membrane mimetics. 
 
Topology and function 
Contradicting data and competing topological models As the intracytoplasmic 
localization of the CTT has been predominantly reinforced implicitly with functional data, 
the topology and function of the CTT will be presented together. As alluded to above, 
the topology of the CTT has long been considered to have an entirely cytoplasmic 
localization. Accumulating recent evidence suggests that this may not be the case, or is 
at least not always the case. Initial studies suggestive of a non-cytoplasmic localization 
for the CTT were not explicitly performed to determine the CTT topology, and thus 
appear to have been largely ignored. These studies found that serum from a rabbit 
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immunized with a gp41 peptide (residues 728 - 745, the Kennedy epitope) bound to HIV 
Env, and that serum from HIV-1 infected patients bound the synthetic peptide (Kennedy 
et al., 1986). More importantly, subsequent studies demonstrated that anti-Kennedy 
epitope serum could specifically neutralize HIV in vitro (Chanh et al., 1986). Since 
antibody cannot cross intact lipid membranes, these results implied the localization of 
the Kennedy epitope on the outer surface of the virion, in direct contrast to the 
presumed intravirion localization. A few years later, topogenesis studies suggested the 
organization of Env as a type I membrane protein (Haffar et al., 1988), a view that was 
predominant and was implicitly reinforced by a number of experimental functional 
studies.  
 Nearly all functional studies to date reinforce the traditional cytoplasmically-
localized CTT model. This is largely due to genetic evidence demonstrating functional, 
but not physical interactions of the CTT with intracellular or intravirion partners. These 
functional interactions have been found to regulate: (i) Env incorporation into viral 
particles (Freed and Martin, 1995, 1996; Jiang and Aiken, 2007; Murakami, 2008; 
Murakami and Freed, 2000a, b); (ii) virion maturation (Jiang and Aiken, 2007; Joyner et 
al., 2011; Kol et al., 2007; Wyma et al., 2004); and, (iii) endocytosis of Env from the cell 
surface to late endosomes (Byland et al., 2007; Ohno et al., 1997). 
 
Virion Env incorporation In the mid-1990s, studies were published that demonstrated 
a functionally important role for the CTT. These studies are crucial to the current CTT 
field in that they established conclusively that the CTT was of functional importance in 
contrast to the view that arose from studies published in the late 1980s which 
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demonstrated that the CTT was dispensable for virus replication (Chakrabarti et al., 
1989; Hirsch et al., 1989; Kodama et al., 1989). In addition, these studies demonstrated 
increased Env content in virions containing a CTT-deleted Env and proposed that 
deletion of the CTT would be a means to boost the anti-Env immune response through 
the increase in Env per virion. This was the prevailing attitude until seminal studies by 
Freed and Martin demonstrated that the CTT was implicated in the incorporation of Env 
into virions through interactions with the MA domain of Gag. Their first study used site-
directed mutagenesis to demonstrate that mutations in specific amino acids in Gag MA 
resulted in deficiencies in incorporation of Env with a full-length CTT (Freed and Martin, 
1995). The MA mutations did not, however, lead to reduced incorporation of 
heterologous retroviral Env proteins with naturally short CTT sequences. Further, 
specific truncation of CTT sequences to seven or 47 residues (from the original 150) 
reversed the Env-incorporation block imposed by the MA mutations. This paper 
demonstrated for the first time conclusive evidence of a functional role for the CTT 
through direct or indirect interactions with an intracellular partner, Gag MA. 
 The role and localization of sequences important in the MA-CTT interaction has 
been further elucidated. A subsequent paper by the same authors demonstrated that 
truncating up to 56 residues from the CTT (leaving a 94 residue CTT) resulted in no Env 
incorporation in MA viruses containing mutations leading to deficiencies in Env 
incorporation, but that truncations of 93 amino acids or greater (leaving only 57 amino 
acid CTT) relieved the block caused by MA mutations, resulting in efficient Env 
incorporation (Freed and Martin, 1996). Later papers from this group localized the MA-
CTT interaction to LLP2 in the CTT (Murakami and Freed, 2000a) and further 
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demonstrated that the interaction was crucial for Env virion incorporation in a cell-type 
specific manner (Murakami and Freed, 2000b). 
 The above studies, while important in establishing a functional role for the CTT, do 
not provide evidence for a direct interaction of the CTT with MA; in fact, there is to date 
no experimental evidence for a direct MA-CTT interaction. The closest evidence for a 
stable interaction between Gag and the Env CTT also suggested a role of the CTT in 
HIV virion maturation, and as such, will be described below. 
 
Virion maturation Aiken and colleagues have come the closest to demonstrating a 
direct interaction of the Env CTT with MA by examining the effect of pelleting immature 
HIV virus particles (in which the Pr55Gag has not been cleaved) through detergent (Wyma 
et al., 2000). Pelleting particles through detergent strips away the viral lipid membrane 
in which the CTT is embedded, leaving viral protein cores. Their reasoning was if the 
CTT and Pr55Gag interact, then gp41 should be associated with the pelleted viral cores. 
They found that the pelleted cores retained the major fraction of the gp41 found in 
untreated virions (Wyma et al., 2000). Virions treated similarly but with a truncated CTT 
did not remain associated with the pelleted cores (Wyma et al., 2000). This study does 
not preclude, however, the presence of a mediating protein that facilitates the 
interaction between gp41 CTT and PR55Gag. Interestingly, a previous study using mature 
viral particles for a similar analysis demonstrated no association of the CTT with MA 
(Kotov et al., 1999). Thus, taken together these results suggested that the association 
of the CTT with Pr55Gag was dependent on the maturation state of the virion. 
 This maturation-dependent association of the CTT with Gag has been extended to 
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examine the role of the CTT in viral fusion. It is a well-established fact that HIV particles 
are not infectious until proteolytic cleavage of the Pr55Gag into its constituent domains 
(MA, CA, and NC, predominantly). Using a reporter assay to measure virus-cell fusion, 
Wyma et al. demonstrate that immature virions are less fusogenic than mature virions in 
a manner that is dependent on the CTT, as truncations of the CTT resulted in identical 
fusogenicity of immature and mature viral particles (Wyma et al., 2004). More recent 
results suggest that the extreme C-terminus of the CTT, LLP1, modulates the 
maturation dependence of infectivity, while deletion of this region does not affect the 
incorporation of Env into immature viral particles (Jiang and Aiken, 2007). The CTT has 
also been shown to modulate the mechanical stability of immature virus particles 
relative to mature virus particles, presumably through its interactions with Pr55Gag (Kol et 
al., 2007). These results collectively demonstrate that the interaction of the CTT and 
Gag have specific effects on the infectivity and structural stability of HIV particles. 
 
Env endocytosis Another functional role of the CTT has implicitly reinforced the 
traditional topological model. The gp41 CTT of both SIV and HIV have long been known 
to contain endocytic signals. The first was demonstrated in SIV, where a consensus 
YXXΦ motif in the CTT was shown to interact with members of the adaptor protein 
medium chain family (Ohno et al., 1997). It has also been demonstrated that CTT 
sequences interact specifically with the AP-2 clathrin adaptor (Boge et al., 1998). Most 
recently, Byland et al. demonstrated that the CTT contains two functional endocytic 
signals: a 711GYXXΦ motif located near the N-terminus of the CTT, and a dileucine motif 
at the extreme C-terminus (Byland et al., 2007). Their results indicate that in order to 
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completely abolish endocytosis of Env from the cell surface to late endosomes, both 
motifs must be mutated, suggesting that both the N- and C-termini of the CTT are 
cytoplasmically-localized. 
 Overall, known CTT functions in Env virion incorporation, virion maturation, and 
endocytosis of Env from the cell surface all provide support for the traditional 
intracytoplasmic (intravirion) model for the CTT. Figure 8 presents an overview of the 
known functionalities associated with the CTT sequences. 
 
Evidence for alternative CTT topologies 
Surface exposure of the Kennedy epitope The derivation of an alternative topological 
model for the CTT comes from a mixture of indirect (inferred from neutralization of HIV 
infection by anti-CTT antibodies) and direct biochemical evidence, as opposed to the 
indirect evidence supporting the tradition model. The earliest studies by Kennedy and 
colleagues, discussed above, demonstrated that antiserum directed against a CTT 
peptide both bound gp160, and most importantly, neutralized HIV in vitro (Chanh et al., 
1986; Kennedy et al., 1986). These are the earliest studies where the 
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Figure 8. Sites of functional consequence in genetic studies of the HIV gp41 CTT 
A visual overview of a subset of the sites that demonstrate functional alterations when mutated in 
genetic studies of the gp41 CTT. The wide distribution of sites over the entirety of the CTT sequence 
suggests the internal localization of the CTT, consistent with the traditional model. The sequence is 
from HIV-1 89.6. 
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results suggest an external localization of CTT sequences. However, for reasons that 
have also been detailed above, the traditional model was, and still remains, the 
predominating topological model. 
 In 2003, the mantle for the exposure of CTT sequences was assumed by a 
professor at the University of Warwick in the United Kingdom, Dr. Nigel Dimmock. Over 
three years and five manuscripts, his group provided the most extensive, although at 
times contradictory, evidence for the extravirion and/or extracellular localization of CTT 
sequences, and it is his group that proposed the alternative topological model presented 
in Figure 9. 
 The initial evidence for external localization of Kennedy epitope sequences were 
the result of antibody neutralization and binding studies of anti-CTT antibodies to viral 
particles (Cleveland et al., 2003). This study used epitope-purified antiserum (against 
the epitope 746ERDRD750, and termed EPES) to demonstrate high levels of 
neutralization (Concentration necessary to achieve 50% neutralization (NC50) = 0.3 
μg/ml) of HIV in vitro. Importantly, EPES did not have any neutralizing activity against 
viruses with a CTT-deleted Env. They further demonstrated that EPES could bind to 
intact viral particles (as evidenced by lack of binding by anti-MA and anti-CA 
antibodies), and that this binding was abolished by protease treatment of the particles 
(Cleveland et al., 2003). This report provided the first direct evidence for exposure of 
CTT sequences on viral particles. 
 A second study from Dimmock's group described a monoclonal antibody, termed 
SAR1 that is directed against the Kennedy epitope, as well as its neutralization activity 
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Figure 9. Proposed topology models for HIV gp41 CTT 
The two predominant CTT topology models are presented. (Left) Traditional CTT topology model, with 
completely intracytoplasmic CTT. (Right) Model proposed by Hollier and Dimmock (Hollier and 
Dimmock, 2005), with the Kennedy epitope (yellow) extracellularly localized. Transmembrane domains 
are as presented in detail in Figure 7. Red boxes indicate functional endocytic sequences as 
determined in (Byland et al., 2007). 
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(Reading et al., 2003). SAR1 was derived by immunizing a mouse with a plant virus 
engineered to express the 745GERDRDR751 sequence from the Kennedy epitope in the 
CTT. The resulting antibody was found to bind to both soluble peptides and proteins 
containing the GERDRDR sequence. More interesting, however, was that SAR1 bound 
to cells infected with all different HIV strains tested, but only to some virions 
representing the same strains. Moreover, SAR1 did not exhibit neutralization activity in 
a standard neutralization assay, but was able to neutralize effectively in a post-
attachment neutralization (PAN) assay. In a standard neutralization assay, antibody and 
virus are incubated together prior to adding to the cells to allow the interaction to reach 
equilibrium before addition to target cells; neutralizing antibodies reduce viral infection in 
a concentration-dependent manner. In a PAN assay, however, antibody, virus, and 
target cells are incubated together, but at temperatures that do not support virus-cell 
fusion (usually ≤ 31 °C) for a defined period of time before washing free virus from the 
cells and incubating at 37 °C to allow infection to occur (or not, if the antibody 
neutralizes) (Reading et al., 2003). The inability of SAR1 to neutralize in a traditional 
assay, but exhibit PAN activity, suggested a transient exposure of the Kennedy epitope 
during the fusion process. The mechanism of the PAN activity of SAR1 was confirmed 
in a subsequent paper to act through the blocking of virus-cell fusion (Heap et al., 
2005). Reading, et al. also demonstrated that SAR1 acted to block the production of 
infectious progeny virus from infected cells (Reading et al., 2003). These results 
provided increased evidence for an alternative topology for the CTT, where the 
Kennedy epitope is exposed to antibody binding, although not universally as SAR1 did 
not bind to virions from all HIV strains tested. 
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 Finally, in an effort to provide a condensation of results from these studies and to 
provide a working topological model explaining their results, Hollier and Dimmock used 
sequence analyses to provide theoretical support to their observed exposure of CTT 
sequences. Using a combination of secondary structure predictions with hydrophobicity 
analyses, Hollier and Dimmock proposed that the CTT can form a tail loop structure 
supported by three membrane-spanning beta sheets that result in the extracellular 
localization of the Kennedy epitope (Hollier and Dimmock, 2005). This is the alternative 
topological model presented in Figure 9. Hollier and Dimmock acknowledge that their 
proposed topological model positions the N-terminal GYXXΦ endocytic signal in an 
extracellular position, implying that it cannot be functional. As discussed above, this 
model is in direct contrast with subsequent results demonstrating the GYXXΦ signal to 
be active in AP-2 mediated endocytosis (Byland et al., 2007). Hollier and Dimmock 
propose that the majority of cell surface Env is in a state similar to the traditional 
topological model, with a single MSD, but that a minor population exists in their newly 
proposed topological state, and that it is this Kennedy-epitope exposed Env that is 
preferentially incorporated into progeny virions (Hollier and Dimmock, 2005). It is 
important to note that at the time of its proposal the alternative model was consistent 
with a majority of published studies, both functional studies discussed in the previous 
section as well as their own biochemical data, excluding the inconsistent HIV virion 
binding. A major argument against this model is the improbable existence of a MSD 
composed entirely of beta-sheet with an odd number of membrane-interacting 
sequences. One of the "construction rules" of beta sheet membrane proteins is that they 
must have an even number of MSDs as beta sheets hydrogen bond most efficiently in 
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an anti-parallel fashion (Schulz, 2000). An odd number of beta sheet MSD sequences 
would leave a lone beta strand and its hydrogen-bonding backbone amide and carboxyl 
groups exposed to the hydrocarbon interior of the membrane, an energetically 
unfavorable situation (Schulz, 2000). This untenable arrangement would be further 
compounded upon Env trimerization, where there would now be three naked beta 
sheets in the interior of the membrane, all arranged in a parallel fashion and unable to 
relieve the unfavorable interactions. 
 
Dynamic exposure of LLP2 sequences In addition to the evidence for possible 
Kennedy epitope exposure, recent studies present data supporting the exposure of 
additional CTT sequences, in particular the LLP2 domain. A study by Lu, et al. 
determined the exposure of CTT sequences in Env-expressing cells under native 
conditions as well as during the fusion process (Lu et al., 2008). Using antibodies 
directed at the C-terminal 90 amino acids of the CTT, and to the LLP2 region only, Lu et 
al. determined that no exposure of the 90 C-terminal amino acids were detected under 
normal conditions, nor did they observe exposure during cell-cell fusion carried out at 37 
°C as measured by flow cytometry. They did, however, observe LLP2 exposure during 
cell-cell fusion by slowing the fusion reaction by incubation at 31.5 °C (Lu et al., 2008). 
These same antibodies were also demonstrated to inhibit cell-cell fusion in a 
concentration-dependent manner at 31.5 °C, but not at 37 °C. Their results suggest a 
transient exposure of LLP2 sequences during membrane fusion, and are consistent with 
results demonstrating membrane association of LLP2 both pre- and post-fusion (Viard 
et al., 2008). 
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CTT influences overall Env structure The final known function of the CTT is its role in 
modulating overall Env structure. Data from these studies provide no direct topological 
implications and are included and discussed as further evidence supporting the 
functional importance of the CTT. 
 One of the earliest observations that the CTT could influence overall Env structure 
was provided by the insight that viruses with CTT-deleted Env proteins could infect 
target cells in a CD4-independent manner (Edinger et al., 1997). Until that time, the 
paradigm for HIV infection of target cells was that gp120 binding to CD4 was necessary 
to induce conformational changes that allowed binding to coreceptor. Edinger et al. 
demonstrated that viruses with a CTT-deleted Env were able to infect CD4 negative, 
coreceptor positive cells, suggesting a different conformation for the Env that was 
dependent on the CTT. 
 Initially, direct evidence for CTT-dependent alterations in Env structure was 
provided by differential reactivity between CTT-deleted and wild-type Env with 
conformationally-dependent antibodies. Edwards, et al. demonstrated that truncation of 
the CTT to 27 amino acids resulted in increased binding by monoclonal antibodies 
directed to both the CD4 binding site and the CD4-induced coreceptor binding site 
(Edwards et al., 2002). In Env with a full-length CTT, monoclonal antibodies directed to 
the coreceptor binding site only bound if the Env was preincubated with soluble CD4. 
The study also demonstrated differential reactivity of conformational monoclonal 
antibodies directed at the ectodomain of gp41 between CTT-truncated and full-length 
CTT (Edwards et al., 2002). This study was the first to demonstrate that the CTT 
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modulates the conformation of overall Env structure, even in the non-covalently 
attached gp120 that is located (presumably) on the opposite side of the membrane. 
 Additional, and arguably more interesting, data on this was published a few years 
later from our lab. Kalia et al. demonstrated that, like the Edwards study, alterations in 
the CTT could modulate the antigenic conformation of both gp120 and the gp41 
ectodomain. Instead of utilizing large deletions in the CTT, however, Kalia demonstrated 
that mutation of two conserved arginine residues in LLP2 to glutamate was sufficient to 
alter the conformation of both gp120 and the gp41 ectodomain on the surface of Env-
expressing cells (Kalia et al., 2005). The mutations were shown in a previous 
manuscript to have no effect on the levels of virion Env incorporation or viral replication, 
but did decrease the efficiency of cell-cell fusion (Kalia et al., 2003). In addition to 
demonstrating antigenic distinctions between wild-type and mutant Env on the cell 
surface, differences were seen in the viral sensitivity to antibody-mediated neutralization 
by antibodies directed at the CD4 binding site, with the mutant virus demonstrating an 
approximately 40-fold decrease in neutralization sensitivity (Kalia et al., 2005). This 
study importantly demonstrated that point mutations in the CTT were sufficient to alter 
overall Env conformation, and equally importantly, provided the first glint of information 
regarding the critical nature of the conserved arginine residues in the LLP regions. 
 A very recent paper has extended the study of CTT-dependent alterations in 
overall Env antigenicity from the cell surface to the surface of viral particles (Joyner et 
al., 2011). Under the guise of maturation-induced cloaking of neutralization epitopes, 
Joyner et al. demonstrated that Env on immature virions (protease deleted) reacted 
differently to a number of conformationally-dependent monoclonal antibodies in a 
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manner that was dependent on the presence or absence of the CTT (Joyner et al., 
2011). This study provided the first direct evidence that the CTT plays a major role in 
modulating the conformation of the CTT in the virion in addition to on the cell surface. 
 There is also recent structural evidence for the role of the CTT in the modulation 
of overall Env conformation. Subramaniam and colleagues recently published the cryo-
EM structures of CTT-deleted Env on the surface of SIV viral particles (White et al., 
2010). In comparison to wild-type virus containing the full-length CTT, CTT-deleted Env 
existed in a naturally "open" state, displaying large differences in the localization of 
electron density that are consistent with the conformational changes normally 
associated with CD4 binding (Figure 10). This study, finally, provides the first conclusive 
structural evidence that the CTT sequences, aside from any functional roles, also plays 




Figure 10. CTT-dependence of Env conformation 
 
Cryo-EM structures of SIVmacE11S (full-length Env; left) and SIV CP-MAC (CTT-truncated Env; right). 
The CTT-truncated Env displays large alterations in the positioning of the gp120 units, as a function of 
both the monomeric unit as well as in the overall quaternary arrangement. Figure made using VMD 
1.8.7 and EM Database coordinates EMD-5272 (E11S) and EMD-5274 (CP-MAC). Contour levels 
were set as recommended. 
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CTT conclusions I hope that it is clear to the reader at this point that the questions and 
data surrounding the topology of the gp41 CTT present a complicated, and often 
conflicting, picture. While the majority of functional data support the traditional idea that 
the CTT sequences must be cytoplasmically localized, accumulating biochemical data 
suggest that some of the CTT sequences are localized to the exterior of the cellular or 
viral membrane, if not always, then at least some of the time. The conflicting data 
provided what we believed to be an excellent space to attempt to find answers 
explaining the topological confusion regarding the gp41 CTT. Before discussing our 
hypotheses regarding CTT topology, however, it is necessary to provide some 
background on the theoretical considerations of membrane protein topogenesis and 
folding. 
1.2 MEMBRANE PROTEIN TOPOLOGY 
In vivo, membrane protein topology is derived from the cotranslational insertion of the 
protein (regions) into the lipid membrane by the cellular translation and translocation 
machinery (White and von Heijne, 2008). While this sounds like a relatively 
straightforward process, insomuch as it can be described in a single sentence, resulting 
membrane protein topologies can be anything but simple. The study of membrane 
protein topology has evolved from basic descriptions of "on which side of the membrane 
do sequences reside" to concepts including topological distributions of single protein 
sequences with differing numbers of transmembrane domains, dual-topology proteins 
that arrange in opposite topologies in equal stoichiometry, and dynamic reorientation of 
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protein sequences across a membrane in response to changes in membrane lipid 
composition (reviewed in (Dowhan and Bogdanov, 2009; von Heijne, 2006; White and 
von Heijne, 2008)). In the years since the proposal of the traditional and alternative CTT 
topological models, the understanding of membrane protein topology has undergone a 
"quiet revolution" that has not yet reached mainstream biology. Thus, to be considered 
valid, any proposed model for CTT topology must account for all experimental data, 
both functional and biochemical, as well as conform to the principles of membrane 
protein folding and topology. As has been discussed above, the alternative model with 
its three membrane-spanning beta strands does not conform to the known principles for 
beta sheet membrane proteins and cannot be considered a valid model. As such, to 
provide proper context for the data surrounding the topology of the gp41 CTT, the 
following section will provide an overview of the current understanding of alpha-helical 
membrane protein topology. 
1.2.1 Membrane protein classifications 
It is perhaps most useful to start with a brief description of the basic classifications of 
membrane proteins and their topology. Membrane proteins belong to two broad classes: 
alpha-helical (bundle) membrane proteins and beta barrel membrane proteins (Elofsson 
and von Heijne, 2007; White and Wimley, 1999). As their names suggest, helical 
membrane proteins span the lipid bilayer as a single (or bundle of) alpha helix(es), while 
the beta barrel proteins are constructed of an even number (8 - 22) of membrane-
spanning beta sheets arranged in an anti-parallel fashion (Elofsson and von Heijne, 
2007). It is likely that helices and anti-parallel beta sheets are the major secondary 
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structural elements of membrane proteins as these arrangements minimize the energy 
of the protein-lipid interaction by satisfying the hydrogen bonding potential of the peptide 
bond (Figure 11) (White and Wimley, 1999). Additionally, depending on the number of 
membrane-spanning segments, membrane proteins can be classified as monotopic 
(having an in-plane anchor or a re-entrant loop), bitopic (one membrane spanning 
domain), or polytopic (two or more membrane spanning segments) (Blobel, 1980). 
Membrane proteins can also be classified into three distinct groups based on the 
localization of their termini: (i) Type I membrane proteins have a cleavable membrane-
localization signal peptide and an exoplasmic N-terminus and cytoplasmic C-terminus; 
(ii) Type II membrane proteins contain a signal anchoring domain and a cytoplasmic N-
terminus and exoplasmic C-terminus: and, (iii) Type III membrane proteins have a 
reverse signal anchor and an exoplasmic N-terminus and a cytoplasmic C-terminus, 
similar to Type I proteins (White and von Heijne, 2004). These topological classifications 
are generally held to describe both single-membrane spanning proteins, as well as 
more complex multi-domain proteins, where ultimate topology depends on the number 
of transmembrane domains (Goder and Spiess, 2001). HIV Env is generally considered 
to be a bitopic type I membrane protein with an extreme cleavable N-terminal signal 
before the soluble gp120, and a single membrane spanning domain in gp41. 
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Figure 11. Hydrogen bonding between peptide main chain groups 
Hydrogen bonding (green dashed lines) is demonstrated between backbone amide nitrogen (blue) and 
carbonyl oxygen (red). (Left) Hydrogen bonding between i and i+4 residues in an alpha helix. (Right) 
Hydrogen bonding between residues in anti-parallel beta sheets. Image created using MacPymol. 
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1.2.2 Membrane protein assembly and topogenic signals  
Membrane protein assembly and topogenesis requires the coordinated activity of 
several events (reviewed in (von Heijne, 2006; White and von Heijne, 2004, 2008). Very 
briefly, the major steps that apply to all transmembrane proteins are the recognition and 
targeting of the nascent translating chain to the membrane-localized translocation 
machinery, including the translocon (Sec61 in eukaryotes), which coordinates the 
selection, orientation, and membrane insertion of transmembrane helices into the 
bilayer milieu. Bitopic proteins are generally considered "finished" at this step, while 
polytopic membrane proteins undergo further helical packing interactions to attain their 
properly folded tertiary structure. Details of the process as they potentially impact 
topology will be added in following sections. 
For membrane proteins, topology is ultimately governed by a set of topogenic 
signals that are encoded in the amino acid sequence. Additional information is captured 
by rules that have been determined by statistical analyses of known transmembrane 
proteins. The main topogenic signals are detailed below and presented in Figure 12. 
The major signal for membrane integration of a protein segment is its overall 
hydrophobicity (von Heijne, 2006; White and von Heijne, 2008). The orientation of a 
transmembrane domain, however, is influenced by a complex confluence of a number 
of signals. These signals include: (i) the presence and orientation of charged residues 
flanking the helix, with positive charges localizing internally (Goder et al., 2004; Goder  
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Figure 12. Sequence properties influence final topology 
The main determinant of transmembrane insertion is the overall hydrophobicity of a sequence 
(depicted as a gradient of red, with darker hues indicating greater hydrophobicity). Additional factors 
that exert an influence on membrane protein topology are: (1) the presence and orientation of charges 
flanking the transmembrane region; (2) a hydrophobic gradient that leads to the more hydrophobic end 
being oriented out; (3) transmembrane region length, where for very hydrophobic sequences, short 
transmembrane regions orient C-terminal end out, while long sequences orient N-terminal end out; (4) 
the presence and relative abundance of charged lipids; (5) long-range interactions such as salt-
bridging can lead to the insertion of a charged helix; (6) the positive inside rule; and (7) the positive out 
membrane potential leads to translocation of negative sequences. 
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and Spiess, 2003); (ii) the hydrophobic gradient of the domain, with the more 
hydrophobic end oriented outward (Harley et al., 1998); and, (iii) preferential orientation 
of highly hydrophobic transmembrane domains, with the C-terminus oriented out if the 
domain is short, and the N-terminus out if it is long (Cao et al., 1994). Long-range 
interactions can also influence the topology during polytopic protein folding, where salt-
bridge formation can stabilize the transmembrane orientation of an otherwise poorly-
inserting charged domain (Bogdanov et al., 2008). Finally, the generally positive 
outward membrane potential favors the translocation of net negative domains and the 
retention of net positive domains (Dowhan and Bogdanov, 2009). 
Additionally, topological rules for membrane protein topology have been gleaned 
from statistical analyses of membrane protein structures. The most well known is the 
positive-inside rule. This rule was identified as a four-fold overrepresentation of 
positively charged residues in the cytoplasmic, as opposed to non-cytoplasmic domains, 
of proteins (von Heijne, 1986). Subsequent studies have determined that the molecular 
mechanism(s) of action for the positive inside rule include charged residues flanking the 
transmembrane domain interacting directly with the translocon (Goder et al., 2004; 
Goder and Spiess, 2003), charged residues in the protein interacting with ionizable 
head groups on membrane phospholipids (Dowhan and Bogdanov, 2009), and the 
overall positive out cellular membrane potential leading to translocation of negative 
domains and retention of positively charged protein domains (Dowhan and Bogdanov, 
2009). In addition to the skewed cytoplasmic:non-cytoplasmic distribution of positive 
charges, statistical analyses have identified distinct distribution profiles for all the amino 
acids relative to their position on transmembrane helices (Ulmschneider et al., 2005). 
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This study demonstrated that the frequency of the hydrophobic residues alanine, 
isoleucine, leucine, phenylalanine, and valine peaks at the center of the membrane, 
while the aromatic residues tyrosine and tryptophan (but not phenylalanine) peak at the 
membrane-water interface. In contrast, the polar and charged residues are largely 
absent from the membrane center. These rules have held up remarkably well as new 
membrane protein structures have been identified, and contribute positively to the 
prediction of transmembrane domains and topology in protein sequences of 
undetermined structure. 
1.2.3 Transmembrane domain and topology prediction 
One of the first modern techniques used to identify helical membrane proteins was to 
computationally scan protein sequences for (predominantly) hydrophobic stretches of 
amino acids long enough to span the membrane lipid bilayer (Henderson and Unwin, 
1975; Khorana et al., 1979; Ovchinnikov et al., 1977, 1979; Tomita and Marchesi, 
1975). Hydrophobicity scanning, and thus topological prediction, was performed by 
scanning the amino acid sequence of a protein using a moving average of a specified 
length, usually 10 - 20 residues (Engelman and Steitz, 1981; Kyte and Doolittle, 1982; 
von Heijne and Blomberg, 1979). Early hydrophobicity studies were performed using 
hydropathy scales derived from experimental studies of amino acid side chain analogs 
partitioning between water and hydrophobic solvents or calculations from accessible 
surface areas of amino acids in helical peptides (Engelman and Steitz, 1981; Kyte and 
Doolittle, 1982; von Heijne and Blomberg, 1979). Topological predictions from these 
data relied on the fact that transmembrane helices are on average more hydrophobic 
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than extramembranous loops. Results from these studies provided good information on 
what sequences were likely to be transmembrane helices, but the identification of 
sidedness was less accurate. The inclusion of the positive inside rule into topological 
prediction algorithms greatly increased the accuracy of sequence assignment to the 
appropriate side of the membrane (von Heijne, 1986, 1992). 
An important recent development in the prediction of transmembrane helices is 
the determination of more relevant hydrophobicity scales. As stated above, the original 
hydrophobicity scales were derived from the partitioning free energy of amino acid side 
chain analogs into hydrophobic solvents (Kyte and Doolittle, 1982). These scales did 
not take into account the partitioning free energy for the entire amino acid, particularly in 
a peptide environment, including the polar peptide bond, as it would be present in a 
protein sequence. To this end, Wimley and White derived whole-residue hydrophobicity 
scales based on partitioning free energies for amino acids in host pentapeptides, at both 
a membrane interface as well as into n-octanol as a measure of partitioning into the 
apolar environment of the membrane center (White and Wimley, 1998, 1999; Wimley et 
al., 1996; Wimley and White, 1996). These scales generally predicted lower free energy 
barriers to partitioning of charged and polar amino acids than the older scales, while still 
maintaining the ability to reliably identify transmembrane segments (White and Wimley, 
1999). 
1.2.3.1 A biological hydrophobicity scale 
All the predictive scales suffered from the same criticism, namely that they are based on 
the partitioning of elements (side chain analogs, amino acids, or peptides) solely 
between water and a hydrophobic (or interfacial) environment, a situation that is not 
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necessarily similar to what occurs in vivo. This criticism was elegantly addressed by the 
generation of a biological hydrophobicity scale by von Heijne and colleagues (Hessa et 
al., 2005a). Using a glycosylation reporter system to directly measure the efficiency of 
transmembrane insertion, they determined the apparent free energy, ∆Gapp, for each 
amino acid in the middle of a transmembrane helix, as well as for all positions in a 
transmembrane helix (Hessa et al., 2005a). The results from these studies correlated 
very well with the Wimley-White predictive scale (R = 0.85), suggesting that the 
predictive scale based on peptide partitioning provides a good approximation of the in 
vivo situation (Hessa et al., 2005a). The major implication of this correlation is that the 
insertion of membrane proteins into the lipid bilayer by the protein translocation 
machinery takes place as a partitioning event governed by the thermodynamics of the 
protein-lipid interaction (Hessa et al., 2005a; von Heijne, 2006; White and von Heijne, 
2008). Importantly, this suggests that transmembrane segments with ∆Gapp ≈ 0 exist as a 
thermodynamic equilibrium between inserted and non-inserted states, leading to the 
potential for proteins with a distribution of topological states. 
 This biological hydrophobicity scale is currently considered to be the most 
accurate of the predictive scales. Importantly, it has been used recently to demonstrate 
that transmembrane helices can reposition during membrane folding (Kauko et al., 
2010). Here, the authors noted that the transmembrane helices predicted using the 
position-dependent biological hydrophobicity scale did not match the position of the 
helices relative to the membrane in the crystal structure of the glutamate transporter 
homolog GltPh from Pyrococcus horikoshii. The authors demonstrated that three of the 
GltPh transmembrane helices are inefficiently recognized and inserted by the 
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translocon, but that they overlap with more hydrophobic segments with higher insertion 
efficiencies. They then postulated that tertiary and quaternary rearrangements (i.e. long-
range interactions) must occur during folding-induced shifts in the positions of these 
helices relative to the membrane. This induced shift resulted in the insertion of polar and 
charged residues present on two of the helices into the membrane, presumably in such 
a manner that they do not directly contact the hydrocarbon interior of the membrane 
(Kauko et al., 2010). These results provoke an interesting concept in the structure of 
membrane proteins, i.e. that the structure inserted by the translocation machinery may 
not exactly match the protein's "final" functional structure. 
1.2.4 Alternative protein topologies 
An implicit assumption underlying the discussion of membrane protein topology, as 
presented above, is that translation and translocation of a protein sequence results in a 
single protein structure with a defined, stable topology. The goal of this section is to 
address the potential for protein sequences to adopt "non-standard" topologies, or 
topologies not taught in introductory biochemistry. As many comprehensive, full reviews 
of membrane protein insertion and topologies exist (Elofsson and von Heijne, 2007; 
Goder and Spiess, 2001; von Heijne, 2006; White and von Heijne, 2004, 2008; White 
and Wimley, 1999), in an attempt to keep the discussion more relevant, only examples 
demonstrated to exist in viral proteins will be discussed. 
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1.2.4.1 Dynamic topology 
As indicated above, the use of the biological hydrophobicity scale has led to a larger-
scale identification of protein sequences that reorient post-insertion to arrive at their final 
topology with respect to the membrane (Kauko et al., 2010). These relatively minor 
rearrangements are interesting, but can be considered mild when considering the 
topological changes that have been observed for some viral proteins. A dramatic 
example is presented by the hepatitis B virus large envelope glycoprotein. In this case, 
the glycoprotein is initially synthesized with a cytoplasmically-localized N-terminus. 
During a post-translational, chaperone-dependent maturation process, the N-terminus is 
translocated across the membrane into the lumen in about 50% of the molecules, 
resulting in a protein of mixed topology in the cell (Lambert et al., 2004; Lambert and 
Prange, 2001; Lambert and Prange, 2003). There is also evidence for a similar 
functionally-necessary cytoplasmic to periplasmic translocation of a highly-charged N-
terminal domain in the phage lambda S107 holin protein that is apparently driven by a 
decrease in the membrane electrochemical potential, leading to hole formation and lysis 
of the infected cell (Graschopf and Bläsi, 1999). 
The envelope virus protein from the hepatitis C virus displays a different, but no 
less complicated, dynamic topology (Cocquerel et al., 2002). In this case, the envelope 
glycoprotein is synthesized as a polyprotein consisting of the individual proteins E1, E2, 
and p7. The E1 protein has a cleavable N-terminal signal peptide and a hydrophobic C-
terminal anchoring sequence. This E1 anchoring sequence additionally acts as the 
signal peptide for E2 that also has a C-terminal anchor that is the signal peptide for p7. 
The anchor/signal peptide segments are thought to initially insert as helical hairpins with 
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sharp cytoplasmic loops. Following cleavage of the signal peptides by the signal 
peptidase, located in the lumen, the C-termini of the signal peptide reorients across the 
membrane, finally localizing to the cytoplasm (Cocquerel et al., 2002). 
1.2.4.2 In-plane membrane anchoring sequences 
In-plane membrane anchors have also been described for viral proteins, with the 
majority of examples coming from the Flaviviridae family in the Pestivirus genus. In the 
Pestivirus viruses, both bovine viral diarrheal virus (BVDV) and the hepatitis C virus 
have been shown to produce proteins that associate with the membrane through the 
use of in-plane membrane anchors, resulting in proteins with a monotopic topology 
(Brass et al., 2007; Sapay et al., 2006b; Tews and Meyers, 2007). For BVDV and 
hepatitis C, the non-structural protein NS5A has been demonstrated to associate with 
the membrane by means of a 28 residue N-terminal amphipathic helix that is required 
for the assembly of a functional replication complex (Brass et al., 2007). NMR structure 
determinations and MD simulations indicate that the N-terminal amphipathic helix 
mediates membrane association through stable localization to the membrane-water 
interface (Sapay et al., 2006b). 
An additional pestivirus protein has been demonstrated to associate with 
membranes via an in-plane helix. The envelope glycoprotein Erns from BVDV is 
anchored to the membrane by a C-terminal amphipathic helix, albeit on the lumenal side 
of the membrane, as opposed to the cytosolic localization of the other pestivirus 
proteins with in-plane anchors (Tews and Meyers, 2007). Importantly, mutations that 
resulted in destabilization of the amphiphilicity of the anchor sequence resulted in 
decreased membrane association of the protein concomitant with decreased viral 
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infectivity. This was the first report of a glycoprotein anchored to the membrane via an 
in-plane helix. The existence of in-plane anchoring sequences has important 
implications for topology prediction because current predictive methods do not 
distinguish well between monotopic and bitopic proteins (Bernsel and von Heijne, 2005), 
and the very recent finding that minor flanking sequence differences can result in 
adoption of monotopic (in-plane or re-entrant loop) or bitopic (transmembrane) topology 
for anchoring segments (Norholm et al., 2011). 
1.2.5 Effects of lipids on membrane protein topology 
Probably the most recent, and controversial, topic regarding membrane protein topology 
is the concept that the lipid environment in which the protein exists can, by itself, play a 
determining role in the protein's topological arrangement. Key studies demonstrating 
this lipid-dependence of protein topology were carried out on the LacY lactose 
transporter for Escherichia coli by Dowhan and colleagues (Bogdanov et al., 2002; 
Bogdanov et al., 2008; Dowhan and Bogdanov, 2009, 2011; Wang et al., 2002; Xie et 
al., 2006; Zhang et al., 2003; Zhang et al., 2005). Crucial to these studies was the use 
of E. coli genetically engineered to inducibly synthesize phosphatidylethanolamine (PE), 
a zwitterionic lipid. Wild-type E. coli membranes are composed of ~70% PE, 20% 
phosphatidylglycerol (PG, an anionic lipid), and 5% cardiolipin (CL, also an anionic lipid) 
(Dowhan and Bogdanov, 2009). LacY folding in wild-type E. coli, then, takes place in an 
abundance of PE, which serves to mitigate the level of negative charge at the 
membrane imposed by PG and CL (Dowhan and Bogdanov, 2009). In the PE-inducible 
E. coli, however, protein synthesis, and thus membrane protein folding, can occur in the 
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absence of PE, and in the presence of a large negative charge on the cytosolic leaflet 
owing to the overwhelming presence of PG and CL (Dowhan and Bogdanov, 2011). 
This system was used to demonstrate that LacY synthesized in the absence of PE 
contained a topologically-inverted N-terminal six-helix bundle that resulted in protein 
inactivity (Bogdanov et al., 2008). Following the blockage of new protein synthesis and 
induction of PE synthesis, the authors demonstrated that the N-terminally-inverted LacY 
reoriented the N-terminal bundle to assume a native state that restored uphill lactose 
transport activity (Bogdanov et al., 2008). This result suggests that alterations in lipid 
content alone can result in topological reorientation of membrane proteins outside the 
environment of the translocation machinery. The authors further demonstrated that the 
addition of negative charge to loops normally located in the cytoplasm was sufficient to 
lead to inverted N-terminal topology, even in wild-type E. coli, suggesting that increasing 
the negative charge of the protein can override the positive inside rule (Bogdanov et al., 
2008). Overall, results from Dowhan and colleagues collectively suggest that the 
interaction of the lipid and protein play a role on the final topology of the protein 
(Bogdanov et al., 2002; Bogdanov et al., 2008; Dowhan and Bogdanov, 2009, 2011; 
Wang et al., 2002; Xie et al., 2006; Zhang et al., 2003; Zhang et al., 2005). The 
application of these concepts to eukaryotic systems is uncertain, however, as 
membrane content cannot be controlled to the same extent as in the prokaryotic 
system, nor do there exist such extensive natural variations in membrane content. Of 
potential interest, however, is the fact that the eukaryotic endoplasmic reticulum (ER) 
membrane displays a symmetrical distribution of lipids between the lumenal and 
cytosolic leaflets. Further, asymmetry with respect to the lipid content of the bilayer 
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leaflets is only introduced to the biosynthetic pathway in the Golgi network, with PE and 
negatively charged phospholipid phosphatidylserine (PS) being transported to and 
maintained on the cytosolic leaflet in an energy-dependent fashion (Dowhan, 1997; van 
Meer et al., 2008). This presents the hypothetical possibility for post-translational lipid-
dependent protein topological changes based on membrane leaflet segregation, where 
the negatively charged PS becomes solely cytoplasmically-localized in the Golgi after 
the protein is translocated and membrane inserted in the ER. It is then possible, if lipid-
protein interactions can determine topology, that as the protein traffics from the ER to 
the Golgi, topological rearrangements may occur due to the interaction between protein 
charges and the now cytoplasmically-oriented PS. 
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2.0  HYPOTHESIS AND SPECIFIC AIMS 
2.1 HYPOTHESIS 
Retroviral envelope proteins serve as major determinants for replication, immunologic, 
and pathogenic properties, and variations in envelope (Env) sequences can markedly 
alter viral phenotypes. Studies of the HIV-1 Env have focused predominantly on the 
surface unit (SU) gp120 and the ectodomain of the transmembrane (TM) Env gp41, 
reflecting an early bias toward a negligible functional role for the gp41 CTT. 
Concurrently, Env immunology has generally ignored the CTT since most Env-based 
vaccines are engineered without CTT sequences to increase Env expression or to make 
a soluble protein. More recent studies indicate (i) that HIV-1 and SIV CTT sequences 
mediate specific interactions with cellular protein components of endocytic and signal 
transduction pathways, (ii) that deletions and truncations in HIV-1 and SIV CTT 
sequences can alter viral Env conformation, function, and antigenicity, and (iii) that CTT 
mutations can strongly attenuate SIV replication and pathogenesis in experimentally 
infected monkeys. Recent results from our lab demonstrated that select point mutations 
in the CTT can markedly alter the antigenic and functional properties of gp120 and 
gp41, indicating that even minor variations in CTT sequences affect Env structure and 
function. In addition, a series of experimental and modeling studies of CTT structure 
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suggest that portions of the CTT may be exposed on the membrane surface, 
contrasting the generally-held view of gp41 as a type I integral membrane protein. This 
proposed topology is supported by studies identifying CTT sequences as targets for 
neutralizing monoclonal and polyclonal antibodies in vitro. Finally, recent studies 
suggest a transient exposure of a discrete CTT region during the fusion process, 
providing further evidence for complex CTT topology. Thus, a definitive topological 
analysis of the Env CTT is warranted. 
 Based on these observations, I hypothesize that the gp41 CTT serves as a 
critical determinant of Env structure and function by modulation of its topological 
arrangement with and within the membrane lipid bilayer. To address this hypothesis, I 
propose to: (i) define the conservation of gp41 CTT sequence and structural elements 
from diverse HIV strains; (ii) determine the native topology of the Env CTT on the 
surface of intact cells and viral particles; and (iii) examine the influence of the fusion 
process on the topology of the CTT. 
2.2 SPECIFIC AIMS 
2.2.1 Aim 1. To define the conservation of gp41 CTT sequence and structural 
elements from diverse HIV strains. 
The sequence conservation of the gp41 CTT was compared to that of gp120 and the 
gp41 ectodomain. Phylogenetic and diversity analyses of approximately 2000 
sequences from HIV clades A, B, C, D, F, G and groups N and O demonstrated that the 
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CTT was intermediately variable between the highly variable gp120 and the more 
conserved gp41 ectodomain. In spite of relatively high variability, the gp41 CTT 
displayed remarkable conservation of the physicochemical characteristics of the 
lentivirus lytic peptide (LLP) regions, with an extraordinary conservation of arginine 
residues, especially as compared to lysine. Computational folding of consensus LLP 
peptide sequences from all clades/groups demonstrated overall conservation of helical 
secondary structure. In addition, circular dichroism studies of synthetic LLP peptides 
representing consensus as well as naturally-occurring sequences from clades B, C, and 
group O confirmed a high level of helicity in membrane mimetic environments including 
sodium dodecyl sulfate (SDS) micelles and trifluoroethanol. Results from these studies 
indicate that the CTT contains conserved structural elements in spite of high levels of 
sequence variation. 
2.2.2 Aim 2. To determine the native topology of the Env CTT on the surface of 
intact cells and viral particles and examine the effect of the fusion process on the 
topology of the CTT. 
The topology of the CTT was determined by a combination of epitope tagging of the 
CTT sequence and the use of monoclonal antibodies targeting the wild-type sequence.  
For epitope tagging studies, the VSV-G epitope tag (amino acid sequence 
YTDIEMNRLK) was used to serially replace HIV sequences along the entirety of the 
CTT. To map the topology of the CTT, intact Env-expressing cells and pseudoviral 
particles were analyzed for reactivity with anti-CTT antibodies by flow cytometry, 
immunoprecipitation, and surface plasmon resonance (SPR) spectroscopy assays. 
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Results from these studies demonstrated topological differences in Env expressed on 
the cell surface compared to virion-associated Env. 
 The potential for the CTT to undergo dynamic topological changes was 
addressed through the use of a post-attachment neutralization assay. When the fusion 
process was slowed by incubation at 31 °C, a CTT-specific monoclonal antibody 
neutralized virus infection, but did not neutralize under standard neutralization at 37 °C. 
These results indicate that the CTT, which is not exposed under native conditions on 
the virion, undergoes dynamic, transient rearrangement during the fusion process. 
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3.0  HIGHLY CONSERVED STRUCTURAL PROPERTIES OF THE C-TERMINAL 
TAIL OF HIV-1 GP41 DESPITE SUBSTANTIAL SEQUENCE VARIATION AMONG 
DIVERSE CLADES: IMPLICATIONS FOR FUNCTIONS IN VIRAL REPLICATION 
This research was originally published in the Journal of Biological Chemistry. Jonathan 
D. Steckbeck, Jodi K. Craigo, Christopher O. Barnes, Ronald C. Montelaro. Highly 
Conserved Structural Properties Of The C-Terminal Tail Of HIV-1 gp41 Despite 
Substantial Sequence Variation Among Diverse Clades: Implications For Functions In 
Viral Replication. Journal of Biological Chemistry. 2011; 286: 27156-27166. © the 
American Society for Biochemistry and Molecular Biology. 
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3.1 INTRODUCTION 
The envelope (Env) proteins of retroviruses in general, and HIV-1 in particular, have 
been shown to serve as a major determinant of viral replication, antigenic, and 
pathogenic properties, such that natural and experimental variations in envelope 
sequence can markedly alter these viral phenotypes (Evans and Desrosiers, 2001; 
Levy, 2009; Roux and Taylor, 2007). Fundamentally, HIV-1 Env is the mediator of viral 
infection. Env is translated as a full-length gp160 polyprotein that is post-translationally 
cleaved into non-covalently associated gp120 and gp41 subunits that yield the 
functional Env monomer that then forms the virion associated Env trimer complex. The 
gp120 and gp41 subunits of Env each mediate specific functions during the infection 
process. The function of gp120 is to bind the primary receptor, CD4, and subsequently 
the co-receptor, primarily CCR5 or CXCR4. Receptor binding leads to conformational 
changes in gp41 such that the previously sequestered fusion peptide at the N-terminus 
of gp41 inserts into the cellular membrane. This is followed by refolding events that 
function to bring the cellular and viral membranes into proximity finally leading to fusion 
and infection. 
The gp41 protein is organized into three distinct domains: (i) the ectodomain, 
including the fusion peptide, the N- and C-terminal heptad repeat regions, and the 
membrane proximal external region (MPER), a target for broadly-neutralizing 
monoclonal antibodies (MAbs); (ii) the membrane spanning domain (MSD), the 
sequence that anchors Env into the membrane; and (iii) the C-terminal tail (CTT), 
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demonstrated to function in cellular Env trafficking (Byland et al., 2007; Lopez-Vergès et 
al., 2006; Ohno et al., 1997) and virion incorporation (Kalia et al., 2003; Murakami and 
Freed, 2000b; Wyma et al., 2000). The gp41 ectodomain has historically been the focus 
of many studies examining its role in the fusion process and as a target for neutralizing 
antibodies, while the MSD has been the subject of detailed studies to determine its 
precise length and structure (Gangupomu and Abrams, 2010; Kim et al., 2009; Shang et 
al., 2008; West et al., 2001; Yue et al., 2009). In contrast to these gp41 domains, the 
CTT has been relatively less studied, having only recently been demonstrated as 
playing a major role in Env trafficking and viral Env incorporation (Byland et al., 2007; 
Kalia et al., 2003; Lopez-Vergès et al., 2006; Murakami and Freed, 2000b; Ohno et al., 
1997; Wyma et al., 2000). 
The CTT first came to prominence in the 1980s when it was reported that serum 
targeting a peptide from the CTT could bind gp160 (Kennedy et al., 1986) and 
neutralize virus infectivity (Chanh et al., 1986; Ho et al., 1987). This apparent exposure 
of the CTT to neutralizing antibodies implied a surface exposure not predicted from the 
intracytoplasmic location predicted for the CTT sequences. In the following years, 
however, the CTT was thought to be dispensable for virus replication based on studies 
indicating the replication competence of proviral constructs in which the CTT was 
deleted from the Env gene (Chakrabarti et al., 1989; Hirsch et al., 1989; Kodama et al., 
1989). More recently the CTT has been demonstrated to contain a number of trafficking 
signals that control the level of Env expression at the cellular membrane. The CTT 
contains two functional endocytic motifs that lead to the rapid removal of Env from the 
surface of Env-expressing cells into late endosomes (Byland et al., 2007; Ohno et al., 
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1997). The CTT has also been shown to contain sequences involved in virion 
incorporation (Kalia et al., 2003; Lopez-Vergès et al., 2006; Murakami and Freed, 
2000a, b; Wyma et al., 2000), particularly through a proposed interaction with the matrix 
domain of HIV Gag (Murakami, 2008; Murakami and Freed, 2000a). Additionally, 
various studies have demonstrated that the CTT is a critical determinant of overall Env 
conformational properties, as variations in CTT sequences can alter Env fusogenicity 
and antigenicity mediated by the gp120 protein and the gp41 ectodomain (Kalia et al., 
2005). Finally, the CTT has been demonstrated to contain sequences required for 
association with detergent-resistant membranes, including a crucial role for the alpha-
helical nature of the LLP regions in maintaining lipid raft association (Yang et al., 2010). 
While high-resolution structures have been determined for sequences in the 
gp41 ectodomain, little is known about the structure of the CTT. There are no high-
resolution structures for any sequences of the CTT, although various studies have 
indicated that discrete domains in the CTT, known as the lentivirus lytic peptides (LLP), 
are helical in membrane mimetic environments (Chernomordik et al., 1994; Kliger and 
Shai, 1997; Srinivas et al., 1992). Topologically, gp41 is generally considered to be a 
type I membrane protein with an extracellular N-terminus and a cytoplasmic C-terminal 
tail following the predicted membrane spanning domain. The model of the CTT as an 
exclusively intracytoplasmic domain is consistent with the location of functional 
endocytic motifs that affect Env trafficking.  However, this generalization is challenged 
by conflicting data indicating that the Kennedy epitope is the target for neutralizing 
antibodies, suggesting an external localization of CTT sequences, perhaps most evident 
after receptor binding (Chanh et al., 1986; Heap et al., 2005; Ho et al., 1987). Indeed, 
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recent studies have also demonstrated differential exposure of CTT sequences on viral 
and cellular membranes (Steckbeck et al., 2010), and biochemical studies have 
revealed transient exposure of CTT sequences during the Env fusion to cellular 
membranes (Lu et al., 2008). 
Sequence analyses of Env have focused almost exclusively on the gp120 
subunit and the gp41 ectodomain (Korber et al., 2001; Pieniazek et al., 1998) and the 
effects of sequence variation on viral phenotypes, e.g. tropism (Scarlatti et al., 1997) 
and neutralization (Karlsson Hedestam et al., 2008).  To date, there have been no 
comprehensive analyses of the sequence variability of the CTT domain.  In light of 
recent observations that even minor variations in CTT sequence can markedly alter Env 
structural and functional properties, the current study was designed to determine the 
extent of amino acid sequence variation in the CTT of diverse HIV-1 strains and to 
analyze the effects of this sequence variation on the physicochemical and structural 
properties of variant CTT species.  The results of these studies for the first time provide 
evidence for evolutionary pressures on CTT sequences that are balanced by a 
remarkable conservation of uniquely characteristic physicochemical and structural 
properties, apparently to maintain critical functional roles in virus replication. These data 
indicate the need for further characterization of these CTT-mediated functions. 
 61 
3.2 MATERIALS AND METHODS 
3.2.1 Sequence acquisition and processing 
Sequences were obtained from the Los Alamos National Labs (LANL) HIV sequence 
database. Full-length (gp160) HIV-1 Env amino acid alignments were collected from 
years including 1997 through 2008 and were separated into clades A, B, C, D, F, and G, 
and Groups N and O for eight total sequence groupings. The sequences in each 
clade/group were further processed as full-length Env sequences to remove duplicate 
sequences using the ElimDupes tool from Los Alamos National Labs 
(http://www.hiv.lanl.gov/content/sequence/ELIMDUPES/elimdupes.html). Sequences 
were then separated into the three main domains of Env (gp120, the gp41 ectodomain, 
and the gp41 CTT) and aligned as described in the following section. The collection of 
sequences and subsequent processing yielded a total of approximately 2,000 unique 
sequences. Total sequences in each clade/group were as follows: 150 in clade A; 888 
in clade B; 626 in clade C; 118 in clade D; 34 in clade F; 48 in clade G; 6 in group N; 
and 126 in group O. 
3.2.2 Sequence alignments and evolutionary analyses 
Sequences from each clade/group were individually aligned within the respective 
domain (gp120, gp41 ectodomain, and gp41 CTT) for a total of 24 alignments (8 
clades/groups and 3 protein domains). Global alignments were performed using 
Geneious Pro 5.0.4 (Biomatters Ltd., NZ) (Drummond et al.) using the Pam250 cost 
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matrix. The gap opening/extension penalties were set to 16/8, with 30 refinement 
iterations performed for each alignment. Sequences were hand-edited where 
necessary, particularly around the variable regions in gp120. Evolutionary analyses 
included amino acid diversity computations and phylogenetic tree construction. The 
diversity of each domain (gp120, gp41 ectodomain, gp41 CTT) was measured by 
comparing the calculated distances of all sequences within a group in the alignment to 
one another. Genetic distances of aligned sequences were determined utilizing Kimura 
population distance calculations for amino acid sequences with no gap weighting, as 
executed in the program distmat from the EMBOSS package of software. Statistical 
significance values of the mean diversity of the domains were calculated in GraphPad 
Prism 5.0 (GraphPad Software, San Diego, CA). The statistical significance of diversity 
was calculated using two-tailed unpaired t-tests, as implemented in GraphPad InStat 
version 3.00 (GraphPad Software, San Diego California USA). Phylogenetic analyses 
were performed on the individual domain alignments of the hand edited, aligned 
sequences. The phylogenetic trees were constructed by the neighbor-joining method of 
Kimura corrected measurements with the optimality criterion set to distance as 
measured in PAUP (Swofford) and implemented in Geneious Pro version 5.0.4 
(Drummond et al.). Statistical significance of branchings and clustering were assessed 
by bootstrap re-sampling of 1000 pseudoreplicates on the complete data set and the 
confidence level set to 75. The trees were edited for publication using FigTree version 
1.1.2 (Morariu et al., 2008). 
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3.2.3 Characterization of physicochemical properties of consensus LLP peptide 
sequences 
MPER, MSD, and LLP sequences from all clades/groups were extracted from 
consensus sequences determined from alignments generated with Geneious Pro 5.0.4 
(Drummond et al.). The physicochemical characteristics (hydrophobic moment, net 
charge, and hydrophobicity) and helical wheel diagrams of the extracted regions were 
determined using HeliQuest (http://heliquest.ipmc.cnrs.fr/). One-way ANOVA using 
Tukey’s multiple comparison test and Bartlett’s test for equal variances was performed 
using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA). 
3.2.4 PEP-FOLD structure prediction for LLP peptides 
LLP and Kennedy epitope (KE) sequences for all clades/groups were extracted from the 
consensus sequences generated by the global multiple sequence alignments. 
Sequences were submitted to the PEP-FOLD server (Maupetit et al., 2009; Maupetit et 
al., 2010; Maupetit et al., 2007) for peptide folding including PSIPRED predictions 
(Jones, 1999). The number of clusters and the percentage of total structures occupying 
each cluster were graphed to demonstrate conformational diversity for each peptide 
sequence. Conservation of secondary structure for the peptides was determined by 
finding the root mean square deviation (RMSD) for the peptides as follows. For KE, 
LLP1, and LLP3, the models were aligned as described (Kabsch, 1976, 1978) using the 
RMSD align function of VMD (Humphrey, 1996). Due to the predicted random coil 
nature of the C-terminal half of the group O LLP2 model, the LLP2 models were aligned 
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using the STAMP structural alignment method (Russell, 1992), instead of aligning to the 
minimum RMSD. To take into consideration the differences in the predicted differences 
in LLP2 lengths, the LLP2 analysis was done using the first 14 residues of 
clades/groups A, C, G, N, and O and residues 3-16 of clades B, D, and F. Average 
RMSD was then determined for all residues on the STAMP-aligned models. 
3.2.5 Circular dichroism (CD) spectroscopy to determine peptide secondary 
structure 
LLP sequences for clades B and C and group O were extracted from the consensus 
sequences generated by the global multiple sequence alignments. In addition to the 
domains derived from the consensus sequences, we also determined the sequence 
with the lowest average divergence (LAD) from all sequences within each clade/group 
to select a representative natural isolate for secondary structure characterization. LLP 
sequences were also extracted from these LAD sequences. All 17 peptides (LLP2 from 
clade B consensus and LAD were identical) were synthesized using standard FMOC 
chemistry with a carboxylated N-terminus and amidated C-terminus to mimic their native 
chemistry within a longer polypeptide sequence. Peptides were resuspended in 10 mM 
HEPES, 10 mM SDS in 10 mM HEPES, or 60% TFE in 10 mM HEPES to a 
concentration of 50 μM. CD spectra were determined at 37 °C on a Jasco 810 CD 
spectrometer from 195 - 250 nm. Spectra are presented as the average of 10 
acquisitions. Peptide mean residue ellipticity was determined using CDPro (Sreerama 
and Woody, 2000; Sreerama and Woody, 2004). 
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3.3 RESULTS 
3.3.1 CTT sequence variation is intermediate between gp120 and the gp41 
ectodomain 
Initial analyses of the variation present in the individual domains of the Env protein 
involved a comparative alignment of the amino acid sequences of the approximately 
2,000 isolates available in the Los Alamos database (see Materials and Methods for 
inclusion/exclusion determinations).  Alignments of the respective gp120, gp41 
ectodomain, and the CTT domains were performed within and between all sequences of 
all clades and groups (data not shown). Subsequently, phylogenetic analyses by 
construction of neighbor-joining trees were performed to demonstrate the fundamental 
ancestral associations between the clades/groups at these three domains (Figure 13). 
All phylogenetic inferences were made by comparing the resultant ancestral 
relationships of the three domains at a similar scale.  The results demonstrated the least 
genetic relatedness for the gp120 sequences within a clade/group, as evidenced by the 
greatest average distance between sequences. In contrast, the gp41 ectodomain 
sequences were most closely related to each other within a clade/group, as exhibited by 
the least average distance between sequences. Finally, the gp41 CTT sequences were  
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Figure 13. Phylogenetic analysis of Env domains 
The phylogenetic relationship between the Env domains of clades A, B, C, D, F, G and groups N and O 
were examined. A neighbor-joining tree of aligned amino acid sequences was constructed from Kimura 
corrected distances. Bootstrap values were determined over 1000 iterations and the confidence level set 
to 75. Branch lengths are proportional to the phylogenetic distance existing between the sequences. 
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more related to each other than gp120 sequences, but less related to each other than 
the gp41 ectodomain sequences. 
 Diversity analyses were performed to provide a more quantitative distance 
measure between the sequences of each clade/group (Figure 14). Similar to the results 
from the phylogenetic analyses, gp120 was observed to have the highest overall 
diversity within each clade/group, with the mean diversity ranging from 20.32 - 37.75%. 
The gp41 ectodomain sequences displayed the lowest mean diversity, ranging from 
6.63 - 18.96%. Finally, CTT sequences exhibited intermediate diversity between gp120 
and gp41 ectodomain, with a mean diversity range of 12.36 - 26.78%.  
Together these results demonstrate an intermediate level of amino acid 
sequence relatedness and diversity for the CTT in comparison to gp120 and gp41 
ectodomain domains, suggesting a previously unrecognized evolutionary pressure on 
the CTT domain. 
3.3.2 Physicochemical characteristics of CTT domains are conserved 
In light of the relatively high level of diversity calculated for the CTT domain, we next 
sought to analyze the effects of CTT sequence variation on the physicochemical 
properties of defined segments of the CTT domain. To achieve a practical means of 
comparing the large number of CTT sequences in the database, we chose to 
additionally perform an alignment of the consensus sequences of the CTT domain for all 
of the clades (Figure 15).  Consensus sequences of the entire CTT region of each clade  
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Figure 14. Comparison of average diversity in Env indicates intermediate CTT variation relative to 
other domains 
Tukey box and whisker plots (GraphPad Prism v. 5.0) of Env gp120, gp41 Ecto, and the CTT domain 
amino acid diversity are plotted for all clades/groups.  Statistical significance of the differences between 
all populations (box and whisker plots) was performed using an unpaired two-tailed t-test with Welch’s 
corrections. The differences in all the medians are statistically significant. 
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Figure 15. Comparison of the amino acid sequence of the CTT domain 
Consensus sequences for the CTT region of the Env of each clade or group were derived from hand-
edited alignments of all the isolates downloaded from the Los Alamos database (see Materials and 
Methods).  Derived CTT region sequences were aligned and compared to the clade B consensus 
sequence for visualization purposes.  Only the amino acid residues different from clade B are reported on 
the alignment.  Dots (·) indicate residues identical to the clade B consensus sequence; dashes (-) indicate 
alignment gaps. Previously described LLP regions and the Kennedy epitope are boxed. 
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were derived from hand-edited alignments and aligned to one another as described in 
Materials and Methods. To more thoroughly understand the potential impact of amino 
acid variability, we investigated the conservation of the physicochemical characteristics 
of discrete, putative membrane-associated domains of the CTT compared to two other 
defined membrane-associated domains of gp41, the MPER and the MSD. We 
calculated the hydrophobic moment (μH), net charge, and hydrophobicity (H) of the 
peptide domains derived from the consensus sequences for the MPER, MSD, and the 
LLP regions of the CTT for all clades/groups (Figure 16). The results of these analyses 
reveal that the LLP domains have significantly higher hydrophobic moments (mean μH 
= 0.6003, 0.3640, and 0.3945 for LLPs 1, 2, and 3, respectively) than the MPER and 
MSD (mean μH = 0.1520 and 0.1153, respectively), and that the calculated LLP1 
hydrophobic moment is significantly higher than LLP2 and LLP3 (Figure 16A). Both 
LLP1 and LLP2 (+5 and +3 mean charges, respectively) are significantly more cationic 
than the MPER, MSD, or LLP3 (-0.25, +1, and +0.25 mean charges, respectively) 
(Figure 16B). The LLP regions were also found to be significantly less hydrophobic 
(0.3643, 0.4974, and 0.6650 mean H for LLPs 1, 2, and 3, respectively) than either the 
MPER (0.8268 mean H) or the MSD (1.133 mean H) (Figure 16C). Comparison of the 
variances of the calculated hydrophobic moments and net charge between the 
clades/groups indicate in general a similar level of variation in the sequences across 
clades/groups. However, the variances between clades/groups did differ for 




Figure 16. LLP Sequences have different physicochemical properties than MPER or MSD 
sequences 
Physicochemical properties of lipophilic domains from gp41 were determined from consensus sequences 
from each clade/group. Data presented as the mean and standard deviation of clades/groups, and 
differences between columns are significant at p < 0.001 unless otherwise noted. A.) Hydrophobic 
moments were calculated to determine amphipathic potential, and LLPs were found to be significantly 
more amphipathic than MPER or MSD sequences. B.) Average net charges demonstrate that LLPs 1 and 
2 are highly cationic. C.) MPER and MSD are significantly more hydrophobic than LLP regions. n.s. - not 
significant; * p < 0.05 
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across all clades/groups, indicating that the hydrophobicity of the MPER and MSD 
peptide sequences is more conserved than for the LLP peptide sequences. 
As the consensus LLP sequences were found to have high hydrophobic 
moments, and thus high amphipathic potential, we modeled the LLP peptide sequences 
using helical wheel diagrams (Figure 17). Inspection of the helical wheel diagrams 
confirms the amphipathic nature of the peptide sequences, with the charged and polar 
residues concentrated on one helical face and the hydrophobic and nonpolar residues 
concentrated on the opposite helical face. This amphipathic nature is highly conserved 
across all groups and clades, indicated by the similar incidence and position of the 
charged residues on the polar helical face. 
While overall charge for the LLP sequences was conserved (Figure 16B), the 
consensus sequences suggest a preference for arginine relative to lysine in the cationic 
LLP1 and LLP2 sequences. To test this apparent preference for arginine in LLP 
sequences, we calculated the frequency of arginine and lysine in the CTT of HIV-1 Env 
using 1,675 sequences from clades A, B, C, D, F, and G, and groups N and O from the 
Los Alamos National Labs 2009 HIV-1 Env sequence alignment (http:// 
www.hiv.lanl.gov/) and compared the calculated frequencies to the arginine and lysine 
frequencies for all proteins represented in the UniProtKB/Swiss-Prot protein 
knowledgebase release 2010_09 (http://ca.expasy.org/sprot/relnotes/relstat.html). 
Overall, arginine was found to occur at a frequency of 12.7% in the CTT (5.9% for all of 
Env) compared to a frequency of 5.5% observed for all proteins in the UniProtKB/Swiss- 
Prot protein knowledgebase. This increased frequency of arginine was accompanied by  
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Figure 17. Helical wheel diagrams demonstrate the conservation of the amphipathic nature of LLP 
regions despite sequence variation 
Consensus LLP sequences were plotted as helical wheels to observe the relative conservation of 
amphipathicity predicted by the hydrophobic moment analysis. The direction and relative magnitude of 
the hydrophobic moment is shown by the arrow. Amphipathicity of the sequences is clearly observed as a 
clustering of charged and polar residues on one helical face opposite the direction of the hydrophobic 
moment with concomitant clustering of hydrophobic residues on the opposite helical face. 
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a marked decrease in the frequency of lysine (1.9% CTT vs. 5.9% UniProtKB/Swiss- 
Prot; 5.0% for all of HIV Env), implying an important functional role for the arginine 
residue relative to lysine in the CTT. To ascertain position-specific arginine/lysine 
substitutions, we prepared logo diagrams for the LLP regions to determine the most 
conserved positively charged positions (Figure 18). Positions where the probability of 
arginine/lysine was >0.9 across all clades/groups were considered to be highly 
conserved. For the most highly conserved arginine residues in LLP1 and LLP2, lysine 
was substituted for arginine 0.40% of the time (40 out of 10,044 possible instances), 
while in LLP3 the conserved lysines were replaced by arginine in 4.84% of instances 
(162 of 3,348). Collectively these results indicate that the physicochemical properties of 
the LLP regions are conserved in spite of high sequence variation and suggest a 
preference for arginine over lysine, particularly in LLP1 and LLP2. 
3.3.3 Secondary structure of the LLP regions of the CTT is predicted to be highly 
conserved 
After determining that the physicochemical characteristics of the LLP regions were 
conserved, we examined the conservation of LLP secondary structure using PEP-FOLD 
computational peptide folding (Maupetit et al., 2009; Maupetit et al., 2010; Maupetit et 
al., 2007). Since peptide analogs of the LLP regions are proposed to be helical in 
conformation (Chernomordik et al., 1994; Kliger and Shai, 1997; Srinivas et al., 1992), 
we included as a control another reference CTT sequence, the Kennedy epitope (KE), 
that is predicted to exist in a non-helical conformation (Hollier and Dimmock, 2005).  
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Figure 18. Specific arginine residues are highly conserved in LLP1 and LLP2 
Logo diagrams were created using the probability scale to determine the most highly conserved residues 
in the LLP regions. In the cationic LLP1 and LLP2, there are six arginine residues that have ≥ 0.9 
probability of occurrence across all clades/groups. In LLP3, arginine is not preferred, while there are two 
highly conserved lysine residues. Arrows represent positions with ≥ 0.9 probability of occurrence of the 
indicated amino acid. 
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Each PEP-FOLD run included 50 simulations followed by comparison of the returned 
models by cluster analysis to assess conformational diversity, with models < 3 Å Cα- 
RMSD (cRMSD; for peptides > 20 residues) grouped together in a cluster (Maupetit et 
al., 2009). Figure 19 shows the number of clusters returned by PEP-FOLD for each CTT 
domain and the relative percentage of the total population comprised by each cluster. 
The conformational diversity of the KE was high for all the clades/groups, with between 
13 and 33 clusters identified, consistent with a random coil conformation. The LLP 
regions, on the other hand, were more conformationally homogeneous, with 21 of the 
24 LLP regions tested returning only one cluster. Models from the three LLP domains 
that returned more than one cluster are shown in Figure 20. Clade A LLP2 (Figure 20A) 
and clade C LLP1 (Figure 20B) both returned two clusters of high helical content, with a 
kinked second, higher-energy structure. Group O LLP2 returned seven clusters. 
However, the 16 N-terminal amino acids (LLSNLASGIQKVISHL) were consistently 
helical while the remaining nine C-terminal amino acids (GLGLWILGQ) adopted a 
random coil conformation (Figure 20C). Finally, to assess overall conservation of the 
predicted secondary structure of the LLP domain, we compared the lowest energy PEP-
FOLD models for each consensus domain sequence from all of the clades/groups 
(Figure 21) and determined the average cRMSD (Table 1). In general for the LLP 
peptides the average cRMSD was <1 indicating a high level of structural conservation. 
In contrast to the other consensus LLP sequences, a cRMSD value of approximately 6 
was calculated for the group O LLP2 consensus sequence due to the predicted random 
coil nature of the C-terminal nine amino acids. As expected from the 
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Figure 19. LLP sequences are predicted to be structurally homogeneous 
 
Results from PEP-FOLD-based folding simulations were analyzed to determine structural homogeneity of 
CTT sequences. The number of clusters returned by PEP-FOLD for each peptide sequence was plotted 
with each structurally similar cluster represented by a different hue. For each cluster (hue), the height of 
each bar represents the relative prevalence of the cluster as a percentage of the total number of 




Figure 20. PEP-FOLD simulations return multiple clusters for some LLP peptides 
 
 
The lowest energy structures from each returned cluster were aligned using the STAMP structural 
alignment method for (A) clade A LLP2, (B) clade C LLP1, and (C) group O LLP2. Each cluster is 
represented as a different hue. (A) and (B) contain two clusters of predominantly helical content, while (C) 






Figure 21. LLP peptide structural alignments reveal high level of structural similarity across 
clades/groups 
 
The Cα traces from the lowest energy PEP-FOLD models for each peptide sequence from each clade/ 
group were aligned as described in Materials and Methods. Peptides are presented with the N-terminus 
on the left and the C-terminus on the right. KE demonstrated little structural similarity, consistent with a 
random coil conformation. Cα traces for the LLP peptides demonstrate high structure conservation across 
clades/groups with the exception of Group O LLP2. Clade A – blue; clade B – red; clade C – gray; clade 
D – orange; clade F – yellow; clade G – green; group N – magenta; group O – cyan 
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Table 1. Average cRMSD of PEP-FOLD-predicted structures 
Clade/Group KE LLP2 LLP3 LLP1 
Clade A 3.59427 0.83105 0.14509 0.12035 
Clade B 3.57269 0.88990 0.07386 0.14126 
Clade C 3.64798 0.91100 0.08960 0.11856 
Clade D 5.87318 0.95789 0.05237 0.14982 
Clade F 3.21947 0.98239 0.06398 0.12540 
Clade G 2.92300 0.98992 0.06398 0.10418 
Group N 3.17061 0.90760 0.26369 0.17850 
Group O 6.47101 6.04013 0.12948 0.33790 
The lowest energy models from each clade/group were aligned and the average cRMSD was determined 
and compared between all clades/groups for each peptide region (KE, LLP2, LLP3, and LLP1). KE – 
Kennedy epitope; LLP – lentivirus lytic peptide 
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predicted random coil conformation of the KE consensus sequence, the average 
cRMSD calculated for the KE ranged from ~2.9 - 6.5. These predictive experiments and 
analyses suggest that the alpha helical structure of the LLP regions is conserved across 
all the clades/groups for the consensus sequences generated from multiple sequence 
alignments. 
3.3.4 LLP peptide analogs adopt helical structure in membrane-mimetic and 
hydrophobic environments 
As the PEP-FOLD experiments predicted that consensus sequences of the LLP regions 
adopt stable helical conformations, we endeavored to explicitly measure the secondary 
structure of LLP sequence peptide analogs. Towards this objective, peptides were 
synthesized corresponding to the LLP regions from the consensus sequences from 
clades B and C, and group O and from the lowest average divergence (LAD) sequences 
determined from the CTT alignments for the same clades/groups (Table 2). These 
clades/group were chosen as they represent the most widely studied HIV-1 sequences 
(clades B and C) and the most structurally divergent as predicted by the PEP-FOLD 
analyses (group O, particularly for LLP2). CD spectroscopy measurements of the LLP 
peptides were performed in three solutions: 10 mM HEPES; 10 mM SDS in 10 mM 
HEPES; and 60% TFE in 10 mM HEPES. For peptides in aqueous solution, spectra 
were consistent with predominantly random coil conformation with the exception of 
LLP1 from the clade C LAD sequence and LLP2 from clade B (Figures 22A and 23). 
Addition of 10 mM SDS to 10 mM HEPES resulted in an increase (or a maintenance, in  
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Underlined residues are different between the Consensus and LAD sequences. 
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Figure 22. SDS and TFE induce increased helicity in synthetic LLP peptides 
 
CD spectra from synthetic LLP peptides were determined in (A) 10 mM HEPES; (B) 10 mM HEPES + 10 




Figure 23. Relative helicity of LLP peptides by mean residue ellipticity 
Mean residue ellipticity (MRE) at 222 nm was calculated for each peptide from the data presented in 
Figure 22. Results were plotted for each peptide-solute combination to facilitate a simple visual 
comparison of relative helicity of each peptide in the different solutes. 
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the case of clade B LLP2 and clade C LAD LLP1) in helical content relative to 10 mM 
HEPES (Figures 22B and 23). Likewise, addition of 60% TFE to 10 mM HEPES 
maintained, or moderately increased, helical content compared to that observed with 10 
mM SDS (Figures 22C and 23). Results from CD spectroscopy measurements of LLP 
peptide analogs confirm predictions obtained by PEP-FOLD analysis that the alpha 
helical nature of the LLP peptides in membrane mimetic environments (i.e. SDS 
micelles and/or TFE) is broadly conserved among clades/groups in spite of extensive 
amino acid variation. 
3.4 DISCUSSION 
Contemporary research has placed Env structure and function as a high priority 
research focus for HIV-1. While the majority of published studies focus on the gp120 
protein or gp41 ectodomain, recent studies have implicated the CTT in the modulation 
of overall Env structure and function (Kalia et al., 2003, 2005; Newman et al., 2007). 
These recent observations increase the need for a more detailed characterization of 
CTT sequences among diverse isolates of HIV-1 and the effects of sequence variation 
on CTT structure. Thus, the current study was designed to provide a comprehensive 
comparative analysis of CTT species among different groups and clades of HIV-1. 
In the present study, we examined the conservation of the CTT of HIV-1 gp41 in 
clades A, B, C, D, F, and G and groups N and O as compared both to gp120 and to the 
gp41 ectodomain. In addition, we characterized the conservation of physicochemical 
and structural properties among variant CTT sequences. Our results demonstrate that 
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the CTT is intermediately conserved relative to the highly variable gp120 and the more 
conserved gp41 ectodomain. In spite of the relatively high level of amino acid diversity 
present in the CTT, the physicochemical properties of LLP domains are remarkably 
conserved across the clades/groups examined. Secondary structure predictions using 
PEP-FOLD indicate a high level of structure conservation in the LLP regions, results 
that are confirmed by CD spectroscopy of peptide analogs of the LLP regions from 
consensus and isolate sequences from clades B and C and group O. 
The finding that the CTT exhibits intermediate sequence variation between the 
highly variable gp120 and the least variable gp41 ectodomain provokes thought as to 
the source of the evolutionary pressures and significance of the substantial sequence 
evolution on putative CTT functions. The relatively high level of sequence variation 
observed in HIV-1 gp120 is due to a combination of random genomic alterations 
associated with reverse transcription and selective pressure by host immune responses 
leading to evolution of Env gp120 populations during persistent infection. While the 
gp41 gene is also similarly subject to mutations during reverse transcription, the 
relatively low variation in the gp41 ectodomain is likely due to more strict requirements 
for structure and function in light of large conformational rearrangements that occur 
during the fusion process. Intermediate variation observed in the CTT suggests two 
possibilities: (i) CTT sequences are exposed to the immune system and therefore 
variation is observed as a result of immune selection; or (ii) the CTT is not an important 
functional domain in Env and as such can vary randomly without detrimental effect. In 
our opinion, the observed conservation of LLP structure and the selective incorporation 
of arginine residues indicate a functional importance that is incompatible with random 
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variation. Additionally, when we examined whether the presence of accessory protein 
coding sequences (Tat and Rev) affected CTT sequence variation, we found no 
significant differences in sequence variability between regions utilizing one (CTT-only), 
two (CTT and Rev), or all three (CTT, Rev, and Tat) open reading frames (data not 
shown). As LLP2 and LLP3 occur in the region including the Rev coding sequence, and 
LLP1 occurs in the CTT-only region, the conservation of the LLP regions is not likely 
due to extraneous influence (e.g. accessory proteins) and is further indicative of a 
functional relevance for the sequences. This perspective is further supported by the 
observations that minor point mutations in LLP sequences can result in major 
alterations in overall Env structural and functional properties (Kalia et al., 2005). 
In stark contrast to the overall observed sequence variability in the CTT is the 
conservation, and indeed prevalence, of arginine in the CTT, especially relative to the 
other basic amino acid, lysine (c.f., Figure 18). While the two highly basic amino acids 
lysine and arginine are generally considered to be interchangeable and able to readily 
substitute for one another, the data presented here directly controvert that assumption 
for the CTT. As indicated by the current analyses of CTT basic residues, the CTT 
arginine residues are highly conserved and only very rarely replaced by lysine. In fact, 
arginine replacement by lysine in the CTT occurs at a much lower incidence as 
compared to its general prevalence in proteins. This selective preference for arginine in 
the CTT is likely due to functional requirements for the unique properties of the arginine 
side chain that terminates in a guanidinium group. Arginine demonstrates properties 
that make it particularly well suited to occur in membrane-interactive regions of proteins, 
as exemplified by the highly conserved arginine in the MSD of HIV-1 gp41. Primary is 
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the potential for the arginine side chain to “snorkel” from a membrane-embedded main 
chain position into the extramembranous space, providing an energetically favorable 
interaction with aqueous substrates (Killian and von Heijne, 2000). Additional recent 
controversy surrounds the potential for arginine to reside in or near the membrane 
center, although the mechanism by which this may occur is unclear (Dorairaj and Allen, 
2007; Krishnakumar and London, 2007; MacCallum et al., 2007, 2008). It is thought that 
the guanidinium group of arginine may be hydrated by membrane-resident waters 
(Krepkiy et al., 2009). More clearly demonstrated and well-established is the cation-pi 
interaction of the arginine side chain with proximal phenylalanine, tryptophan, and 
tyrosine side chains (Dougherty, 1996; Ma and Dougherty, 1997). In this interaction the 
dispersed positive charge of the guanidinium group interacts with the quadrupole 
moment of planar hydrocarbon rings to form an energetically stable “bond” that can 
subsequently pass into the membrane hydrocarbon core (Dougherty, 1996; Jing et al., 
2003). Any and all of these arginine-specific properties may play a role in the well-
documented ability of arginine-rich sequences to pass through biological membranes 
(Futaki, 2005; Mitchell et al., 2000; Tung and Weissleder, 2003), and it is this 
metaproperty that likely is of the greatest significance to the prevalence of arginine in 
the CTT. 
The sequence variation that is characteristic of the CTT appears to indicate an 
exposure to immune selection perhaps indicative of surface accessibility of the target 
sequences. Recent findings have demonstrated transient exposure of LLP2 sequences 
on the surface of Env-expressing cells (Lu et al., 2008). In particular, Chen and 
colleagues determined that LLP2 is exposed to antibody binding during cell-cell fusion 
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under conditions that slow the fusion process (i.e. at 31 °C), but not under physiological 
conditions (37 °C), suggesting highly dynamic LLP2 exposure. This is consistent with 
published data demonstrating lipid-association of LLP2 both pre- and post-fusion (Viard 
et al., 2008). The arginine-rich nature of LLP2 may contribute to the demonstrated 
transient exposure of LLP2 requiring membrane penetration and traversion, as arginine- 
rich peptides have been demonstrated to freely cross biological membranes, and 
indeed have been utilized to transport soluble proteins into live cells (Futaki, 2005; 
Inomata et al., 2009; Mitchell et al., 2000; Tung and Weissleder, 2003). Additionally, this 
ability of arginine-rich peptides to carry soluble proteins across membranes may be the 
mechanism by which the KE appears to be transiently exposed on the virion surface 
during the fusion process (Heap et al., 2005; Reading et al., 2003). As LLP2 is moving 
through the membrane, it is plausible that it can transport the highly charged KE through 
to the extravirion space where it becomes a neutralizing epitope under proper 
conditions. 
In addition to conservation of specific arginine residues in the CTT in an 
environment of generally high sequence variation, we also found that the 
physicochemical and structural properties of the CTT are well conserved across clades/ 
groups. LLP regions of the CTT display significantly higher hydrophobic moments than 
the MPER and MSD regions, the other membrane-interactive regions of gp41, indicating 
a preference for the membrane-water interfacial region (Eisenberg et al., 1984). LLP1 
and LLP2 also display conserved cationic properties, due to the enrichment in arginine 
described above, and the amphipathic nature of the LLP sequences is also conserved 
across clades/groups. Conservation of these biochemical properties suggests that there 
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is functionality to the CTT beyond current characterizations. Conservation of 
amphipathicity and high hydrophobic moments suggest that the LLP sequences help to 
localize and anchor the majority of the CTT sequence to the inner leaflet of the cell 
membrane. This is consistent with findings indicating membrane association of LLP1 
and LLP2 in virus and cells (Viard et al., 2008). 
The finding that the secondary structure of the LLP peptide sequences is 
conserved is also suggestive of critical but undefined functionality for the CTT. That 
LLP2 has been demonstrated to alternate accessibility to antibody binding during the 
fusion process suggests that the LLP2 sequence must traverse the membrane during 
the fusion process. The adoption of helical secondary structure would facilitate this 
process as helical structure internally satisfies all hydrogen bonding requirements and 
minimizes the free energy of the peptide-lipid interaction (White and Wimley, 1999). In 
conjunction with the demonstrated preference for arginine in the CTT, conserved helicity 
may be a means by which LLP2 is able to pass through the biological membrane during 
the fusion process and become accessible to antibody binding. Indeed, when conserved 
arginines in LLP2 were replaced by glutamate, Env-mediated fusogenicity and virion 
infectivity was abolished, even though Env virion incorporation was similar to wild-type 
virus (Kalia et al., 2003). 
Recent studies have highlighted the ability of the CTT to modulate HIV-1 Env 
structure and functional properties, but the mechanisms for this control remain to be 
defined. In addition, the current CTT sequence and structure studies indicate highly 
conserved physicochemical and structural properties that may mediate critical functions 
in the life cycle of HIV-1. In light of the genetic economy intrinsic to viruses, there 
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appears to be increasing data for a reevaluation of CTT functional relevance in HIV 
replication and Env structural and antigenic properties. 
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4.0  TOPOLOGY OF THE C-TERMINAL TAIL OF HIV-1 GP41: DIFFERENTIAL 
EXPOSURE OF THE KENNEDY EPITOPE ON CELL AND VIRAL MEMBRANES 
This research was originally published in the journal PLoS One and is used under a 
Creative Commons license. Jonathan D. Steckbeck, Chengqun Sun, Timothy J. 
Sturgeon, Ronald C. Montelaro. Topology of the C-terminal tail of HIV-1 gp41: 




Human immunodeficiency virus (HIV) infects humans predominantly through interaction 
of the viral envelope glycoprotein (Env) with the primary receptor CD4 and coreceptors 
CCR5 or CXCR4 on the surface of target cells. Env is produced as a 160 kDa 
polyprotein that is subsequently processed by extensive glycosylation, multimerization, 
and proteolytic cleavage to yield the virion-associated trimeric complexes of non- 
covalently associated gp120-gp41 dimers (Evans and Desrosiers, 2001; Luciw et al., 
2002). Numerous studies have identified Env as a primary determinant of viral 
phenotypes; variations in Env sequence can affect cellular tropism, viral replication 
levels, immune recognition, and pathogenesis (Evans and Desrosiers, 2001; Luciw et 
al., 2002). Additionally, Env sequence variation has recently been experimentally 
demonstrated to be a primary determinant of lentivirus vaccine efficacy (Craigo et al., 
2007). The majority of Env structural studies have focused on gp120 and the 
ectodomain of gp41; there is to date no definitive structural information on the 
approximately 150 amino acid long C-terminal tail that follows the proposed membrane- 
spanning domain (MSD) of gp41. 
Studies addressing the CTT have traditionally examined: (i) the role of the CTT in 
viral Env incorporation (Freed and Martin, 1995, 1996; Jiang and Aiken, 2007; 
Murakami and Freed, 2000a, b); (ii) the influence of the CTT on virion maturation (Jiang 
and Aiken, 2007; Kol et al., 2007; Wyma et al., 2004); and (iii) the function of predicted 
endocytic signals present in the CTT (Byland et al., 2007; Ohno et al., 1997). Various 
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studies of the interactions of both cellular and other viral proteins as intracellular 
partners with Env have implicitly reinforced the traditional model of CTT topology as 
being localized completely within the inner surface of the cell or viral lipid membrane 
(Figure 24, left). 
Early evidence for an alternative topological model for the CTT was provided by 
Kennedy and colleagues (Chanh et al., 1986; Kennedy et al., 1986) who first reported 
that antiserum produced against a synthetic peptide from gp41 (residues 728-745) 
bound to HIV-1 Env, and that serum from HIV-1-infected humans also recognized this 
synthetic peptide (Kennedy et al., 1986). Importantly, this group subsequently reported 
that antiserum raised against this synthetic peptide could specifically neutralize HIV in 
vitro (Chanh et al., 1986). These observations indicated exposure of the Kennedy 
epitope (KE) on the virion surface to allow antibody binding and neutralization, in direct 
contrast to the presumed intracytoplasmic location of the entire C-terminal sequences of 
gp41 following the MSD. 
More recently, Dimmock and colleagues have attempted to address this apparent 
discrepancy between the traditional model of an exclusively intracytoplasmic CTT and 
an alternative model where the KE is exposed (Cleveland et al., 2003; Hollier and 
Dimmock, 2005). Using antibodies directed to the 739ERDRD743 sequence and MAbs 
directed to the upstream 727PDRPEG732 and 733IEEE736 sequences in the KE, Dimmock 
and colleagues demonstrated virion binding and viral neutralization that was abrogated 
after pre-exposing virions to proteases (Cleveland et al., 2003). Subsequent 
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Figure 24. Schematic models of the HIV-1 CTT 
 
(Left) Traditional CTT model with one membrane-spanning α-helix and a completely intracytoplasmic 
localization of the remaining CTT sequence. LLP domains have been placed at their presumed 
membrane-localized position. (Right) Alternative CTT model with multiple MSD segments as proposed by 
Hollier and Dimmock (Hollier and Dimmock, 2005). This model proposes three membrane-spanning β-
sheets and an extracellular localization of the KE. 
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experiments using a MAb, SAR1, directed to 739ERDRD743 demonstrated that SAR1 
effectively neutralized HIV-1 by apparently post-attachment binding at lower 
temperatures; negligible neutralization was observed when virus and cells were pre-
incubated at 37 °C (Heap et al., 2005; Reading et al., 2003). SAR1 was also shown to 
effectively inhibit virus replication in HIV-1 infected cells incubated in the presence of 
SAR1 antibody (Reading et al., 2003), likely through a decrease in cell-cell spread 
mediated by SAR1 inhibition of HIV-1 gp41-induced cell-cell fusion (Cheung et al., 
2005). On the basis of these antibody accessibility studies, Dimmock and colleagues 
have proposed an alternative model for the topology of the HIV-1 gp41 CTT that 
predicts multiple MSDs and surface loops (Figure 24, right) (Cleveland et al., 2003; 
Hollier and Dimmock, 2005). 
This multiple MSD topology model is compatible with various studies that have 
identified intracellular partners proposed to interact with CTT sequences (Freed and 
Martin, 1996; Lopez-Vergès et al., 2006; Murakami and Freed, 2000a; Ohno et al., 
1997; Wyma et al., 2000), but is incompatible with recent data indicating a requirement 
for both the tyrosine-based sorting signal 711GYSPL715 and the extreme C-terminal 
dileucine sorting signal (boxed in red in Figure 24) in the CTT to facilitate Env 
endocytosis from the cell surface (Byland et al., 2007; Ohno et al., 1997; Rowell et al., 
1995). 
Finally, more recent studies have examined the accessibility of the lentivirus lytic 
peptide (LLP) regions of the CTT (c.f. Figure 24) to antibody on Env-expressing cells 
(Lu et al., 2008). Under native conditions, cell surface Env was not reactive with LLP1 
and LLP2-specific antibodies, consistent with a sequestered localization of the LLP1 
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and LLP2 sequences (Viard et al., 2008). Interestingly, however, when Env-expressing 
cells were incubated with CD4- and CCR5-expressing target cells at 31.5 °C, binding of 
LLP2-specific antibodies was observed (Lu et al., 2008). LLP2-specific MAbs did not 
bind when effector and target cells were incubated at 37 °C, indicating a highly transient 
exposure of the LLP2 sequence (Lu et al., 2008), consistent with prior reports of LLP2 
membrane association post-fusion (Viard et al., 2008). These results indicate the need 
to reconsider the current static model of CTT topology and suggest that the CTT may be 
a more dynamic structure than previously thought. 
In the current study, we sought to test the proposed topology models by 
experimentally determining the surface exposure of the KE sequences of gp41 for 
comparison to the external and internal locations predicted by the respective CTT 
models. Towards this goal, we have examined the accessibility of the KE to antibody 
binding on the surface of Env-expressing cells and on the surface of intact mature 
virions using a combination of flow cytometry, immunoprecipitation, and surface 
plasmon resonance (SPR) spectroscopy techniques that minimize the potential for 
disruption of the lipid membrane, the integrity of which is crucial to topology mapping 
studies (see Figure 25 for CTT sequences used). Our results indicate that the KE is 
topologically distinct on the cell surface as compared to the virion and that the topology 
of the CTT may be more complex and dynamic than indicated by current Env structural 
models. 
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Sequence alignment of the membrane-spanning domain (MSD) and CTT of the Env proteins used in this 
study. All Env proteins were full-length gp160, however, only the sequences from K665 to the C-terminus 
are shown for simplicity. Structural and sequence domains are indicated in boxes above the 
corresponding sequence. VSV-G epitope tag indicated in bold; SAR1 and 1577 epitope indicated in gray 





4.2 MATERIALS AND METHODS 
4.2.1 Cells and virus preparations 
HEK293T cells (ATCC) were maintained in DMEM (Invitrogen) supplemented with 10% 
(v/v) FBS. Cells were used at passage numbers less than 30. Gradient purified 
aldrithiol-2-inactivated HIV-1 NL4-3 virus (generously provided by Dr. Jeff Lifson, SAIC 
Frederick, Inc) used in this study has been described previously (Rossio et al., 1998) 
and recently used for cryo-electron microscopy studies of virion-associated Env (Liu et 
al., 2008; Zanetti et al., 2006; Zhu et al., 2006; Zhu et al., 2008). The SAR1 hybridoma 
was a kind gift from Dr. Nigel Dimmock. 
4.2.2 VSV-G epitope tag substitutions 
As described for topology mapping of other membrane proteins (Anand, 2000; Das et 
al., 2008; Obermeyer et al., 2007), we determined the antibody reactivity of selected 
Env constructs containing selected VSV-G epitope substitutions in the CTT. For these 
studies, the codon-optimized Env gene of HIV-1 (89.6) was cloned into a p2CI vector 
derived from PCR2.1 by insertion of the CMV promoter and polyA signal sequence from 
pcDNA3.1(hygro) (Invitrogen) and PCR-amplified IRES-Neomycin resistant sequence 
from pFB-Neo-LacZ vector (Stratagene). Overlapping PCR was used for the 
construction of the VSV-G substitution mutants of gp160. The two hybrid primers were 
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constructed containing VSV-G tag sequences at the 5’-ends and HIV gp160 specific 
sequences at the 3’-ends of both the primers used for the substitutions. Final 
overlapping PCR products were then subcloned into the HIV-1 gp160 expression vector 
using the appropriate restriction enzymes and the Rapid DNA Ligation Kit (Roche 
Applied Science). All mutants were verified by DNA sequencing. 
4.2.3 Cell culture and transfections 
HEK293T cells were plated into six-well plates 24 hours prior to transfection. 80% 
confluent cells were transfected with 2.5 μg of the selected HIV-1 Env mutant DNA 
using LipofectamineTM LTX reagent and PLUSTM reagent, as recommended by the 
manufacturer (Invitrogen). 
4.2.4 Cellular FACS analysis 
Cells were harvested 24 hours post-transfection by treatment with 2 mM EDTA. Cells 
were resuspended and washed twice with FACS wash buffer (1X PBS with 5% FBS) at 
4 °C prior to antibody staining. Reference MAbs to VSV-G (Roche Diagnostics), gp41 
(SAR1), and actin (Sigma-Aldrich) were labeled immediately prior to staining using 
Zenon labeling kits (Invitrogen) following manufacturer’s instructions. 106 cells were 
dual-stained by incubating with 5 μg fluorophore-labeled antibody (VSV-G or gp41) and 
7.5 μg fluorophore-labeled actin antibody for 30 minutes on ice. Following staining, cells 
were washed thrice with FACS wash buffer at 4 °C. Washed cells were resuspended 
and stained with 7-amino-actinomycin D (7-AAD). Cells were not fixed prior to analysis. 
 101 
Fluorescently-labeled cells were analyzed on a FACSAria (BD Biosciences). Live, intact 
cells (7-AAD negative) were selected for scatter characteristics, including selection of 
single-cell populations by doublet-discrimination analysis. PMT settings were adjusted 
on identically-stained mock transfected cells prior to analysis of Env-transfected cells. 
Data was collected for 5x104 7-AAD negative cells and analyzed for reactivity with 
fluorescently-labeled VSV-G or gp41 and actin antibodies. 
4.2.5 Isolation of detergent resistant membranes 
HEK293T cells were transfected with 89.6 WT, VSV-G-KE, or VSV-G-LLP2 plasmids. 
48 hours post-transfection, cells were subjected to sucrose gradient floatation as 
previously described (Chan et al., 2005). Briefly, cells were collected and washed in ice-
cold 1X phosphate buffered saline (PBS). Washed cells were extracted on ice for 30 
minutes with 0.5 ml ice-cold 1% Triton X-100 in NTE buffer (25 mM Tris-HCl; 0.15 M 
NaCL; 5 mM EDTA; pH 7.5) with phenylmethylsulfonyl fluoride and complete protease 
inhibitor (Roche). Cell lysates were centrifuged at 8,000 x g for 10 minutes at 4 °C. 
Clarified extracts were mixed with an equal volume of 85% sucrose in NTE and loaded 
into a prechilled centrifuge tube. Extracts were overlaid with 6 ml 30% sucrose in NTE, 
followed by 5 ml 5% sucrose in NTE. Tubes were centrifuged at 100,000 x g for 18 
hours at 4 °C. The gradients were fractionated from the top manually by pipetting into 
~1 ml fractions. Aliquots of the samples were precipitated with trichloroacetic acid, 
resuspended in SDS-PAGE running buffer, and subjected to SDS-PAGE followed by 
western blot with anti-gp41 MAb Chessie 8. Blots were developed with PicoWest 
substrate (Pierce) and visualized on X-ray film. 
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4.2.6 Viral immunoprecipitation and western blotting 
Protein G Dynabeads (Invitrogen) were prepared according to the manufacturer’s 
directions. Briefly, anti-Env or anti-Gag antibodies (4 μg) were incubated with 20 μl 
protein G Dynabeads in 35 μl citrate-phosphate buffer, pH 5.0, with gentle shaking for 
45 minutes at room temperature. Isotype-matched IgG controls were used for each 
species (murine, human, etc.) from which a MAb was derived. Beads were washed 
thrice with 0.5 ml citrate-phosphate buffer followed by resuspension in either 26 μl PBS 
(for intact virus) or 26 μl PBS with 1% Triton X-100 (for lysed virus) and 4 μl NL4-3 virus 
(equivalent to 1.1 μg p24). Virus-bead suspensions were incubated at 4 °C for one hour 
with gentle shaking and subsequently washed thrice with 1X PBS. Following the final 
wash, beads were resuspended in NuPAGE SDS-PAGE buffer, heated at 70 °C for 10 
minutes, and the supernatant loaded onto 4-12% Bis-Tris NuPAGE gels. Gels were 
electrophoresed followed by transfer to polyvinylidene fluoride (PVDF) membranes 
using the Invitrogen iBlot system. Blots were blocked for one hour in 5% blotto (1X PBS 
with 5% dry milk). After blocking, blots were cut to allow separate staining of gp120 (>60 
kDa), gp41 (30 – 60 kDa), and p24 (<30 kDa). gp120 was stained with rabbit anti-gp120 
(Advanced Biotechnologies, Inc.), gp41 stained with Chessie 8, and p24 stained with 
Ag3.0 for 1.5 hours at room temperature. Blots were washed thrice with 1X PBS and 
0.025% Tween 20 (PBS-T), followed by incubation with appropriate secondary antibody 
(anti-rabbit IgG or anti-mouse IgG conjugated to horseradish peroxidase) for one hour 
at room temperature. Blots were washed thrice in PBS-T with the gp120 blot receiving 
an additional wash in 1X PBS with 0.1% Triton X-100. Finally, blots were incubated with 
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PicoWest substrate (Pierce) for one minute and reassembled for visualization on X-ray 
film. 
4.2.7 Western blot quantitation 
Antibody IPs were quantified by densitometry analysis. For each IP, three independent 
X-ray exposures were scanned and analyzed using ImageJ (NIH). For intact virus, p24 
bands, and for solubilized virus bands from each MAb’s target antigen, were selected 
for each protein, and the integrated area under the densitometry curve was compared to 
that of the viral input band to yield percent of the input protein in the immunoprecipitate. 
Percent inputs for each protein for each of the three exposures were averaged to yield 
the overall percent input immunoprecipitated per experiment. This was repeated for 
three independent experiments, and the results were averaged to yield the final percent 
input immunoprecipitated per antibody. One-way ANOVA analysis was performed in 
Prism 5.0b with the Dunnett Multiple Comparison test and IgG as the control column. 
The P value of the test was <0.0001. Individual P values for antibodies compared to the 
IgG control are indicated in each data set. 
4.2.8 SPR spectroscopy analysis of antibody-virus interactions 
Antibody-virus interactions were analyzed using SPR spectroscopy using a Biacore 
3000 instrument. Protein A was immobilized on CM5 sensor chips as described 
(Steckbeck et al., 2006; Steckbeck et al., 2005). For analysis of the binding interaction, 
MAbs were captured on the protein A surface to ~1500 RU with a protein A-only surface 
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serving as a reference surface to account for virus-protein A non-specific interactions. 
Virus (2.5 mg/ml total protein; 172 μg/ml p24) diluted in 10 mM sodium phosphate 
buffer, pH 7.2 was injected over parallel reference and MAb-captured flowcells at 10 μl/ 
min for 2 minutes. A buffer-only injection served to account for MAb dissociation from 
the protein A surface and was subtracted from each MAb binding experiment. Thus, 
presented sensorgrams are double referenced (Myszka, 1999). 
4.3 RESULTS 
4.3.1 Exposure of CTT sequences on the surface of Env-transfected cells 
To experimentally determine the exposure of the KE on the surface of Env-expressing 
cells, the antibody reactivity of transfected cells expressing HIV-1 89.6 Env with the 
VSV-G tag substituted in the KE (VSV-G-KE) or LLP2 (VSV-G-LLP2) segments was 
analyzed. The selected epitope allowed the use of a high affinity commercial anti-VSV- 
G MAb to compare the accessibility of a common epitope in the context of the KE 
segment and in a putative internal LLP2 segment of the CTT (Lu et al., 2008; Viard et 
al., 2008). Cells transfected with VSV-G-KE or VSV-G-LLP2 were compared to cells 
transfected with 89.6 WT following staining with anti-VSV-G and anti-actin antibodies. 
Anti-actin was used as a control for cellular membrane integrity, providing the ability to 
distinguish VSV-G positive intact cells from cells with compromised membranes. 
As shown in Figure 26A, VSV-G-KE-expressing cells (middle) exhibit increased 
VSV-G-specific staining with no increase in actin staining compared to 89.6 WT (left) 
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transfected cells, while VSV-G-LLP2-expressing cells (right) stain for neither VSV-G nor 
actin, similar to the control cells. Since the insertion of the VSV-G tag into the KE 
strategically conserved a key epitope for an existing KE-specific MAb (SAR1), cells 
expressing the various Env constructs were also tested for reactivity with this native 
sequence-specific MAb. All cells expressing Env show similarly increased SAR1 
reactivity compared to mock-transfected cells without an increase in actin staining 
(Figure 26B). In addition to confirming the KE antibody accessibility results obtained 
with VSV-G-KE, this result also suggests that the observed lack of staining of 89.6 WT 
and VSV-G-LLP2 in Figure 26A is not due to decreased cell surface gp160 expression, 
as SAR1 reacted similarly with all Envs. Finally, to demonstrate the sensitivity of the 
actin stain to detect permeable membranes, SAR1 staining was repeated on 
permeabilized cells (Figure 26C). When the cell membrane integrity was compromised, 
anti-actin fluorescence intensity increased at least 10-fold, and 75-85% of permeabilized 
cells stained positive for actin. This result indicates that the lack of actin staining 
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Figure 26. FACS analysis of intact Env-expressing cells demonstrates extracellular exposure of 
the KE sequence 
Cells transfected with HIV-1 89.6 WT, VSV-G-KE, or VSV-G-LLP2 were analyzed by FACS to determine 
VSV-G epitope accessibility to anti-VSV-G MAb. A.) Intact, non-permeabilized Env-expressing cells were 
stained with α-VSV-G (AlexaFluor (AF) 700) and α-actin (AF 488). B.) Intact cells expressing Env were 
stained for surface exposure of the KE using a native KE antibody, SAR1. C.) Same as (B) except cells 
were permeabilized prior to staining. 
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observed in Figure 26A and 26B reflects intact cell membranes and not poor actin 
reactivity. 
Finally, as the CTT has been shown to contain signals important for association 
with detergent-resistant membranes (DRMs) (Yang et al., 2010), association of the Env 
constructs with detergent-resistant membranes (DRMs) was determined. Cells 
expressing 89.6 WT, VSV-G-KE, and VSV-G-LLP2 were subjected to membrane 
sucrose floatation gradients. As seen in Figure 27, all three Env constructs exhibited 
similar association with DRMs, suggesting that the VSV-G tag replacement strategy did 
not result in disruption of cell surface Env distribution. Taken together, these results 
indicate that the KE can be exposed on the surface of the plasma membrane, as the KE 
sequence is accessible to antibody binding in intact cells expressing Env, both in the 
context of the VSV-G epitope tag substitution and the native sequence. 
4.3.2 KE-specific antibodies do not bind to intact viral particles 
Next, immunoprecipitation studies were performed to assess the ability of MAbs 
directed at the KE to pull down intact viral particles using protein G-coated 
paramagnetic beads. Both a gp120-specific antibody (termed C11) and a gp41 
ectodomain specific antibody (7B2) were used to provide positive controls for Env 
binding and virion pull down. A p24-specific MAb (183-H12-5C) was used to detect 
disrupted virions in the pull down assays as a control for virion integrity. Of particular 
importance, several reference MAbs (2F5, 4E10, Z13e1) directed to the membrane 
proximal external region (MPER) of gp41 were used as controls, as this epitope is 
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Figure 27. VSV-G epitope insertions do not disrupt Env association with detergent-resistant 
membranes 
Env association with detergent resistant membranes was determined by sucrose gradient floatation 
followed by western blot analysis. Lane 1 represents the top of the gradient and lane 12 the bottom of the 




known to be closely associated with the membrane surface (Haynes and Alam, 2008; 
Schibli et al., 2001; Sun et al., 2008; Zwick, 2005). Together these MAbs provided 
highly specific controls for antibody accessibility to viral membrane-associated epitopes, 
as predicted for the KE sequences in the Dimmock topology model (see Figure 24, 
right). For intact virus immune precipitations, the level of antibody reactivity to its target 
antigen was measured by the relative level of viral p24 precipitated by the anti-Env 
MAbs (without lytic agents) compared to the amount of p24 (virus) input into the 
reaction. 
To ensure that all the reference MAbs were able to bind their target protein, 
immunoprecipitations were initially performed with MAbs incubated with purified virions 
solubilized with Triton X-100. The product immunoprecipitates were then characterized 
by SDS-PAGE and western blot for the respective target protein (e.g. C11 
immunoblotted for gp120, 7B2 immunoblotted for gp41, etc.). The open bars in Figure 
28 summarize the average results obtained for each MAb from three independent 
reactions with detergent-solubilized viral preparations. These data demonstrate that all 
of the reference MAbs effectively pulled down ≥50% of the total amount of target protein 
from solubilized virions; in contrast, the nonspecific IgG control precipitated less than 
3% of the virion p24 indicating minimal nonspecific precipitation under these 
experimental conditions. 
Having established that the MAbs were able to bind their target antigen in this 
assay format, we next tested the ability of the reference MAbs to precipitate intact 
virions under conditions similar to those used above without detergent solubilization. 
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Figure 28. Anti-KE MAbs do not bind to intact virions 
The indicated proteins and viral particles were immunoprecipitated using reference MAbs coupled to 
protein G-coated paramagnetic beads. (Top) Open bars represent % of target antigen precipitated when 
incubated with solubilized virus, while closed bars represent the % of input p24 precipitated by the 
corresponding MAb under native (intact virus) conditions. # = p < 0.05 for MAbs compared to IgG control 
with solubilized virus; * = p < 0.05 for MAbs with intact virus compared to IgG control. (Bottom) 
Representative p24 bands immunoprecipitated using the MAbs indicated in top panel with intact virus 
(Intact) or the bands of the target antigen from each MAb in detergent-disrupted virus (Solubilized). 
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Results presented in Figure 28 (solid bars) demonstrate that only MAbs specific for 
gp120 (C11) or the known gp41 ectodomain epitopes (7B2, 2F5, 4E10, and z13e1) 
effectively pulled down the intact virus particles, as measured by p24 levels in the 
immunoprecipitate. In marked contrast, both KE-specific MAbs (1577 and SAR1) failed 
to immunoprecipitate virus (p24) to significant levels above the IgG control, indicating a 
lack of reactivity of these reference MAbs with the KE in the context of intact virions. 
Additionally, the p24-specific MAb (183-H12-5C) also failed to pull down p24 in intact 
virions, confirming the integrity of the virion preparation. Taken together, the results 
from these immunoprecipitation experiments indicate that the KE is not accessible to 
antibody binding in the context of intact viral particles. 
To complement these immunoprecipitation studies, binding analyses of gp41- 
specific MAbs to purified virions in solution were performed using SPR spectroscopy. 
This technique allowed the assessment of qualitative differences in relative antibody 
affinity in real time during the course of the interaction. Specifically, SPR assays were 
used to address the possibility that both KE and MPER-specific MAbs bound viral 
particles equally well, but that KE MAb binding to virions was unstable during the 
washing procedures used in the immunoprecipitation assay. 
As shown in Figure 29, the SPR results demonstrate stable binding of MAb 2F5 
to the MPER of intact HIV-1 virions, but no detectable binding of SAR1 to the KE of 
gp41 in intact virions, despite the highly sensitive nature of this assay. These results are 
consistent with our viral immunoprecipitation observations and confirm that the KE is 
apparently inaccessible to antibody binding on the surface of viral particles and that the
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Figure 29. Comparison of MPER and KE MAb binding using SPR spectroscopy 
 
MAbs 2F5 (MPER) and SAR1 (KE) were compared for relative binding rates and affinity using SPR 
spectroscopy to monitor antibody binding to purified intact HIV-1 virions. RU – resonance units. 
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observed difference in KE accessibility in cells and viruses cannot be attributed to 
differences in the stability of antibody binding. 
4.4 DISCUSSION 
The current studies were designed to distinguish between the two distinct topological 
models currently proposed for HIV-1 gp41 by determining the accessibility of key CTT 
sequences in the context of virions and Env-expressing cells to binding by reference 
MAbs. The results of these studies for the first time reveal in parallel assays a marked 
difference in the accessibility to antibody binding of the KE in a primary-isolate Env 
expressed on the surface of cells compared to intact virions. Thus, these observations 
indicate that the CTT may exist in different topologies depending on the membrane 
environment, suggesting that the CTT may actually be dynamic in its association with 
different lipid membranes or other cofactors. 
While the goal of this study was to distinguish between the alternative models of 
CTT topology, the current data is only partially compatible with both models. In the case 
of virion-associated Env, the lack of KE exposure to antibody binding is consistent with 
the classical model of Env topology (Figure 24, left) in which the entire CTT sequence is 
sequestered within the lipid bilayer. In the case of Env expressed on the surface of 
cells, the accessibility of KE to antibody binding (and the inaccessibility of the LLP2) is 
consistent with an alternative Env topology (Figure 24, right) in which parts of the CTT 
are exposed to the exterior of the lipid bilayer. To reconcile these two different models, it 
seems necessary to discard the static model of Env topology and to assume a new 
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perspective in which CTT association with membranes is dynamic, perhaps controlled 
by interactions with other membrane binding proteins or lipid composition. 
A dynamic model for CTT topology is consistent with the published studies by the 
Dimmock lab (Heap et al., 2005; Reading et al., 2003) indicating that the KE is 
inaccessible to inactivation by SAR1 in free virions, but that the KE becomes exposed to 
SAR1 inactivation only after virion binding to target cells. The current data are also 
consistent with initial studies by Kennedy et al (Chanh et al., 1986; Kennedy et al., 
1986) demonstrating that rabbit antiserum prepared against a KE synthetic peptide 
could inactivate HIV-1, as these early studies used an assay format in which the serum 
antibody was incubated with the virus and the target cells. Further supporting the 
concept of a dynamic CTT topology is the recent report indicating that the LLP2 domain 
of the CTT is only accessible to antibody during cell-cell membrane fusion, suggesting 
major changes in virion Env topology post receptor binding (Lu et al., 2008). 
Interestingly, this would not be the first case of a viral envelope protein exhibiting a 
dynamic topology. The large envelope glycoprotein of hepatitis B virus is initially 
inserted into the endoplasmic reticulum membrane with its N-terminus located in the 
cytoplasm (von Heijne, 2006). After a post-translational maturation process, the N- 
terminus is translocated across the membrane by insertion of another transmembrane 
helix in about 50% of the molecules (Lambert and Prange, 2003). It will be interesting 
and important to determine the extent and precise localization of KE-exposed Env on 
the cell surface. 
Recent structural studies of diverse membrane proteins have resulted in an 
increased appreciation of the complexity and dynamics of membrane protein topology 
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(von Heijne, 2006). Earlier topology models were based on the simple concept that 
membrane proteins of the helix-bundle type were assembled from long hydrophobic 
alpha helices that were oriented perpendicular to the membrane plane (von Heijne, 
1999). However, based on high resolution structures of membrane proteins obtained 
during the past decade, it is now recognized that membrane helices can adopt a 
remarkable range of orientations relative to a membrane lipid bilayer and that 
membrane helices can dynamically reorient across the membrane in response to 
changes in the environment (von Heijne, 2006). Specifically, a recent study has 
demonstrated that the six helix N-terminal domain of LacY can undergo topological 
inversion due solely to the introduction of phosphatidylethanolamine into the lipid 
membrane, illustrating that environmental changes can cause specific alterations in 
membrane protein topology (Bogdanov et al., 2008). Additionally, recent advances in 
understanding the properties of the lipid membrane have led to new insights into 
membrane protein-lipid interactions (Engelman, 2005; Phillips et al., 2009). In particular, 
hydrophobic matching of protein transmembrane segment length to lipid domains of 
similar thickness has been shown to affect membrane protein segregation, structure, 
and function (Andersen and Koeppe, 2007; Epand, 2008; Lee, 2004; Phillips et al., 
2009). It is intriguing to consider, in the context of data presented here, the possibility 
that the gp41 CTT may undergo a dynamic change in topology due to alterations in the 
lipid environment. Alternatively, in order to minimize hydrophobic mismatch, Env with 
the CTT in the traditional topology could be selectively incorporated into the lipid rafts 
that serve as the sites of virion assembly. 
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A second aspect of current membrane protein structure studies that appears to 
be relevant to the case for a reconsideration of HIV-1 CTT membrane topology is the 
unique role of arginine (Arg) in membrane-associated proteins. While the early 
paradigm predicted Arg residues to be excluded from hydrophobic environments like a 
membrane lipid bilayer, more recent structural data indicate unique biochemical 
properties of Arg that produce unexpected functional properties for membrane proteins. 
For example, Arg residues can be incorporated as critical components of the membrane 
spanning domains of proteins, as observed with highly conserved Arg residue in the 
MSD of HIV-1 (c.f. Figure 24). The ability of the positively charged Arg to be located in a 
lipid environment is evidently due to the capacity of the Arg guanidinium group to form 
an energetically favorable cation-π bond with tryptophan, tyrosine, or phenylalanine 
residues in a stacked helix (Dougherty, 1996; Ma and Dougherty, 1997). Interestingly, a 
highly conserved phenylalanine is located three residues C-terminal to the Arg in the 
HIV-1 MSD (Figure 25). 
A second unique property of Arg is its ability in a repeat sequence (or 
homopeptide) to mediate transport of proteins and DNA or RNA across intact biological 
membranes, in contrast to homopeptides of other charged amino acids such as lysine 
(Lys) and histidine (His) that fail to efficiently cross lipid bilayers (Mitchell et al., 2000). 
Thus membrane protein segments rich in Arg residues have a propensity to cross 
biological membranes under certain environmental conditions, offering the potential for 
a dynamic membrane topology. For example, the Arg-rich helical S4 segment of the 
voltage-gated potassium channel KvAP is proposed to move across the membrane as 
the channel opens and closes in response to changes in the membrane electric field 
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(Jiang et al., 2003). While this was initially controversial due to the number of Arg 
residues (four) in the S4 segment, more recent studies have demonstrated that the S4 
segment can insert into the membrane of eukaryotic cells as a transmembrane helix in 
spite of the four Arg residues (Hessa et al., 2005b). These findings, when viewed in light 
of observations by Lu et al (Lu et al., 2008) demonstrating transient LLP2 exposure on 
Env-expressing cells undergoing fusion, may provide an explanation for the 
predominance of Arg residues in the HIV gp41 CTT relative to other cationic residues. 
A unique characteristic of the gp41 CTT of HIV-1 is that it contains two cationic 
amphipathic helical segments (LLP1 and LLP2) that are rich in Arg. In addition, the CTT 
contains a number of other highly conserved Arg residues. We and others have 
previously shown that synthetic LLP1 and LLP2 peptides assume a random coil 
conformation in aqueous environments, but rapidly convert to a helical conformation in a 
hydrophobic or membrane mimetic environment (Fujii et al., 1992; Srinivas et al., 1992; 
Yuan et al., 1995). In addition, we have shown that synthetic LLP1 and LLP2 peptides 
are able to readily traverse biological membranes of intact mammalian cells. These 
observations are consistent with the concept of the Arg-rich CTT being intimately 
associated with the membrane lipids and being able to cross the lipid bilayer of an intact 
viral or cell membrane. 
Finally, we and others have previously reported that modifications in CTT length 
or amino acid composition can have marked affects on global Env structure and 
function, including virion incorporation, fusogenicity, and antibody reactivity. For 
example, we found that the mutation of two Arg residues to glutamate (Glu) residues in 
LLP2 of an HIV-1 provirus substantially reduced Env fusogenicity and altered the 
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antibody reactivity and neutralization sensitivity of epitopes located in both the gp120 
protein and the ectodomain of gp41 (Kalia et al., 2005). These observations have been 
interpreted to indicate that changes in CTT result in allosteric alterations in global Env 
conformation that are reflected in altered functional properties, including reduced 
fusogenicity. It is interesting to speculate that altering the Arg content may affect the 
association of the LLP segments with the lipid bilayer and perhaps the ability of the CTT 
to traverse the membrane during the fusion process. 
As often happens in HIV-1 research, our efforts to test two relatively simple 
models for CTT topology have indicated the need to consider more complicated and 
dynamic models of CTT membrane topology. This is perhaps a timely pursuit in light of 
the new paradigms of membrane structure and the importance of understanding the 
mechanisms by which the CTT serves as a determinant of HIV-1 Env structure and 
function on the surface of virions and cells. 
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5.0  EXISTENCE OF A CELL SURFACE TOPOLOGY FOR THE HIV GP41 C- 
TERMINAL TAIL THAT IS DISTINCT FROM THE VIRAL TOPOLOGY 
5.1 INTRODUCTION 
The envelope (Env) protein of HIV, as the only virally-encoded protein present on the 
surface of the virion, is the primary target of the humoral immune response (McElrath 
and Haynes, 2010). Env is composed of two subunits that are translated as a 160 kDa 
polyprotein that is post-translationally cleaved to yield the highly glycosylated gp120 (or 
surface unit - SU) and the transmembrane (TM) protein gp41 (Luciw et al., 2002). In 
addition, gp41 is composed of three distinct domains: the ectodomain; the (putative) 
membrane spanning domain (MSD) that is thought to anchor Env in the membrane; and 
the C-terminal tail (CTT). gp120 functions to mediate binding to the primary receptor, 
CD4, and the coreceptor, primarily CXCR4 or CCR5, while gp41 mediates fusion of the 
viral and cellular membranes, resulting in infection (Luciw et al., 2002). 
The gp120 protein and the gp41 ectodomain have both been extensively studied, 
both structurally and functionally, as they appear to be the important targets of the 
antibody response in infected individuals (McElrath and Haynes, 2010). Likewise, the 
gp41 MSD is the focus of intensive study to determine the exact sequences involved in 
spanning the cellular and viral lipid bilayers (Haffar et al., 1988; Miyauchi et al., 2005; 
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Shang and Hunter, 2010; Shang et al., 2008; West et al., 2001; Yue et al., 2009). The 
CTT, on the other hand, has largely been studied at a functional level, and has been 
demonstrated to play a role in viral Env incorporation (Freed and Martin, 1995, 1996; 
Murakami and Freed, 2000a, b), virion maturation (Jiang and Aiken, 2007; Kol et al., 
2007; Wyma et al., 2004; Wyma et al., 2000), cellular Env trafficking (Byland et al., 
2007; Ohno et al., 1997), and more recently, as a modulator of Env gp120 conformation 
on both the cell and virion surfaces (Joyner et al., 2011; Kalia et al., 2005). However, 
relatively little is known about the structure of the CTT aside from characterizations of 
peptide analogs of CTT subdomains, known as the lentivirus lytic peptides (LLPs), that 
have been demonstrated to be predominantly helical in membrane and membrane-like 
environments (Fujii et al., 1992; Kliger and Shai, 1997; Srinivas et al., 1992; Steckbeck 
et al., 2011). 
The topology of the CTT has been largely ignored as a topic of study in the 
otherwise vastly explored field of Env structure. The prevailing model, which has never 
been experimentally demonstrated, is that Env gp41 exists as a type 1 membrane 
protein, with an extracellular (or extravirion) N-terminal domain (the ectodomain), a 
single (helical) transmembrane domain, and a cytoplasmically-localized, approximately 
150 amino acid long C-terminal domain. Originally, this model was described based on 
sequence and structural comparisons with other retroviral Env proteins, particularly the 
oncogenic retroviruses that have a single transmembrane domain followed by a short 
cytoplasmic tail (Miller et al., 1991). More recently, an alternative topology for the CTT 
has been proposed based on reactivity of viral particles (Cheung et al., 2005; Heap et 
al., 2005; Hollier and Dimmock, 2005) and Env-expressing cells with a monoclonal 
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antibody (MAb) directed at the CTT (Cheung et al., 2005; Heap et al., 2005; Hollier and 
Dimmock, 2005; Steckbeck et al., 2010). Interestingly, this alternative topology was 
suggested in the 1980s when Kennedy and colleagues discovered that serum from 
rabbits immunized with a peptide from the gp41 CTT could neutralize virus (Kennedy et 
al., 1986), and that antibodies reactive to that particular peptide were found in infected 
humans (Chanh et al., 1986; Ho et al., 1987). These results suggested exposure of the 
peptide epitope, known as the Kennedy epitope (KE), on the virion surface, as antibody 
cannot cross intact lipid membranes. 
More recent studies have yielded interesting, if sometimes conflicting, results 
regarding CTT topology. Initial studies of CTT topology by Dimmock and colleagues 
suggested that the KE was exposed on both the cellular and viral surface (Cleveland et 
al., 2003; Reading et al., 2003). Later experiments, however, demonstrated that the KE 
appeared to be exposed on the cell, but not the virion (Cheung et al., 2005; Heap et al., 
2005). Our lab has recently published similar results demonstrating the exposure of the 
Kennedy epitope on the surface of intact Env-expressing cells, but no apparent 
exposure on the virion (Steckbeck et al., 2010). These cellular results are in contrast to 
another recent study using GFP-fused gp41 truncation mutants (Liu et al., 2010). In that 
study, the gp41 CTT was only observed in a cytoplasmic orientation in Env-expressing 
cells (Liu et al., 2010). 
Complicating CTT topology studies even further are results suggesting that the 
CTT undergoes dynamic rearrangements during the fusion process. This was first 
observed using the post-attachment neutralization (PAN) assay and finding that an anti- 
KE MAb, SAR1, could neutralize HIV when preincubated with virus and cells at 25 °C, 
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but did not neutralize either at 37 °C (in the PAN format) or in a traditional neutralization 
assay (Cheung et al., 2005; Heap et al., 2005). A more recent study has also indicated 
that topological rearrangements of the CTT take place during the membrane fusion 
process. Using an antibody directed at LLP2, Chen and colleagues found that they 
could detect LLP2 if cell-cell fusion was carried out at 31.5 °C, but not at 37 °C (Lu et 
al., 2008). These results are similar to those obtained with the PAN assay in that CTT 
sequence exposure is only observed when the fusion process is delayed using a lower 
temperature (Lu et al., 2008) suggesting that the exposure during fusion is likely to be 
highly transient. This model is consistent with data demonstrating that the LLP2 
sequence is membrane associated both during and after membrane fusion (Viard et al., 
2008). Together, the current published results present an uncertain picture of CTT 
membrane topology. 
In an effort to provide a comprehensive experimental CTT topological map, we 
have extended previously published experiments (Steckbeck et al., 2010) using the 
VSV-G epitope tag insertion technique to determine the reactivity of the entirety of the 
CTT sequence, both on the surface of Env-expressing cells and on viral particles. 
Results indicate that a majority of the CTT sequence is accessible to antibody binding 
on the surface of intact, Env-expressing cells. On the contrary, no apparent exposure of 
CTT sequences was observed on pseudoviral particles containing VSV-G-tagged Env. 
These results provide further evidence for a complex CTT topology beyond the widely 
accepted intracytoplasmic model. 
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5.2 MATERIALS AND METHODS 
5.2.1 Cell and virus construct 
HEK293T cells (ATCC) and TZM-bl cells (from the AIDS Reference and Reagent 
Program) were maintained in DMEM (Invitrogen) supplemented with 10% (v/v) FBS. 
Cells were used at passage numbers less than 30. The pSG3ΔEnv used for 
pseudovirus production was provided by the NIH Aids Reference and Reagent 
Program. 
5.2.2 VSV-G epitope tag substitutions 
The VSV-G epitope tag was cloned serially into the CTT of HIV-1 89.6 Env as 
previously described (Steckbeck et al., 2010), and shown schematically in Figure 30. 
Briefly, the codon-optimized Env gene was cloned into a p2CI vector derived from 
PCR2.1 by insertion of the CMV promoter and polyA signal sequence from 
pcDNA3.1(hygro) (Invitrogen) and PCR-amplified IRES-Neomycin resistant sequence 
from pFB-Neo-LacZ vector (Stratagene). Overlapping PCR was used for the 
construction of the VSV-G substitution mutants of gp160. The two hybrid primers were 
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Figure 30. Replacement of HIV gp41 sequences with VSV-G sequences 
 
The VSV-G epitope tag was used to replace gp41 CTT sequences serially across the length of the CTT 
as indicated, from CTT1 to CTT14. The VSV-G epitope tag sequence is listed above CTT1. 
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constructed containing VSV-G tag sequences at the 5’-ends and HIV gp160 specific 
sequences at the 3’-ends of both primers used for the substitutions. Final overlapping 
PCR products were then subcloned into the HIV-1 gp160 expression vector using the 
appropriate restriction enzymes and the Rapid DNA Ligation Kit (Roche Applied 
Science). All VSV-G substitutions were verified by DNA sequencing. 
5.2.3 Cell culture and transfections 
HEK293T cells were plated into six-well plates 24 hours prior to transfection. For 
evaluation of VSV-G epitope exposure on Env-expressing cells, 80% confluent cells 
were transfected with 2.5 μg of the selected HIV-1 Env mutant DNA using 
LipofectamineTM LTX reagent and PLUSTM reagent, as recommended by the 
manufacturer (Invitrogen). 
5.2.4 Cellular FACS analysis 
Cells were harvested 24 hours post-transfection by treatment with 2 mM EDTA. Cells 
were resuspended and washed twice with FACS wash buffer (1X PBS with 5% FBS) at 
4 °C prior to antibody staining. Reference MAbs specific for VSV-G (Roche 
Diagnostics), gp41 (SAR1), and actin (Sigma-Aldrich) were labeled immediately prior to 
staining using Zenon labeling kits (Invitrogen) following manufacturer instructions. A 
sample of 106 cells was dual-stained by incubating with 5 μg fluorophore-labeled 
antibody (VSV-G- or gp41-specific) and 7.5 μg fluorophore-labeled actin antibody for 30 
minutes on ice. Following staining, cells were washed thrice with FACS wash buffer at 4 
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°C. Washed cells were resuspended and stained with 7-amino-actinomycin D (7-AAD). 
Cells were not fixed prior to analysis. Fluorescently-labeled cells were analyzed on a 
FACSAria (BD Biosciences). Live intact cells (7-AAD negative) were selected for scatter 
characteristics, including selection of single-cell populations by doublet-discrimination 
analysis. PMT settings were adjusted on identically-stained mock transfected cells prior 
to analysis of Env-transfected cells. Data was collected for 5x104 7-AAD negative cells 
and analyzed for reactivity with fluorescently-labeled VSV-G or gp41 and actin 
antibodies. 
5.2.5 Production of pseudoviral particles with VSV-G tagged Env 
To produce VSV-G tagged pseudovirions, HEK293T cells were plated and transfected 
as above, with 1.25 μg VSV-G tagged Env DNA and 1.25 μg pSG3ΔEnv. Cellular 
supernatants were harvested 48 hours post-transfection and clarified at 1,500 x g for 10 
minutes. The clarified supernatant was pelleted for 1.5 hours at 21,000 x g over a 20% 
glycerol cushion. The pelleted virus was resuspended in 1X PBS and further purified on 
a 30%/45% sucrose step gradient. The viral band was collected, pelleted through a 20% 
glycerol cushion, and resuspended at a 1000X concentration in 1X PBS. 
5.2.6 Pseudoviral immunoprecipitation and Western blotting 
Protein G Dynabeads (Invitrogen) were prepared according to the manufacturer’s 
directions. Briefly, anti-Env or anti-Gag antibodies (4 μg) were incubated with 20 μl 
protein G Dynabeads in 35 μl citrate-phosphate buffer, pH 5.0, with gentle shaking for 
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45 minutes at room temperature. Isotype-matched IgG controls were used for each 
species (murine, human, etc.) from which a MAb was derived. Beads were washed 
thrice with 0.5 ml citrate-phosphate buffer followed by resuspension in either 26 μl PBS 
(for intact virus) or 26 μl PBS with 1% Triton X-100 (for lysed virus) and 4 μl NL4-3 virus 
(equivalent to 1.1 μg p24). Virus-bead suspensions were incubated at 4 °C for one hour 
with gentle shaking and subsequently washed thrice with 1X PBS. Following the final 
wash, beads were resuspended in NuPAGE SDS-PAGE buffer, heated at 70 °C for 10 
minutes, and the supernatant loaded onto 4-12% Bis-Tris NuPAGE gels. Gels were 
electrophoresed followed by transfer to polyvinylidene fluoride (PVDF) membranes 
using the Invitrogen iBlot system. Blots were blocked for one hour in 5% blotto (1X PBS 
with 5% dry milk). After blocking, blots were cut to allow separate staining of gp120 (>60 
kDa), gp41 (30 - 60 kDa), and p24 (<30 kDa). gp120 was stained with rabbit anti-gp120 
(Advanced Biotechnologies, Inc.), gp41 stained with Chessie 8, and p24 stained with 
Ag3.0 for 1.5 hours at room temperature. Blots were washed thrice with 1X PBS and 
0.025% Tween 20 (PBS-T), followed by incubation with appropriate secondary antibody 
(anti-rabbit IgG or anti-mouse IgG conjugated to horseradish peroxidase) for one hour 
at room temperature. Blots were washed thrice in PBS-T with the gp120 blot receiving 
an additional wash in 1X PBS with 0.1% Triton X-100. Finally, blots were incubated with 
PicoWest substrate (Pierce) for one minute and reassembled for visualization on X-ray 
film. 
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5.2.7 Western blot quantitation 
Antibody IPs were quantified by densitometry analysis. For each IP, three independent 
X-ray exposures were scanned and analyzed using ImageJ (NIH). When applicable, 
p24 bands were selected for each protein, and the integrated area under the 
densitometry curve was compared to that of the viral input band to yield percent of the 
input protein in the immunoprecipitate. Percent inputs for each protein for each of the 
three exposures were averaged to yield the overall percent input immunoprecipitated 
per experiment. This was repeated for three independent experiments, and the results 
were averaged to yield the final percent input immunoprecipitated per antibody. 
5.3 RESULTS 
5.3.1 The majority of the CTT sequence is exposed on the cell surface 
To map the topology of the CTT, a VSV-G epitope tag was used to serially replace CTT 
sequences over the entirety of the CTT (Anand, 2000; Das et al., 2008; Obermeyer et 
al., 2007; Steckbeck et al., 2010) (Figure 30). Additionally, the HA epitope tag was 
inserted into the V3 region of gp120 to allow for detection of the relative levels of Env in 
cells transfected with the various VSV-G substituted Envs. The resulting constructs 
were then used in assays to determine reactivity with Env on the surface of intact live 
cells, or on the surface of pseudovirus particles (see below). 
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 VSV-G-labeled Env constructs were transfected into 293T cells and analyzed for 
epitope tag reactivity to either anti-HA or anti-VSV-G MAbs as described previously 
(Steckbeck et al., 2010). Initially, cells were dual stained with anti-HA and anti-VSV-G, 
however, no HA (gp120) reactivity was observed in spite of positive VSV-G staining. It 
was determined by separate staining for HA and VSV-G reactivity in aliquots from the 
same transfection that the anti-VSV-G (CTT) MAb was apparently inhibiting the binding 
of the anti-HA MAb (data not shown). Therefore, to determine overall levels of Env 
expression on the cell surface, transfected cells were first stained for reactivity with anti- 
HA MAb (Figure 31A). In general, staining of all CTT constructs resulted in between 
20% to 40% of cells labeling positively for gp120 on the surface of intact, non- 
permeabilized cells, with the exceptions of CTT11 and CTT13. To determine VSV-G, 
and thus CTT, exposure on the cell surface, aliquots of the respective transfected cells 
stained with anti-HA (gp120) were stained in parallel with anti-VSV-G (Figure 31B). In 
general, a similar overall level of staining was observed with the anti-VSV-G MAb, with 
the majority of CTT constructs showing approximately 20% positive labeling, with the 
exception of CTT 6, 7, 8, 12, and 13. Results with CTT3 and CTT7 are consistent with 
results obtained previously with these constructs (Steckbeck et al., 2010). These results 
suggest that the majority of the CTT sequence of gp41 is exposed and reactive with 
antibody on the surface of intact, non-permeabilized Env-expressing cells. 
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Figure 31. HIV Env staining of live intact cells 
Live intact 293T cells transfected with the indicated VSV-G containing Env were stained with (A) anti-HA, 
or (B) anti-VSV-G monoclonal antibodies. (A) Total cell surface Env expression was determined by 
staining cells with anti-HA, targeting HA epitope tag inserted into gp120. (B) CTT exposure was 
determined by staining cells with anti-VSV-G, targeting the VSV-G epitope tag in the CTT sequence as 




5.3.2 CTT-exposed Env constitutes a large proportion of cell-surface Env 
While the above experiments demonstrated that a majority of the CTT sequence 
appears to be exposed on the surface of intact Env-expressing cells, they provide no 
information on the proportion of CTT-exposed Env relative to the total Env on the cell 
surface. In order to determine the relative extent of CTT-exposed Env, we took 
advantage of our previous observation that anti-VSV-G (anti-CTT) antibody prevented 
anti-HA (anti-gp120) binding during attempts at dual staining for FACS analysis. The 
rationale for this experiment is that blocking of anti-gp120 antibody binding by anti-CTT 
antibody allowed a relative quantitation of CTT-exposed Env as a function of the total 
surface Env. As total Env cell surface expression levels differed between each construct 
(Figure 31A), results were normalized to total HA binding in the absence of VSV-G 
antibody to allow a comparison between constructs. Results are presented as the 
percent HA binding inhibited by VSV-G antibody (Figure 32). The majority of constructs 
resulted in >20% inhibition of gp120 binding, with CTT3, CTT12, and CTT13 
approaching 50% inhibition. CTT2, CTT5, CTT7, and CTT11 all demonstrated <15% 
average inhibition. The apparent lack of antibody competition with the CTT7 construct is 
consistent with our previous data indicating that this segment is not exposed to antibody 
binding on the surface of transfected cells (this work and (Steckbeck et al., 2010)). 
CTT1 costaining with anti-120, on the other hand, apparently led to an increase in 
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Figure 32. Inhibition of HA-specific antibody binding by VSV-G-specific antibody 
Env-expressing cells were surface stained first with unlabeled anti-VSV-G (CTT) antibody followed by 
staining with fluorescently-labeled anti-HA (gp120). The percent reduction in HA-labeled cells compared 
to HA-stained cells without VSV-G staining is presented as percent HA-inhibition. 
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antibody reactivity, as evidenced by negative inhibition. These results indicate that CTT- 
exposed Env constitutes at least 20-50% of Env on the cell surface. 
5.3.3 CTT exposure is not apparent on the surface of VSV-G-tagged pseudovirus 
particles 
To provide a direct comparison of the VSV-G epitope tag based topology mapping 
studies on the cell surface, pseudoviruses were made by cotransfecting the VSV-G- 
tagged Env with pSG3ΔEnv. This approach has been widely used to generate infectious 
pseudoviruses for use in neutralization assays (Platt et al., 2009; Platt et al., 1998). 
Infectivity of the resulting transfection supernatants was determined using the TZM-bl 
assay and results are presented in Figure 33. Importantly, all VSV-G-tagged Env clones 
yielded infectious pseudovirus when transfected with pSG3ΔEnv. Luciferase activity 
from all the clones was >200-fold higher than that observed for the mock transfection 
and of the same order of magnitude as the wild-type Env. These results suggest that 
the VSV-G tag substitutions did not evidently interfere with the functional activity of Env 
as the resulting pseudovirions were infectious at a similar level to the wild-type Env from 
which they were derived. As such, the resulting pseudovirus particles were used to map 
the topology of the CTT by immunoprecipitation using the VSV-G epitope tag as the 
potentially exposed target. 
Immunoprecipitations were performed as described previously (Steckbeck et al., 
2010). As a control for antibody accessibility to an exposed membrane-localized 
epitope, immunoprecipitations with the MPER-directed antibody 2F5 were performed in  
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Figure 33. Relative infectivity of pseudoviruses containing VSV-G-tagged Env 
 
Supernatants from 293T cells cotransfected with pSG3ΔEnv and the indicated Env construct were used 
to infect TZM-bl cells to determine infectivity of the resulting pseudovirus particles. Results are presented 
as relative light units (RLU) per 100 μl of transfection supernatant. 
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parallel with the anti-VSV-G pull-downs. As these MAbs are Env-directed, precipitation 
of intact virions was determined by measurement of the amount of p24 bound to MAb- 
coated beads relative to the input p24. The rationale is that p24 could only be bound to 
the beads if the particular MAb of interest bound to an intact virion. Results from the 
immunoprecipitation assays are presented in Figure 34. The MPER-directed MAb 2F5 
was observed to immunoprecipitate intact particles from all VSV-G-tagged pseudoviral 
clones to varying degrees (open bars), ranging from 30-80% of the input p24 bound to 
the beads. In contrast, however, the anti-VSV-G MAb did not pull down p24 from any of 
the pseudoviral clones (closed bars). These results suggest that the CTT sequences 
are not apparently exposed on the surface of intact virions, in distinct contrast to the 
observed exposure on the cell surface. 
5.3.4 Dynamic exposure of CTT sequences during viral infection 
The current results demonstrate that a majority of the CTT is exposed to antibody 
binding on the surface of Env-expressing cells, but is apparently not natively exposed 
on the virion. To address the potential for CTT sequences to demonstrate transient 
exposure, post-attachment neutralization (PAN) assays were performed using a 
monoclonal antibody (SAR1) directed at the Kennedy epitope in the CTT (Figure 35). 
The assay was performed at both 37 °C and 31 °C, as prior studies demonstrated PAN 
activity at temperatures that do not support membrane fusion (Heap et al., 2005). 
Results from this assay demonstrate that SAR1 can mediate PAN when antibody and 
virus are incubated with cells at 31 °C, but not 37 °C. 50% neutralization was reached at  
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Figure 34. Immunoprecipitation of VSV-G-tagged pseudoviral particles 
 
Pseudovirus particles were immunoprecipitated using monoclonal antibodies specific for the VSV-G 
epitope tag (closed bars) or the gp41 MPER (2F5, open bars). Results are presented as the percent of 
input p24 that was immunoprecipitated (IP). 
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Figure 35. Post-attachment neutralization of HIV-1 89.6 by anti-CTT antibody 
Anti-CTT (Kennedy epitope-specific) monoclonal antibody SAR1 was used to determine post-attachment 
neutralization (PAN) activity at 37 °C and 31 °C. SAR1 did not exhibit PAN at 37 °C, but there was a 
statistically significant reduction in viral infection when SAR1 was tested for PAN at 31 °C. * indicates 
statistical significance at p < 0.05. 
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a SAR1 concentration of 25 μg/ml. These results indicate that CTT sequences that are 
not natively exposed on the virus become exposed when the virus-cell fusion process is 
delayed by incubation at lower temperatures. 
5.3.5 Prediction of HIV gp41 sequences to act as an in-plane membrane anchor 
Based on previous results from our lab (Steckbeck et al., 2010), it was expected that the 
VSV-G tag in CTT3 would be accessible to antibody staining. The reactivity of a majority 
of the CTT sequence was, however, unexpected. In essence, the reactivity in Figure 
31B demonstrates that the CTT is nearly entirely exposed on the cell surface, making 
Env in that case a monotopic protein. For that to occur, the region traditionally thought 
of as the MSD must not span the membrane, instead functioning to anchor Env to the 
cell surface by acting as either an in-plane anchoring sequence, or as a reentrant loop. 
This topological arrangement is not without precedent in viral proteins, as the Erns 
proteins from the Pestivirus genus of Flaviviridae are membrane anchored through in- 
plane helices (Fetzer et al., 2005; Sapay et al., 2006b; Tews and Meyers, 2007). 
Predictive programs addressing the ability of a protein sequence to act as either an in- 
plane anchor or reentrant loop were used to examine this idea further. TOPCONS 
analysis of the 89.6 gp41 sequence revealed no evidence for a propensity to form 
reentrant loops (data not shown). On the other hand, analysis using AmphipaSeek 
(Combet et al., 2000; Sapay et al., 2006a) indicated sequence with strong potential to 
exist as an in-plane membrane anchor. The sequence 672FDITNWLWYIRLFIMIVG689 
scored as a strong positive as an in-plane membrane anchoring sequence when tested  
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under conditions of high specificity and low sensitivity (Figure 36). This sequence 
contains the C-terminal end of the MPER and the N-terminal seven residues of the 
traditional MSD. These results demonstrate that Env has sequence characteristics 
similar to those found in in-plane membrane anchors and may demonstrate a propensity 
towards alternative topologies. 
5.4 DISCUSSION 
The current data extend previously published work from our lab on the cell surface 
exposure of the Kennedy epitope to a study of the topology of the entirety of the CTT 
sequence. In the current study, we have demonstrated a differing membrane topology 
for the HIV gp41 CTT on the cell surface compared to that which is present on the 
surface of infectious virions. On the cell surface, much of the CTT appears to be 
exposed to antibody binding on the extracellular side of the membrane, while on the 
virion, no exposure of CTT sequences is detected. These results reiterate the idea that 
the topology of the CTT of gp41 is more complex than the prevailing model of a 
completely cytoplasmic tail. The data also appear to conflict with published studies that 
demonstrate functional interactions between the Env CTT sequences and intracellular 
proteins (Byland et al., 2007; Freed and Martin, 1995, 1996; Lopez-Vergès et al., 2006; 
Murakami and Freed, 2000a, b; Ohno et al., 1997). The question then becomes how 
does the current data fit into the universe of CTT trafficking and functional studies that 
reinforce the traditional cytoplasmic CTT? 
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Figure 36. In-plane anchor prediction for HIV gp41 
The amino acid sequence of HIV-1 89.6 gp41 was subjected to in-plane anchor prediction using the 
AmphipaSeek methodology. The score is presented as a moving average over seven residues. A score 
above zero is considered positive for the propensity of a sequence to serve as an in-plane membrane 
anchor. The results were not dependent on the window size (7 - 15 residues). 
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The simplest explanation for the discrepancy between the current data and the 
traditional model is that the CTT-exposed Env is either misfolded or an alternative fold. 
Misfolding of the Env could be due to protein overexpression in transfected cells. 
However, in general, overexpression of membrane proteins that overwhelm the 
synthetic machinery tend to lead to the cessation of new protein synthesis concomitant 
with the induction of the unfolded protein response (UPR) and ER-associated 
degradation (ERAD) (Brodsky, 2007; Griffith et al., 2003; Kaufman et al., 2002; Meusser 
et al., 2005; Nakatsukasa et al., 2008; Wagner et al., 2006). If the UPR and ERAD 
cannot successfully reduce the accumulation of misfolded protein, the cell ultimately 
undergoes apoptosis (Kaufman et al., 2002). As the current results were determined on 
intact live cells, the observed CTT exposure is not thought to be an artifact of misfolded 
protein. 
A second explanation is that the observed CTT-exposed Env is the result of an 
alternative folding of the Env with respect to its membrane topology. The idea of 
multiple folds for membrane proteins is not without precedent. For example, the large 
envelope glycoprotein of hepatitis B virus is initially inserted in the membrane during 
biosynthesis with a cytoplasmic N-terminus (Lambert and Prange, 2001; Lambert and 
Prange, 2003). Following post-translational maturation, the N-terminus is translocated 
across the membrane in approximately 50% of the molecules by the insertion of another 
membrane helix (Lambert and Prange, 2001; Lambert and Prange, 2003). It is possible 
that during HIV Env biosynthesis a similar process occurs, resulting in a population of 
Env with both cytoplasmic and extracellular CTT sequences. Under this assumption, the 
CTT-exposed Env may be similar to the flavivirus Erns proteins that are attached to the 
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membrane by an in-plane membrane anchor (Brass et al., 2007; Sapay et al., 2006b). It 
is important to note that our data do not exclude the presence of cell-surface Env with 
cytoplasmically-localized CTT sequences; the data only demonstrate that CTT-exposed 
Env exists on the surface of Env-expressing cells. It is possible that both cytoplasmic 
and extracellularly-localized CTT exists at the same time in the same cell, and that CTT- 
exposed Env accumulates on the surface of the cell because it cannot be endocytosed 
due to extracellular localization of the functional endocytic signals (Byland et al., 2007), 
leading to enhanced detection. 
In addressing the extent of surface-exposed CTT, we found that a substantial 
portion of the Env on the cell surface was CTT-exposed. Under our experimental 
conditions, prior binding by anti-VSV-G (CTT) antibody reduced anti-HA (gp120) 
staining by up to 50%. It will be critical to recapitulate these cell surface CTT topology 
results in the context of a natural viral infection. If CTT sequences are exposed on the 
cell surface during the course of a viral infection, the CTT may then become an 
important target for neutralizing antibodies. Previous results have demonstrated that 
anti-Kennedy epitope MAbs can mediate post-attachment neutralization of viral infection 
(Heap et al., 2005; Reading et al., 2003). In addition, the CTT exhibits greater sequence 
conservation than gp120 (Steckbeck et al., 2011). These results, in light of the cell- 
surface CTT exposure demonstrated here, suggest that the in vivo exposure of CTT 
sequences on the surface of infected cells might provide the immune system exposure 
necessary to generate an anti-HIV antibody response. It is important to remember that 
early studies demonstrated an abundance of anti-CTT antibodies in patient sera (Chanh 
et al., 1986; Ho et al., 1987). 
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In contrast to the exposure of the CTT on the cell surface, we were not able to 
detect CTT exposure on the virion. The fact that we were able to make infectious 
pseudoviruses suggests that the Env incorporated into particles is properly functional, a 
result that was not predictable due to the 11-residue sequence replacement required for 
epitope tagging. Production of infectious pseudoviruses in and of itself suggests that 
functional redundancy might be encoded in the CTT, a concept also suggested by 
previous results demonstrating a need to mutate two endocytic sequences in the CTT to 
fully abrogate trafficking of Env to late endosomes (Byland et al., 2007). 
Observed topological differences in the CTT between the cell and virion surfaces 
leads to questions regarding the mechanism by which the observed differences occur. 
There are two potential explanations: (1) the CTT-exposed Env is incorporated into the 
budding virion, and undergoes topological rearrangements to localize to the interior of 
the viral membrane; or (2) the CTT-exposed Env is excluded from the budding virion. 
While (1) is possible, we believe that (2) is the more plausible explanation. 
A number of studies have demonstrated a functional interaction of the CTT with 
proteins localized exclusively in the cellular cytoplasm (Byland et al., 2007; Freed and 
Martin, 1995, 1996; Jiang and Aiken, 2007; Kol et al., 2007; Lopez-Vergès et al., 2006; 
Ohno et al., 1997; Wyma et al., 2004; Wyma et al., 2000). The simplest argument for 
the exclusion of CTT-exposed from the budding virion is that in this arrangement the 
CTT cannot interact with known intracellular partners, and thus does not traffic properly 
into the viral budding site. However, this simple explanation is sufficient to explain the 
exclusion of CTT-exposed Env from the virion only to the extent that Env incorporation 
is an active, regulated process. Evidence from CTT-deleted Env constructs suggests 
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that active Env incorporation is not always necessary. It has been previously 
demonstrated that viruses encoding a truncated CTT of only 17 amino acids past the 
putative membrane spanning domain retain full infectivity in vitro (Chakrabarti et al., 
1989; Hirsch et al., 1989; Kodama et al., 1989). Since CTT-deleted Env cannot be 
actively incorporated into the budding virion through interactions with intracellular 
partners, it must be incorporated passively (Checkley et al., 2011). This then begs the 
question, "Why is the CTT-exposed Env not passively incorporated into budding 
virions?" 
The answer may have to do with the differences in cholesterol and phospholipid 
content between cellular and viral membranes, particularly with regard to changes in 
lipid membranes material properties imposed by cholesterol. Previous reports have 
demonstrated that the cholesterol to total phospholipid ratio of the HIV virion is 
increased relative to the parental cell by approximately 2-2.5 fold (Aloia et al., 1988; 
Aloia et al., 1993; Brügger et al., 2006). Additionally, the levels of saturated lipids in the 
viral membrane is increased relative to the cellular membrane by 3.6 fold, resulting from 
both an enrichment of saturated lipids combined with a reduction in the levels of di- and 
polyunsaturated lipid species, particularly for dipalmitoyl-phosphatidylcholine (Brügger 
et al., 2006). The observed cholesterol and saturated lipid enrichment in the viral 
membrane is important as recent studies have demonstrated that increased levels of 
cholesterol strongly affects the bending modulus, KC, of membranes in which both 
phospholipid acyl chains are unsaturated by increasing the energy required to bend the 
membrane (Pan et al., 2008; Pan et al., 2009). This effect becomes significant in the 
case of protein sorting mediated by the differential effect on lipid bilayer curvature 
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induced by transbilayer versus in-plane protein insertion. Transmembrane helices 
distort both leaflets of the membrane approximately equally with respect to the lipids, 
and therefore would not be expected to induce any membrane curvature. In-plane 
insertion, on the other hand, leads to membrane curvature in laterally uncoupled 
monolayers depending on the depth of insertion (Campelo et al., 2008). Therefore, with 
respect to the cholesterol and unsaturated phospholipid-enriched membrane 
microdomains on the cell surface from which HIV is thought to bud, inclusion of an in-
plane helix relative to a transmembrane helix would be thermodynamically unfavorable 
due to the proposed increase in microdomain KC. This model (see Figure 37) could 
allow for the observed passive incorporation of CTT-deleted Env, while allowing for the 
exclusion of CTT- exposed Env from the membrane of a budding virion. 
While the above model proposes a means by which CTT-exposed Env is 
excluded from budding sites, the transient exposure of CTT sequences as 
demonstrated by use of the PAN assay adds an additional level of complexity to the 
topic of CTT topology. Transient exposure of CTT sequences during membrane fusion 
may provide a mechanistic rationale for the previously demonstrated conservation of 
arginine relative to lysine in the CTT (Steckbeck et al., 2011). In order to become 
transiently exposed during the virus-cell fusion process, CTT sequences would need to 
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Figure 37. Schematic model for exclusion of CTT-exposed Env from viral assembly and budding 
sites 
 
A physical model is proposed for the apparent inability of CTT-exposed to segregate into viral budding 
sites. Lipids with green headgroups have unsaturated acyl chains, while red headgroups have saturated 
acyl chains and are enriched, along with cholesterol (gray), in membrane microdomains and the viral 
membrane. The blue circle represents a helix partially inserted into the membrane interface. KC is the 
bending modulus of the membrane. 
 
 147 
traverse the lipid bilayer from their intravirion localization. Arginine has been 
demonstrated to facilitate translocation of soluble small peptides and large proteins 
through lipid bilayers (Futaki, 2005; Inomata et al., 2009; Mitchell et al., 2000; Tung and 
Weissleder, 2003). It is possible that the functional consequence of arginine 
conservation is to facilitate the movement of CTT sequences through the membrane 
during virus-cell fusion. The functional requirement for CTT translocation remains to be 
mechanistically defined. 
The results presented here introduce a new concept to the topology of the CTT, 
in particular that the CTT has the potential to exist in two distinct states that can differ 
between Env-expressing cells and the virion surface. Combined with the apparently 
transient exposure of CTT sequences during virus-cell fusion, the current studies 
highlight that the CTT sequence is more complex, both functionally and structurally, 
than the current intracytoplasmic model suggests. 
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6.0  GENERAL DISCUSSION OF RESULTS AND FUTURE RESEARCH 
DIRECTIONS 
6.1 SUMMARY OF MAJOR FINDINGS 
The goal of this dissertation project was to provide an experimentally-determined 
topology of the HIV gp41 CTT. Inherent to this goal was finding an amenable 
methodology that would provide a reasonable means of determining the "true" topology 
of the CTT (whatever it might be), on both Env-expressing cells as well as on the virion 
surface. An additional goal was to define the conservation of CTT sequence and 
structural elements to provide a commentary on the overall relevance of the CTT as well 
as to provide the first broad measure of these traits in the CTT literature. In this regard, 
through the use of physicochemical property calculations and computational folding 
simulations combined with experimental secondary structural confirmation, remarkable 
structure and property conservation was observed for CTT domains in spite of relatively 
low phylogenetic relatedness and the resulting high levels of genetic diversity. In 
parallel, the experimental topology determination provided additional evidence for the 
existence of a complex topology for the CTT beyond that of the currently-accepted 
model of Env as strictly a type I integral membrane protein, including transient exposure 
of CTT sequences during the membrane fusion process. These results provide for the 
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first time a consistent systematic topological determination for the CTT on the surface of 
both intact Env-expressing cells and viral particles. Collectively, in light of the 
surrounding CTT literature, these results suggest that the CTT sequence has important 
functional consequences beyond its currently described roles in Env virion incorporation 
and maturation including a functionally-necessary rearrangement during membrane 
fusion that necessitates conservation of sequence and structural properties. These 
findings will be discussed in more detail below. 
6.1.1 Physicochemical and structural characteristics of the CTT are widely 
conserved across genetically distinct viral sequences 
6.1.1.1 Summary of CTT conservation 
The findings from Chapter 3 demonstrated a remarkable conservation of 
physicochemical and structural properties of CTT sequences despite a high level of 
sequence divergence and genetic dissimilarity. In particular, the LLP regions of the CTT 
displayed consistent hydrophobicity, net charge, and hydrophobic moment across 
consensus sequences from eight clades/groups while demonstrating similar levels of 
sequence variability to the non-LLP regions, suggesting that these physicochemical 
characteristics are specifically conserved in otherwise variable sequences. Additionally, 
the CTT displayed a surprising conservation of arginine residues relative to lysine, 
particularly in the LLP regions (see section 3.3.2). 
 From a structural standpoint, the LLP regions of the CTT also displayed a high 
level of conservation. When consensus sequences of the LLP regions were subjected to 
computational folding, the structural diversity was low for each LLP region within a 
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clade/group, as evidenced by few structural clusters, in general (see Section 3.3.3). In 
addition, for each LLP region the structural similarity between clades/groups was 
demonstrated to be quite high (again, see Section 3.3.3, Figure 21). This predicted 
structural conservation was confirmed experimentally, where peptide analogs of the 
consensus sequences (synthetic) and the lowest average divergence sequences (actual 
sequences) from clades B, C, and group O were examined using CD spectroscopy in 
SDS micelles and TFE. The CD spectroscopy results confirmed the conservation of 
helical character in the peptides in both membrane-mimetic environments. 
6.1.1.2 Implications of CTT property and structural conservation 
The conservation of the physicochemical properties is particularly interesting for the LLP 
regions in light of their proposed membrane associating characteristics (Chernomordik 
et al., 1994; Fujii et al., 1992; Kliger and Shai, 1997; Srinivas et al., 1992), where the 
hydrophobic moment and charge may complement each other. The hydrophobic 
moment has been proposed as a measure of the tendency of a sequence to prefer the 
chemically-complex interfacial boundary between the hydrocarbon membrane interior 
and the aqueous phase (Eisenberg et al., 1984). The preference for the chemically 
complex membrane- water interface is suggestive of a role for the LLP regions as 
membrane-anchoring sequences. The (partial) insertion of the LLP sequences into the 
interfacial region would have a physical influence on the local membrane environment 
through introduction of local curvature stress, as well as by affecting the lateral pressure 
profile in the membrane interior (Booth et al., 2001; Cantor, 1997; Cantor, 1999a, b; 
Tillman and Cascio, 2003; van den Brink-van der Laan et al., 2004). These physical 
alterations of the membrane environment by interfacially-localized LLP peptides may 
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provide an explanation for the modulation of Env ectodomain conformation induced by 
point mutations in the LLP (Kalia et al., 2005). While the mutations introduced by Kalia 
et al. maintain the amphipathic potential of the LLP2 region, they alter the net charge of 
the region from +3 to -1 (Kalia et al., 2005). The resulting overall negative charge of the 
region may impact its association with the negatively charged inner membrane leaflet by 
introducing charge-charge incompatibilities with the negatively charged 
phosphatidylserine headgroups. Altered association (i.e. reduced/abrogated 
association) of LLP2 with the inner leaflet of the membrane would lead to a change in 
the local lateral pressure profile of the membrane, which in turn could lead to 
conformational changes in the protein by altering the arrangement of the 
transmembrane helices (Cantor, 1997; Cantor, 1999a; Cantor, 2002; Marsh, 2007; 
Tillman and Cascio, 2003; van den Brink-van der Laan et al., 2004). While it is difficult 
to experimentally validate this argument since the composition and structure of the gp41 
MSD is unknown, recent structural work on full-length and CTT-deleted Env on the 
virion surface hint at differences in the geometry of the MSD with respect to the 
membrane (White et al., 2010). Comparing the approximate geometries of the protein 
near the membrane interface (the best that can be done under these circumstances) 
reveals that the full-length Env adopts a roughly cylindrical shape, while the CTT- 
deleted Env protein exits the membrane in a pyramidal arrangement (c.f. Figure 10). 
Assuming similar lipid content between the full-length and CTT-deleted viruses (which 
may be an invalid assumption as the CTT may interact with and encourage the 
assimilation of specific types of lipids into the budding virion), the only difference then 
would be the presence/absence of the CTT, and resulting subsequent differences in 
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membrane curvature and lateral pressure, which, as indicated above, could account for 
differences in transmembrane helix packing suggested by the recent structural work. 
Likewise, as these two Env proteins are thought to represent distinct functional states 
(with the full-length representing the "resting" or native state of Env, and the CTT- 
deleted representing the receptor-bound, or "activated" Env), the effect of lateral 
pressure changes could, in theory, play a significant role in modulating the conformation 
of membrane-bound Env (Cantor, 1997; Cantor, 1999a; Cantor, 2002). Interestingly, the 
CTT has recently been demonstrated to modulate the conformation of gp120 and the 
gp41 ectodomain in virus particles, where Env with a CTT deletion displayed a more 
open state similar to the CD4-bound state (Joyner et al., 2011; White et al., 2010). 
Thus, there exists the possibility that the CTT, and the LLP regions in particular, evolves 
under pressure to maintain the "native" conformation of Env by maintaining specific 
consistent interactions with the lipid membrane. 
 The potential implications of arginine conservation with respect to LLP2 have 
been discussed in detail in Section 3.4. Briefly, studies demonstrating a transient 
exposure of LLP2 sequences during the cell-cell fusion process are suggestive of a 
mechanism to prefer arginine conservation relative to replacement with lysine. Arginine- 
rich peptides have been demonstrated to cross cellular membranes while peptides with 
lysine instead of arginine do not (Futaki, 2005; Mitchell et al., 2000; Tung and 
Weissleder, 2003). In addition, arginine-rich peptides have been demonstrated to 
deliver soluble proteins into the cytoplasm of live cells (Inomata et al., 2009). The 
observed apparent traversing of the membrane by LLP2 during the fusion process 
would seem, then, to require the presence of arginine. 
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 Implications for the overall observed conservation of arginine in the CTT become 
more interesting when the current topology results are taken into account. The data 
presented in Chapters 4 and 5 demonstrate that the topology of the CTT is (can be) 
distinct between the cellular and virion surface ("can be" as a function of the fact that 
our cellular data does not preclude the existence of virion-like CTT in the cell). This 
discovery of a cellular topology that is distinct from the virion topology is suggestive of 
either an alternative, stable topology that is (apparently) functionally irrelevant to the 
virion, or a dynamic rearrangement of the topology from the extracellular (lumenal or 
exposed) state to the internally-localized (intracytoplasmic) form (It is worth noting at 
this point that these two statements are not wholly incompatible, although some 
conjecture is necessary to align the two; as a membrane-bound protein, it is possible 
that Env interacts with a number of proteins during its biosynthesis. There exists, then, 
the possibility that an unknown interactant could stabilize the exposed topology in a 
subset of the synthesized Env population that may normally undergo dynamic 
topological rearrangement during the biosynthetic process). 
 A potential topological rearrangement will be addressed later in a proposed Env 
model, but for the sake of argument, if CTT-exposed Env must "flip" sides of the 
membrane (crossing the hydrocarbon interior in the process) to reach a different 
topology, the presence of arginine relative to lysine would be energetically preferred 
according to the biological hydrophobicity scale (Hessa et al., 2005a). A movement of 
arginine-rich sequences across a membrane when captive as part of a larger protein 
complex (as opposed to soluble peptide fragments) is perhaps best demonstrated in the 
voltage-sensor paddle of the potassium-gated ion channel KvAP, where the arginine-
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rich S4 helix (with four arginine residues) is proposed to cross the membrane 
hydrocarbon interior in response to changes in the membrane electrical field (Jiang et 
al., 2003). Interestingly, this same helical segment has demonstrated potential to insert 
into the membrane as a transmembrane helix in spite of the four arginine residues 
(Hessa et al., 2005b). 
 In all, the findings from the study of CTT conservation led to the identification of 
sequence and structural elements that contributed to the ability to propose a topological 
model for the CTT that has mechanistic and functional support from other membrane 
protein systems, and is consistent with membrane protein topological principles. 
6.1.2 Distinct CTT topologies on the cell and virion surface 
6.1.2.1 Summary of CTT cellular and viral topology studies 
The findings from Chapters 4 and 5 demonstrate that distinct topologies exist for the 
CTT between the surface of Env-expressing cells and viral particles. In Chapter 4, a 
particularly controversial antibody epitope in the CTT, the Kennedy epitope, was 
examined on cells and virions to provide an assessment of its exposure on each. This 
study introduced the use of an epitope-tagging technique whereby the VSV-G epitope 
tag was used to replace CTT sequences in order to take advantage of a high-affinity, 
well-characterized commercial monoclonal antibody. The results from this study 
demonstrated that the Kennedy epitope was exposed to antibody binding on the surface 
of Env-expressing cells as determined by flow cytometry, but was not apparently 
accessible on the virion surface in an immunoprecipitation assay. The 
immunoprecipitation results were confirmed by SPR spectroscopy to measure the 
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relative affinity of the anti-Kennedy epitope antibody to ensure that the observed lack of 
virion binding was not due to a high dissociation-rate of the antibody-virion complex. 
 The study presented in Chapter 5 extended the use of the VSV-G epitope tag to 
the entirety of the CTT sequence. Here, the VSV-G epitope tag was used to serially 
replace sequences along the entirety of the CTT, and cell surface exposure of each was 
determined by flow cytometry. Additionally, and importantly, the VSV-G-tagged Env 
constructs were used to create pseudoviral particles in an attempt to provide a 
consistent measurement across cellular and virion Env presentation. The VSV-G-
tagged env were co-transfected into 293T cells with pSG3ΔEnv to make pseudoviral 
particles that were determined to be infectious using the TZM-bl assay, suggesting that 
all the VSV-G-tagged Env constructs were functional. These VSV-G tagged 
pseudovirions were then used to determine apparent exposure of the VSV-G epitope 
tag by immunoprecipitation. The results from these studies indicated that a majority of 
the CTT is accessible to antibody binding on the surface of Env-expressing cells. In 
contrast, no CTT sequences were detected on the pseudovirion surface. Finally, the use 
of a post- attachment neutralization assay (PAN) allowed a demonstration of a transient 
exposure of CTT sequence, as virus and anti-CTT MAb incubated at 31 °C resulted in 
viral neutralization while incubation at 37 °C did not. 
6.1.2.2 Implications of different cellular and virion CTT topologies 
The results presented here provided the first systematic evaluation of CTT topology on 
both the cell and virion surface in an experimentally-consistent manner. The first 
important observation comes from the infectivity results using the VSV-G-tagged 
pseudoviral particles. The serial replacement of CTT sequences by the VSV-G epitope 
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tag was expected to yield some constructs that would be non-infectious, as the 
replacement of CTT sequences would be expected to alter important functional 
domains, particularly the demonstrated MA interaction (Freed and Martin, 1995, 1996; 
Murakami and Freed, 2000a, b). This interaction would have been expected to be 
altered in VSV-G constructs CTT8, CTT9, and CTT10 as they each replaced a portion 
of the sequence demonstrated to be important for MA interaction and Env incorporation 
(Murakami and Freed, 2000a, b). Since all constructs did yield infectious virus and 
displayed similar Gag:Env ratios, the results suggest that Env has evolved functional 
redundancies into the CTT. This is not unprecedented for Env, even in the CTT. 
Previous studies have demonstrated the existence of two functionally and 
mechanistically distinct endocytic motifs in the CTT, with locations near the N- and C-
terminal ends of the CTT sequence. The N-terminally-localized YxxΦ interacts with the 
clathrin adaptor protein 2 (AP-2) to mediate Env endocytosis from the plasma 
membrane, while the C-terminal dileucine motif interacts with AP-1 to effect Env 
endocytosis independent of the AP-2 (Byland et al., 2007; Checkley et al., 2011). 
Importantly, mutation of both motifs is required to abolish Env cycling to late endosomes 
from the cell surface (Byland et al., 2007). Additional functional redundancies exist in 
the CTT in the form of motifs that regulate or enhance partitioning of Env to cholesterol-
rich membrane microdomains. Here, acylation of endogenous cysteine residues, the 
presence of a cholesterol recognition amino acid consensus (CRAC) motif, and helicity 
of LLP1 have all been proposed as mechanisms by which the CTT directs Env to the 
cholesterol-rich microdomains from which HIV is thought to bud (Greaves and 
Chamberlain, 2007; Rousso et al., 2000; Yang et al., 1995; Yang et al., 2010). 
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Functional incorporation of VSV-G-tagged Env into infectious pseudoviral particles 
suggests that there are redundancies in the mechanism by which Env is incorporated 
into viral particles, either in the MA-mediated incorporation pathway alone, or through 
the use of multiple incorporation pathways. 
 Another implication of a distinct cellular CTT-exposed topology is the potential for 
the CTT to act as an immunological decoy. This idea is conceptually appealing and 
enjoys support from numerous published studies. Early studies that characterized the 
Kennedy epitope as a potential neutralizing epitope also demonstrated that sera from 
HIV-infected individuals were reactive to the Kennedy epitope peptide (Chanh et al., 
1986; Ho et al., 1987). This observed sera reactivity is suggestive of the fact that the 
CTT can serve as a potent immunogen during the course of viral infection. The cell 
surface-exposed CTT topology demonstrated here suggests a mechanism by which the 
previously-observed immunogenicity may occur. CTT exposure would present non-self 
antigens on the surface of HIV-infected cells. The induction of antibodies to the surface- 
exposed CTT would provide the immune system with a target that is bereft of the other 
immune decoy mechanisms inherent to Env, including high levels of glycosylation and 
conformational masking (Roux and Taylor, 2007). Antibodies to the Kennedy epitope in 
the CTT are of ambiguous utility, with in vitro neutralization demonstrated only in a 
minority of studies at the physiologically-relevant 37 °C (Chanh et al., 1986; Cleveland 
et al., 2003), with most studies requiring a delay of the fusion process by reducing 
temperature to ≦ 31 °C to enable neutralization (Cheung et al., 2005; Heap et al., 2005; 
Reading et al., 2003). If the exposure of the CTT during virus-cell fusion is a transient 
process, as is suggested by these and other studies (Viard et al., 2008), the induction of 
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antibodies to the CTT would result in antibodies with little to no anti-HIV activity. In 
addition to serving as a mechanism to "distract" the immune response, this may explain 
the relatively high levels of sequence variation observed in the CTT as demonstrated in 
Chapter 3. In this regard, data from our collaborators have demonstrated an apparent 
immunodominance of CTT sequences when added to vaccine immunogens containing 
other membrane interactive segments of gp41 (personal communication). In total, these 
results suggest that the cell-surface exposure of CTT sequences results in a directing of 
the immune system toward Env epitopes that are not exposed on the virion and have 
been demonstrated to be functionally ambiguous in vivo. 
 The demonstrated ability of anti-Kennedy epitope antibodies to neutralize virus 
infection in a post-attachment manner also opens up the possibility of targeting the CTT 
to inhibit viral infection. The apparent transient exposure of the Kennedy epitope during 
the fusion process presents a number of problems affecting antibody-mediated 
neutralization that could be overcome through the use of small(er) inhibitors. While 
antibody-antigen binding is generally a high affinity process (on the order of nanomolar 
KD, or lower; the affinity of current anti-CTT monoclonal antibodies for gp41 are not 
known), the architecture of the fusion site is likely to present a major inhibitory influence 
on antibody binding to CTT sequences. The initial contact distance between biological 
membranes during the fusion process is on the order of 10 - 20 nanometers (nm) which 
decreases to 2 - 3 nm prior to the formation of the hemifusion stalk (Chernomordik et 
al., 2006). As it is thought that the major temporal delays in HIV fusion occur at the CD4 
(followed by rapid formation of the pre-hairpin intermediate, leaving the large distance 
between membranes) and co-receptor binding steps (followed by rapid formation of the 
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six-helix bundle, leaving a small distance between membranes) (Gallo et al., 2003), 
under physiological conditions a potentially neutralizing antibody would have a small 
timeframe to reach into the fusion site and bind the transiently-exposed Kennedy 
epitope, as the coreceptor binding step occurs with a 500-fold faster apparent on-rate 
than the CD4 binding interaction (Chang et al., 2005). As the incubation temperature of 
the PAN assay (31 °C) is thought to delay the progression of the gp41 complex from the 
prehairpin intermediate to the formation of the six-helix bundle (Golding et al., 2002), 
and neutralization by anti-Kennedy epitope monoclonal antibodies only occurs at this 
temperature, the assumption must be that the CTT undergoes dynamic rearrangement 
during this time, which as indicated above is brief at 37 °C. The 2 - 3 nm distance at the 
point just before the formation of the hemifusion stalk would exclude antibody, which 
has molecular measurements on the order of 5x5x10 nm. A small molecule, on the 
other hand, could be designed to mimic the neutralizing effect of antibody in a size that 
would be much more amenable to interacting in the narrow confines of membranes 
undergoing the fusion process. The dynamic exposure, then, of sequences that make 
the CTT a potential neutralizing epitope also make the CTT a target for small molecule 
drug development and inhibition. 
 A final implication of a cellular CTT-exposed topology is that there would then be 
the potential for the CTT to act as a target for cytotoxic T-lymphocytes (CTLs). While 
this would appear to be in direct conflict with the concept that endocytic signals exist in 
the CTT in order to effect the active removal of Env from the cell surface so as not to 
“broadcast” the cell’s infected state, time may be on the side of the virus. Assuming the 
observed exposure is a result of accumulation of CTT-exposed Env at the cell surface, 
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and that the same process would take place in an infected cell, there should be 
sufficient time for virion assembly and budding to ensure the propagation of the infection 
before the accumulation of enough CTT-exposed Env to result in CTL recognition and 
cell lysis. 
6.2 A COMPREHENSIVE WORKING MODEL FOR THE CTT 
A new comprehensive model for CTT topology must take into account experimentally-
determined information including both explicit topology data as well as implicit functional 
data. In addition, a proposed model must make theoretical sense and must conform to 
the known principles for membrane protein insertion and topology. Finally, a proposed 
model should ideally provide testable hypotheses where it makes assumptions based 
on predictive results. As such, following a brief theoretical revisitation of CTT topology 
prediction, we propose a comprehensive model for CTT topology that addresses all 
current and published functional and topological data. 
6.2.1 Revisiting the Membrane Association of gp41 - A Theoretical Study 
The experimental data presented here have demonstrated surface accessibility of CTT 
sequences on intact Env-expressing cells with the same sequences being undetectable 
on the virion surface. These results, combined with the calculated propensity for a gp41 
sequence to serve as a potential in-plane anchor, prompted an ab initio theoretical 
study of the association of gp41 with the membrane. Key to this study are recent 
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developments in the understanding of membrane protein biogenesis, chief among which 
was the recent development of a biologically-derived hydrophobicity scale for protein 
insertion into the ER membrane that has provided the best evidence to date that the 
insertion of membrane proteins into the lipid bilayer is a thermodynamically-driven 
partitioning process (Hessa et al., 2005a; Hessa et al., 2007). The important principle 
underlying this finding is that as a thermodynamic process, the insertion of hydrophobic 
segments is an equilibrium event between insertion and translocation of the segment in 
question, dependent on ΔGapp, where ΔGapp = 0 results in a 1:1 ratio of 
insertion:translocation into the ER lumen (Hessa et al., 2005a; White and von Heijne, 
2008). In essence, the goal is to start at the translocon and build a theoretical model for 
gp41 membrane association. 
 The protein translation and translocation machinery of the cell has no knowledge 
of the history or bias inherent to the study of the topology of gp41. It "merely" detects 
and properly partitions protein regions on the basis of their hydrophobicity into either the 
lipid bilayer (for hydrophobic sequences with appropriate properties) or into the lumen of 
the ER (for ultimately soluble, non-cytoplasmic proteins) (von Heijne, 2006; White and 
von Heijne, 2008). The first step was to reexamine the Env sequence using the 
biological hydrophobicity scale to understand the theoretical basis of its membrane 
association since Env is translated as a polyprotein and cleaved into gp120 and gp41 
post-translationally and after trafficking from the ER to the Golgi (Checkley et al., 2011). 
The initial scan identified four regions as potential transmembrane helices in the gp160 
sequence: (i) positions 12-30, with ΔGapp = 0.417 kcal/mol (the signal peptide); positions 
514-542, with ΔGapp = 0.883 kcal/mol (the fusion peptide); positions 678-705 with ΔGapp 
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= -4.28 kcal/mol (N-terminal to, and including the traditional MSD sequence); and 
positions 749-778 (including residues prior to and including the N-terminal 14 amino 
acids of LLP2), with ΔGapp = 0.22 kcal/mol. When converted to Kapp, the predicted ΔGapp 
reveals the relative extent to which a helix should be inserted into the membrane as 
compared to translocated into the lumen of the ER (ΔGapp = -RT ln Kapp; R = universal 
gas constant; T = absolute temperature; Kapp = inserted/non-inserted). It was not 
unexpected to find membrane-insertion propensity for both the signal peptide as well as 
the fusion peptide as the role of each is known to involve membrane interaction. As 
expected, the traditional MSD sequence was predicted to insert as a membrane 
spanning helix. Perhaps unexpected, however, was that residues N-terminal to the MSD 
were included as part of the predicted membrane-inserting region. A comparison of the 
ΔGapp for both the traditional MSD (-0.88 kcal/mol) and the predicted region (-4.28 kcal/ 
mol), reveals that inclusion of the N-terminal residues results in an approximately 282- 
fold increase in the Kapp (1214 versus 4.3, where Kapp is the ratio of inserted:non- 
inserted), leading to a much greater predicted insertion efficiency. It is interesting to 
note that no known MAbs react with the sequences that are part of the predicted 
transmembrane region (from the LANL immunology antibody database, 
www.hiv.lanl.gov/content/immunology/maps/ab/gp160.html). 
Perhaps unexpected was the identification of an additional potential 
transmembrane helix in the CTT, near and including part of the LLP2 region. The 
predicted ΔGapp for this region, at 0.22 kcal/mol, makes this sequence very interesting 
from a membrane interaction standpoint. Conversion to Kapp reveals that the 
inserted:non-inserted ratio is 0.69, suggesting that nearly 40% of the time this region is 
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predicted to insert into the membrane as a transmembrane helix. It will be important to 
experimentally validate the predicted membrane insertion efficiency of this region. 
Predictions using the biological hydrophobicity scale provide insight into the 
potential for protein membrane association during translation. It does not provide explicit 
information on the final folded protein, and in fact, it is becoming clear that many 
membrane proteins may rearrange post-translationally into a structure different from 
that which is inserted by the translocon (Kauko et al., 2010). As such, post-translational 
trimerization of Env may provide an opportunity for rearrangement of the 
transmembrane regions. 
6.2.2 A Proposed Topological Model for the HIV gp41 CTT 
Env is translated as a monomeric unit that is directed to the ER membrane for 
translation and membrane insertion by recognition of the N-terminal signal peptide by 
the signal recognition complex on the translating ribosome. While the env mRNA is 
being translated into protein by the ribosome, the nascent peptide chain is being 
evaluated cotranslationally by the translocation complex, and the translocon in 
particular, for transmembrane sequences. Sequences displaying the correct properties, 
chief among them being sufficient hydrophobicity, are shuttled into the membrane 
environment by what is thought to be a thermodynamically-driven partitioning process 
(Hessa et al., 2005a; von Heijne, 2006; White and von Heijne, 2008). An important point 
to consider before going further is that the ER membrane has symmetric lipid 
distribution between the bilayer leaflets (van Meer et al., 2008) and displays no 
electrical membrane potential (Dowhan and Bogdanov, 2011). Theoretically, then, there 
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should be no charge/lipid influence on membrane protein topology during translocation 
(it is important to note that we believe those factors play a role later in the biosynthetic 
process, particularly upon trafficking to the Golgi). The comprehensive model is 
presented in Figure 38. At this first step, Env gp160 is predicted to display a potential for 
a complex topology. The biological hydrophobicity scale predicts strong membrane 
insertion of a 28 residue segment that includes the traditional MSD sequence, labeled 
MSD1 in Figure 38. Conversion of ΔGapp to Kapp results in an inserted:non-inserted ratio 
of 1214, indicating that MSD1 is predicted to insert as a transmembrane region in the 
vast majority of the translated Env. There would be, however, a very small population (< 
1 in 1000 translated gp160 polyproteins) where this region would not insert as a 
transmembrane helix, and assuming that the remainder of the sequence translocated, 
this would give rise to the topology observed on the cell surface, with nearly the entirety 
of the CTT accessible to antibody binding, and the predicted in-plane anchor sequence 
(which is very similar to the predicted transmembrane sequence) along with the 
inaccessible LLP2 region anchoring Env to the membrane. The observation of this very 
small population would be enhanced at the cell surface due to the fact that the 
functional endocytic signals would be located on the opposite side of the membrane 
from the endocytic machinery, allowing an accumulation of exposed Env on the cell 
surface; Env with a single membrane spanning domain would be rapidly endocytosed, 
as previously described (Byland et al., 2007). This accumulation at the cell surface may 
account for the topological results presented in Chapters 4 and 5. Transmembrane 
insertion of the second region, labeled MSD2, (positions 749-778) would sequester the 
C-terminal 73 amino acids in ~40% of this already small population 
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Figure 38. Proposed topological model for the HIV gp41 CTT 
A proposed gp41 CTT topological model during the protein biosynthetic process, from the initial protein 
translation and translocation into the ER, trafficking to the Golgi and plasma membrane (PM), and finally 
incorporation into viral particles or recycling to the late endosome. The Env ectodomain (gp120 and gp41 
ectodomain) are located on the lumenal side of the membrane. MSD regions are those predicted using 
ΔGPred with the indicated percentages being the relative insertion efficiency based on predicted KApp (red 
for MSD1 and blue for MSD2). This proposed model is consistent with the topological data presented 
here as well as previously published functional data. 
(-) - negatively charged phospholipid headgroups, predominantly phosphatidylserine; yellow “hook” 
represents proposed Env interacting partner that holds the CTT in the exposed orientation 
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into the cytoplasm, but this too would be endocytosed from the cell surface due to the 
presence of the extreme C-terminal dileucine endocytic motif (Byland et al., 2007). As 
suggested in Section 6.1.1.2, an unknown Env interactant could "hold" the CTT-
exposed Env in this conformation throughout the biosynthetic process, resulting in the 
observations presented here in Chapters 4 and 5. This Env would not be expected to 
incorporate into the budding virion, as discussed in Section 5.4. 
Returning to the main predicted transmembrane domain, in the vast majority of 
cases it is predicted to insert as a transmembrane helix, which is in line with current 
thoughts on the Env MSD. In addition, however, the second predicted transmembrane 
region at positions 749-778 is predicted to insert into the membrane with ~40% 
efficiency. Assuming insertion of the first transmembrane sequence, transmembrane 
insertion of this second sequence would result in the lumenal (ER) exposure of the 73 
C-terminal amino acids in ~40% of the translated Env. 
At this point, for the majority of the translated Env (gp160 polyprotein) there is a 
predicted 60/40 distribution of one transmembrane region (with entirely cytoplasmic 
CTT) and two transmembrane regions (with C-terminal 73 residues of the CTT 
lumenally-localized). Before leaving the ER and trafficking to the Golgi, Env undergoes 
a shift from monomers to trimers (Checkley et al., 2011), and here I propose that 
trimerization results in a "shifting" of the predicted transmembrane sequences to 
resemble the traditionally-held MSD sequences and bringing the conserved arginine 
residue to the mid-span position (Figure 39). This proposed mechanism of insertion 
followed by a sequence shift upon trimerization would allow for easier (and 
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Figure 39. Proposed MSD sequence rearrangement upon trimerization 
 
The predicted MSD for HIV gp41 (left) contains an additional six residues compared to the generally 
accepted (traditional) MSD sequence (right). As a monomer (as transcribed and translocated), the 
predicted MSD has a more favorable ΔGapp (-4.28 kcal/mol) than the traditional sequence (-0.88 kcal/ 
mol). Trimerization could result in a more favorable free energy of insertion for the traditional sequence by 
allowing intrahelix interaction of the midspan arginine, as suggested by MD simulations (Kim et al., 2009). 
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energetically-favorable) snorkeling of the arginine in the translocon-inserted form that 
upon trimerization and movement into the membrane interior would serve to stabilize 
the three-helix bundle as proposed (Kim et al., 2009). 
Trafficking to the Golgi introduces a new environment and new forces to the 
translated Env polyprotein. In the Golgi, the membrane leaflets have an asymmetric lipid 
distribution, with the negatively charged phosphatidylserine and the zwitterionic 
phosphatidylethanolamine localizing to the cytoplasmic leaflet (Dowhan, 1997; van 
Meer et al., 2008). Additionally, an electrochemical gradient exists across the Golgi 
membrane such that the electrochemical potential of the membrane is oriented positive 
in (cytoplasmic side is negative) (Glickman et al., 1983; Llopis et al., 1998; Rudnick, 
1986). As the trimerized Env incorporates into the Golgi membrane, this new 
environment and force would be expected to play a role in the membrane topology, as 
has been described (Bogdanov et al., 2008; Dowhan and Bogdanov, 2009, 2011; von 
Heijne, 2006). The traditional Env with the cytoplasmically-localized CTT would not 
need to rearrange in response to the new environment and forces, as the overall 
positively charged nature of the sequence would be situated to interact favorably with 
the negatively charged lipid headgroups as well as be in harmony with the 
electrochemical potential of the membrane. The other 40% of Env with two 
transmembrane domains, however, would likely undergo topological rearrangement as 
the 73 amino acids predicted to be exposed carry a +5 charge. Here, the predicted 
transmembrane domain would act as a hinge region, allowing for the translocation of 
the final 73 amino acids into the cytoplasm from the lumen, brining the structure in line 
with the positive-inside rule (Bogdanov et al., 2008; von Heijne, 1986). This 
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rearrangement would also consolidate the majority of Env into the traditional model, with 
an entirely cytoplasmic CTT. (Aside: The presumption at this step for the CTT-exposed 
Env discussed above must be that whatever is keeping the sequence lumenally 
(extracellularly) localized must be doing so throughout the biosynthetic process, thus 
preventing translocation of the sequence to the cytoplasm in the Golgi (also, 
incidentally, suggesting that such a factor would then have to associate with Env in the 
ER or during the trafficking process to the Golgi)). This rearrangement would result in 
almost totally cytoplasmically-localized Env (with the minor population discussed above) 
and would allow for all the observed functional interactions previously described, 
including interactions with Gag and the endocytic machinery. 
6.3 FUTURE DIRECTIONS 
I would guess that any good dissertation project, while answering the proposed 
questions will, in the advisor's best hope, generate additional questions to be answered 
by those who come after (and thus spins the science "circle of life"). In this regard, this 
project was no different. We have identified a number of interesting possibilities for the 
next generation to advance and investigate the structure of the CTT and the structural 
implications of the CTT on Env ectodomains. 
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6.3.1 Did the epitope mapping technique provide a non-native topology for the 
CTT? 
A natural hesitation regarding the use of sequence substitutions to map protein topology 
would be that the substituted sequence will likely not perfectly replicate the 
physicochemical properties or topological signals inherent to the native sequence. While 
we believe our approach was valid, and that the cell surface topology we reported is 
correct and relevant (particularly as the epitope substitutions ultimately resulted in 
infectious viral particles), it is always useful to provide verification in a manner that will 
absolutely minimize the impact of the methodology on the protein. As such, the logical 
step would be to revisit the use of single cysteine mutants to map the topology of the 
CTT. Replacement of single cysteines would be expected to have a very small impact 
on the topology of a protein, and has been used in many systems to map protein 
topology (Bogdanov et al., 2002; Bogdanov et al., 2008; Bogdanov et al., 2005; Cai et 
al., 2001; Cai et al., 1999; Klein-Seetharaman et al., 1999, 2001; Wang et al., 2002; 
Zhang et al., 2003). Most importantly, this would allow for the determination of CTT 
topology in HIV infected cells as opposed to cells overexpressing Env. While 
overexpression would not be expected to alter the thermodynamic equilibrium of the 
different topological forms, it would increase the relative size of each population and 
might make the CTT-exposed topology more easily observed than it would be in virally- 
infected cells. As such, the use of single cysteine mutants, which have been 
demonstrated to be infectious, would allow for topological determination of the CTT 
under relevant physiological conditions. The difficulty of this technique would occur in 
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preparing purified virus in sufficient quantities away from cellular microvesicles that 
would obscure interpretation of CTT cysteine labeling. 
6.3.2 Why is arginine so highly conserved in the CTT? 
In earlier sections, speculations were proposed regarding why arginine is so highly 
conserved in the LLP domains, especially relative to lysine. This is the first question to 
come out of the current research, and perhaps the easiest to address. Earlier published 
studies addressed the impact of mutating two arginine residues in LLPs 1 and 2 to 
glutamate, which is a drastic mutation, altering the amino acid from a positive to a 
negative charge (Kalia et al., 2003, 2005). The question arising from the current studies 
is "what would happen if the highly conserved arginine residues were replaced with 
lysine?" As has been discussed earlier in section 6.1.1.b, lysine rarely replaces arginine 
in the CTT, especially at the highly conserved positions in the LLP regions. The natural 
experiments, then, are to replace the highly conserved arginine residues in the LLP 
regions with lysine by site-directed mutagenesis and determine the effects on virion Env 
incorporation, Env-mediated membrane fusion, and ultimately viral infectivity. Based on 
the current understanding of the impact of the CTT on Env function and the 
speculations of why arginine is conserved we would expect that lysine replacements 
would not impact levels of Env virion incorporation, as lysine substitutions would retain 
the amphipathic nature of the LLP regions and those positions are not known to play a 
potential role in MA interactions. It is more likely that substituting lysine for arginine, at 
least in LLP2, would have an impact on Env-mediated fusogenicity in the context of cell- 
cell fusion, since even glutamate replacement had no effect on viral infectivity (Kalia et 
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al., 2003). It will also be of interest to determine the impact of arginine to lysine 
substitutions in LLP1 as mutations to glutamate in this region led to decreased Env 
incorporation, decreased Env-mediated cell-cell fusion, and decreased viral infectivity 
(Kalia et al., 2003). An additional point of interest would be to examine the impact of 
lysine substitutions on the regulation of overall Env conformation, as glutamate 
substitutions in LLP2 resulted in alterations in Env conformation and viral neutralization 
sensitivity to conformationally-dependent monoclonal antibodies (Kalia et al., 2005). If 
the regulation of Env conformation is simply a matter of membrane interaction of the 
CTT sequences, then lysine substitution would not be expected to have a large impact 
as it should maintain the amphiphilic potential and the interfacial partitioning preference 
of the LLP regions. These proposed substitutions and experiments should provide 
valuable information on the functions impacting the observed conservation of arginine in 
the CTT. 
6.3.3 Can the CTT be a target for small molecule drugs as HIV inhibitors? 
As we have demonstrated, the CTT can be a target for antibody-mediated neutralization 
by inhibiting virus-cell fusion under the proper conditions, as demonstrated in Section 
5.3 and discussed in Section 6.1.2.b. Additionally, LLP2 is transiently exposed to 
antibody binding during the cell-cell fusion process (Lu et al., 2008) while being 
membrane-associated both pre- and post-fusion (Viard et al., 2008). These findings 
make the CTT a potentially attractive target for small molecule drug development, and 
suggest that binding the exposed CTT sequences during the fusion process and 
preventing reassociation with the membrane could lead to a new class of virus 
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inhibitors. Fortunately, the CTT provides an amenable target in that it contains 
numerous highly conserved sequences and structural properties in the areas 
demonstrated to undergo transient exposure. For example, the Kennedy epitope 
contains a number of charged amino acids that are highly conserved across all clades/ 
groups, and LLP2 is structurally conserved and contains a number of arginine residues 
that are also highly conserved across all clades/groups, as demonstrated in Chapter 3. 
The logical first step would be to screen existing chemical libraries for 
compounds that bind to peptides representing the Kennedy epitope and LLP2. While 
recombinant gp41 would obviously be a better option, thus far no one has demonstrated 
a method to purify gp41 in a functional state. SPR-based screening would be a good 
method for this due to its ability to provide information on the rates and affinity of the 
interaction. Small molecules that were determined to bind to either the Kennedy epitope 
or LLP2 could then be used as a starting point to either derive similar compounds with 
different functional groups, or more likely be used to identify existing compounds with 
structural or chemical similarity for further screening. Compounds with the highest 
affinities for the Kennedy epitope/LLP2 could then be used to examine their effect on 
viral infectivity. Here an adaptation of the TZM-bl assay used currently for antibody- 
mediated neutralization would seem to make the most sense, as the readout involves 
the production of luciferase upon virus infection, leading to a quick and easy screen for 
compounds that result in decreased luciferase production. 
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6.3.4 Do CTT sequences act as immunological decoys? 
Since CTT-exposed Env is not apparently incorporated into budding virions, an idea that 
is attractive from a viral evolutionary standpoint is that it functions as an immunological 
decoy and "distracts" the immune response. As has been alluded to above, unpublished 
data from collaborators suggest that this may be the case, at least in the context of 
attempting to derive a MPER-directed immune response using DNA vaccinations. 
However, it will be important to determine the extent and level of immunogenicity of the 
CTT more thoroughly. In an effort to address this topic, DNA vaccinations of animals 
with chimeric influenza hemagglutinin (HA) ectodomain fused to HIV gp41 MSD-CTT 
sequences are currently being performed by another member of the lab. Serum from 
vaccinated animals will be tested for reactivity to HIV Env, with the expectation that any 
reactivity will by necessity be directed to the CTT, as HA and Env are not cross-
reactive. If reactivity is demonstrated to HIV Env, the serum will be further evaluated for 
standard or post-attachment neutralization to determine any functional properties. 
6.3.5 What is the measured potential for predicted transmembrane region 
insertion? 
The predicted transmembrane regions determined using the biological hydrophobicity 
scale were used, along with the predicted ΔGapp, to derive a topological model for the 
CTT that is consistent with topological mapping and functional studies. It will be of great 
importance to measure the actual ΔGapp to determine to what extent the predicted 
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regions insert into the membrane as transmembrane regions. This would be a critical 
first step towards verifying the proposed CTT topological model (c.f. Figure 38). 
6.4 CLOSING REMARKS 
In summary, we present here data demonstrating that the topology of the CTT can be 
markedly different than that of a type I membrane protein, which is the predominant 
current model for Env CTT topology. At various times in the process of trying to 
understand the data and their implications, we have often found answers in the 
principles of the physical chemistry of protein-lipid interactions. As such, the focus of the 
project slowly but steadily veered from a virological perspective to one based in 
chemical principles, particularly with regards to the interpretation of the results. I 
strongly feel that this type of perspective shift, whether through a philosophical drilling- 
down (e.g. virologist understanding and utilizing physical chemistry, or vice-versa) on 
the part of existing research groups or greater cross-discipline research and 
understanding (e.g. close and long-standing collaborations between virologists and 
chemists/physicists), will be critical to uncovering what is quickly becoming a more 
complicated world of protein topology. And if structure dictates function (axiom alert), 
then the understanding of principles surrounding protein topology and its effects on the 
biology of the protein would be of benefit to virologists, and not relegate Env to being an 
interesting model system to study protein topology. 
Finally, we believe the model proposed here provides a comprehensive 
description of the topology of the CTT that provides a theoretical explanation for the 
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observed differences in cellular and virion CTT topology and is consistent with data 
regarding functional interactions of the CTT with intracellular partners as well as 
experimentally-determined topology data. It will be with great interest that I continue to 
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